Rheumnow Podcast: Recent Episodes
Dr. Cush
Dr. Christina Charles-Schoeman and Dr. Manish Jain are back to discuss treatment considerations after TNFi failure in RA. Join them as they review the latest data from SELECT-SWITCH, including post hoc results in primary and secondary nonresponders presented at EULAR 2026. Learn how those findings impact their clinical decision-making. Sponsored by AbbVie Medical Affairs + Health Impact
Dr. Jack Cush Obesity & Gout
Dr. Tony Merriman Genome-Wide Association Studies in Gout
Dr. Lisa Stamp Gout Management in Patients with Chronic Kidney Disease
Dr. Mark Fisher Gout & Mortality
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com
Dr. Sheila Reyes: QD Clinic: The Highs and Lows of a Woman with Gout
Dr. Jack Cush QD319 A Watched Tophus Never Resolves
Dr. Eric Dein QD316: Addressing Severe Gout Flares
Dr. Janet Pope QD Clinic: RA Mimics — Two Cases That Turned Out to Be Gout
The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, CTD skin disorders. dermatology drugs, biologics, andJAK inhibitors - their use, efficacy and side effects.
Features Dr. Jack Cush, Editor at RheumNow.com.
Show Notes:
- 20 yr. Tx trends in 6583 #SSc pts. 2005 to 2025 endothelin receptor antagonists & prostanoids/prostacyclins from 3% to 28%. CCB & PDE-5 inh stable. CTX shifted to mycophenolate, RTX, & nintedanib. Steriods decr from 50% to 18% https://t.co/nrm1Ov285f https://t.co/ftLn3bGH72
Systemic sclerosis metanalysis of 31 studies (32,134 pts) shows malignancy risk signif increased (SIR 1.66; CI 1.32 - 2.08). Highest: esophageal, liver, cervical, lung, & Heme (SIR 3.35 - 13.95). 7.4 yr mean from SSc to CA dx. https://t.co/IhxvfkMqkf
RZV (Shingrix) response in 76 immunosuppressed SSc & 304 controls (CG) recv two RZV doses. High seroconversion seen in SSc but signif lower than CG (92.6% vs 99.7%, P 0.001), w/ lower concentration but comparable CMI, lower AE (74% vs 86%) https://t.co/ALlnVEZIAt https://t.co/kYYy2JIo2J
Raynauds: Using the Clinical Practice Research Datalink Aurum (PCP) database (1998 - 2023) the prevalence of Raynaud’s 894/100 000, or 158449 cases in 2023. More in elderly & females, less in blacks. Incidence rate 46/100K https://buff.ly/TLjMy21
Guidelines to Spot Cancer in High Risk Dermatomyositis
Psoriatic Arthritis: EULAR 2026
New, Advanced Therapies in Gout explores the rapidly evolving therapeutic landscape beyond conventional urate-lowering therapy. Join our expert panel as they discuss emerging approaches—including cytokine inhibition, uricase therapies, NLRP3 and URAT-1 inhibitors, and the potential role of GLP-1 receptor agonists and SGLT2 inhibitors—while addressing which patients are most likely to benefit, how these agents fit into current treatment algorithms, and whether novel mechanisms of action have the potential to transform gout management. Panelists: Dr. Herbert Baraf Dr. Ken Saag Dr. Naomi Schlesinger Dr. Jack Cush (moderator)
Dr. Robert Terkeltaub 3 New Things it Pays to Know About Gout Pathobiology
Dr. Nicola Dalbeth Outcomes of Tophaceous Gout
Dr. Ted Mikuls Subclinical Inflammation in Intercritical Gout
Dr. Michael Pillinger Gout and Cardiovascular Disease: What's the Risk? What's the Connection?
Dr. John Fitzgerald Gout & Metabolic syndrome
Dr. Karon Jatuworpruk Predicting and managing gout flares in hospitalised patients
Dr. Richard Conway Bespoke Telehealth in Gout: A Missed Opportunity
Dr. Robert Terkeltaub Four things you need to know about allopurinol hypersensitivity syndrome
Dr. Angelo Gaffo Challenges in Gout Diagnosis
Dr. Janet Pope Tips for safe use of allopurinol in patients with gout
Dr Janet Pope: QD Clinic: Can RA and Gout Manifest Simultaneously?
Dr. Mrinalini Dey QD312: Gout, Sepsis… or Both?
Daric Mueller, PA-C QD315: Pegloticase Immunomodulation: What’s on the Menu?
Dr. Richard Conway: QD313: Don't Presume on IL-1 in Gout
Maximizing the Classics (Colchicine, Allopurinol, etc.) examines how to optimize the use of time-tested gout therapies in today's increasingly complex patients. Through practical case discussions, our expert faculty will address colchicine safety and dosing in chronic kidney disease, selecting first-line therapy for acute flares, initiating and titrating urate-lowering therapy, improving treatment adherence, and navigating challenging scenarios such as gout management in patients with CKD and cardiovascular disease.Panelist:Dr. Angelo Gaffo Dr. Lisa Stamp (Lisa.stamp@otago.ac.nz)Dr. Michael Pillinger Dr. Ted Mikuls Moderator:Dr. Jack Cush
Dr. Jack Cush reviews the news, journal articles and Gout features from this past week on RheumNow.com
This webinar explores the evolving role of imaging in the diagnosis and management of gout. Our expert panel will discuss when and how to use ultrasound, dual-energy CT (DECT), crystal identification, and conventional radiography, while addressing practical questions such as the role of imaging in diagnostic uncertainty, serial disease monitoring, and whether ultrasound is changing the need for synovial fluid analysis in everyday practice. Panelists: Dr. Nicola Dalbeth Dr. John Fitzgerald Dr. Sarah Tedeschi Dr. Jack Cush (moderator)
QD307: Senior Year Gout https://youtu.be/_TGgcdQsficQD308: Allopurinol for All Gout? Not Quite https://youtu.be/JAwUb-hqeFsQD309: Cellulitis Paradoxes https://youtu.be/j3feySk5wQoQD310: Gout: Is it the Journey or the Destination? https://youtu.be/1J-ZrbaGsD8QD311: When There's Doubt in Gout https://youtu.be/DpAevfq7Oo0
Dr. Jack Cush reviews the news, journal articles and regulatory decisions from the past week. July is Gout: More than Flares month. Visit https://rheumnow.com/campaign/gout-campaign-july-2026 for all of our coverage throughout July.
(Wang et al., JAMA Internal Medicine, 2025). Together, these studies provide new evidence supporting treat-to-target urate-lowering strategies and their potential impact on cardiovascular and renal outcomes. Panelists: Abhishek Abhishek, MD, PhD, MBBS, FRCP Zeqin Wen, MD Jie Wei, PhD Jack Cush, MD (moderator) Beyond reviewing the evidence, our expert panel will tackle the practical questions rheumatologists face every day.
In August, Dr. Christina Charles-Schoeman and Dr. Manish Jain will return with a new episode exploring the latest clinical data on RA treatment after TNFi failure. Before that episode drops, revisit their 2025 conversation on disease control, real-world data, and guidelines that inform clinical decision-making after TNFi failure. Sponsored by AbbVie Medical Affairs + Health Impact.
Dr. Jack Cush lectures on giving a great presentation; based on 40 years of lecturing in Rheumatology.
Dr. Jack Cush reviews the news and journal articles from RheumNow.com. Updates on tofacitinib, CAR-T therapy and AI.
Arthur Kavanaugh, two of rheumatology’s most trusted voices, provide a breakdown of the latest breakthroughs and hottest topics in rheumatology from the EULAR 2026 meeting in London.
Join Drs. Bella Mehta, Jack Cush, Janet Pope, and Jon Kay for a focused conversation on the latest in rheumatoid arthritis care from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what’s shaping RA practice right now.
Join Drs. Jack Cush, Alfred Kim, Janet Pope, and Yuz Yusof for a focused conversation on the latest in CAR-T from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what's shaping CAR-T practice right now.
Join Drs. Jack Cush, Peter Nash, Antoni Chan, and Nelly Ziade for an expert discussion on the most important psoriatic arthritis developments emerging from EULAR 2026.This focused conversation explores new clinical data, evolving treatment strategies, and practical approaches to managing PsA in everyday practice. From advances in biologic and targeted therapies to ongoing challenges in diagnosis, disease monitoring, and patient care, the panel shares key insights and take-home messages that every rheumatology clinician should know.Tune in for expert perspectives, clinical pearls, and a comprehensive look at what's shaping the future of psoriatic arthritis management.
2026 EULAR PreviewBeyond BMI: Altered Body Composition in Rheumatoid ArthritisCAR-T For Rheumatoid ArthritisThis Is a Woman’s World: Women's Health in Rheumatic DiseaseLow dose Blinatumomab: Many Relapse with an Unexpected SurpriseDoctor's Orders or Patient's Choice: BACH study findingsAnother Way to Leverage NK Cells to Kill B Cells, This Time Without CARsDigital Patient Education in RAMaking Methotrexate More EffectiveAre we failing in the treatment of RA-ILD?Using AI to Predict Progression to RATreat to Target Works in Elderly Onset RARA BRIDGE and RA BRANCH trials: Baricitinib and VTE RiskImproving Referrals for Inflammatory ArthritisCombination Therapy: Off the Shelf Allogenic NK and Rituximab in Rheumatic Disease
Head-to-Head DataTransition from Psoriasis to Psoriatic ArthritisMACE and Safety Profile of bDMARDs/JAKis in axSpA and PsAGuselkumab Delivers Across the PsA Disease Spectrum: APEX Trial
2026 EULAR PreviewCAR-T For Rheumatoid ArthritisWhat Happens when CAR-T Fails Managing Disease RecurrenceManagement of Relapses After CAR-T Therapy in SLE, SSc and IIMHow Many CAR-Ts Do We Need to Test Drive?
Are we failing in the treatment of RA-ILD?Using AI to Predict Progression to RATreat to Target Works in Elderly Onset RA
MACE and Safety Profile of bDMARDs/JAKis in axSpA and PsAHow Many CAR-Ts Do We Need to Test Drive?Making Methotrexate More Effective
Join Drs. Jack Cush, Mrinalini Dey, Antoni Chan, and Yuz Yusof for a lively discussion of the top presentations, breakthrough science, and clinical pearls from Day 4 of the EULAR 2026 Congress. Abstracts discussed included:LB001LB002LB003LB005LB007LB009RA PlenaryPOS1350
Join Drs. Jack Cush, Jiha Lee, Nelly Ziade, and Sheila Reyes for a lively discussion of the top presentations, breakthrough science, and clinical pearls from Days 3 of the EULAR 2026 Congress. Abstracts discussed included:OP0348 POS0290 OP0342 POS1068 POS0201 POS0288
BE BOLD: Going Where No PsA Trial Has Gone BeforeBMI Outranks Treatment in PsA Outcomes?What Happens when CAR-T Fails Managing Disease RecurrenceManagement of Relapses After CAR-T Therapy in SLE, SSc and IIMDoctor's Orders or Patient's Choice: BACH study findingsAnother Way to Leverage NK Cells to Kill B Cells, This Time Without CARs
Low dose Blinatumomab: Many Relapse with an Unexpected SurpriseCan We Stop PsA Before it Starts?Impact of Synovial Biopsy-Driven Therapeutic Stratification in PsA
2 of the EULAR 2026 Congress. Abstracts discussed included:OP0177OP0244 OP001OP008OP0205 OP018OP0204POS0788
Imaging in Subclinical Psoriatic ArthritisCAR-T For Rheumatoid ArthritisThis Is a Woman’s World: Women's Health in Rheumatic DiseaseDietary Interventions in PsA
2026 EULAR Preview - Dr. Jack Cush‘Strong’ Treatment Predictions in Inflammatory Myositis - Dr. Janet PopeBeyond BMI: Altered Body Composition in Rheumatoid Arthritis - Dr Mrinalini DeyWhy PROMS Matter in the Care of People with Lupus - Dr. Mrinalini Dey
Dr. Jack Cush talks of birthdays, Quizes and journal articles this week on the podcast.
Dr. Jack Cush discusses his favorite journal articles from the past week on RheumNow.com.
Dr. Jack Cush lectures on giving a great presentation; based on 40 years of lecturing in Rheumatology.
apremilast in 1700 plaque psoriasis pts https://t.co/DPlzDw5m7N8. Among 1074 #PsA tested annually, RF positivity was found in 16.1% overall (5.1% RF+ at baseline). RF+ rediced odds of MDA (OR 0.53) w/ incr risk of bDMARD discontinuation (OR 2.65) https://buff.ly/BsM7NKQ9. The National Psoriasis Foundation Primer on GLP-1 Receptor Agonists in Psoriasis - Review10. Ixekizumab With Tirzepatide Efficacy in Obese Psoriatic Arthritis11. Brepocitinib in Dermatomyositis
Dr. Jack Cush follows the money and all the news that fits the Rheumatology Gab for this past week.
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.
Dr. Jack Cush reviews the news and journal reports from RheumNow.com this week - including his top four favorite subjects.
Dr. Jack Cush reviews the news and major articles from this week, including FDA safety warnings, reports from AAD, PsA trials.
Dr. Schwartzman and Dr. Ruderman discuss the importance of a domain-based approach in PsA management and consider the potential role of a JAK inhibitor. Sponsored by AbbVie Medical Affairs + Health Impact. https://buff.ly/9gUnxB7
MSK (49%) dz. At 6 months, 26% achieved remission, 66% reached LLDAS, and 57% achieved LLDAS5. Authors claim rapid onset of action https://t.co/16OQatOcPj https://t.co/mU9aciCNcH10. Update on FDA complete response letter to AZ regarding BLA hold for anifrolumab (Saphnelo) for SC use in SLE. CRL originally issued 10/10/25, but announced 2/3/26. FDA CRL cites critical data quality w/ key analyses in SC-TULIP study. A BLA decision expected in 1st half of 2026 https://t.co/zuwtsdL6I911. NEJM: Obinutuzumab in Active Systemic Lupus Erythematosus https://rheumnow.com/news/nejm-obinutuzumab-active-systemic-lupus-erythematosus
Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past week on RheumNow.com
STEP: Obesity and Inflammation: Weight management in Rheumatology. Dr. Uzma Haque STEP: Mitigating Risk for Rheumatic Disease Patients Undergoing Orthopedic Surgery. Dr. Susan Goodman
STEP: Disease Modification in OA - Dr. Tuhina NeogiSTEP: History of Gout - Dr. Robert Terkeltaub
Mortality in Rheumatoid Arthritis: A Story of Decline, Delay, or Plateau? Dr. Elena Myasoedova
current smokers (1.27) https://t.co/1REWmod73WTogether PSO Trial - Combination Ixekizumab and Tirzepatide Today Lilly announced top line results of the TOGETHER-PsO open-label, Phase 3b trial demonstrating the significant benefits of concomitant ixekizumab (IXE: an IL-17A inhibitor) and tirzepatide (TIR: GLP-1agonist) over https://t.co/YWCjN2NyGM
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. Highlights include referral rules, combination biiologics in psoriasis and don't use JAK inhibitors in pregnancy.
Obesity Management in Rheumatology - Uzma Haque, MDMitigating risk for Rheum patients undergoing orthopedic surgery - Susan Goodman, MDParadoxical skin reactions – Dr. Joseph MerolaMortality in RA - Elena Myasoedova, MDThe Mucosal Hypothesis to RA - Kristin Demourelle, MDAdvances in ILD - Jeffrey Sparks, MDSeronegative vs. Seropositive RA - Jack Cush, MD
Dr. Jack Cush reviews the news, journal articles and regulatory news from this past week on RheumNow.com
trial, showing that the combination use of ixekizumab (Taltz) and tirzepatide (Zepbound) was superior to IXE alone, yielding both significant https://t.co/8fOXWULH7w
downloads3. Saturday concert with Colin Boyd 4. Rohit Agarwal does TWO STEP talks!5. Download 400+ rheumatology review QuestionsREGISTER at - RheumNow.live
Dr. Jack Cush reviews rheumatology's highlights, advances and noteworthy trends from the past year - 2025!
This podcast is part one of the Mission: APP Partners in Care Therapeutic Update Series called Underserved and under-treated. This podcast includes videos from: Daric Mueller, PA-C, Rachel Busch-Feuer, DNP, Betsy Kirchner, DNP, Lindsay Tom, PA-C and Vanessa Hill, NP-C
Dr. Jack Cush reviews the news, announcements and journal articles from this past week on RheumNow.com. More on Variable bendability, a better way to treat RA, and a novel advance for GLP1a in PsA; and 2026 Resolutions!
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. Who would've thunk - a PsA FMF connection? Labs to diagnose SSc-ILD? IgA-RF may be important or RZV may not work in JAK inhibitor treated patients?
Join us for our third webinar this month, discussing APP Controversies and Misconceptions. Panelists will cover a range of topics, including APP roles impact; models of care; independence; seeing new patients and complex cases; and more.Panelists:Daric A. Mueller, PA-CLisa Carnago, MSN, FNP-C, RNJack Cush, MD
A with the panelists. Register now to reserve your spot! This is our second Tuesday Night Rheumatology this month as part of our Mission: APP Partners in Care campaign
QD300: Flare or Beware (featuring Lindsay Tom, PA-C and Phong Nguyen, MD)QD301: CAR-T Cell Therapy for Lupus (featuring Philip Mease, MD and Cayla Alexander, DNP)QD302: Unweanable PMR (featuring Jack Cush, MD, and Leilani Law, APN)QD303: Weakness with Fibromyalgia (featuring Jack Cush, MD, and Leilani Law, APN)
Dr. Jack Cush reviews the news and journal reports from RheumNow.com, including info on scleroderma, dermatomyositis and malignancy, rheumatologist and APP salaries concerns.
Watch our kickoff webinar for this month's Mission: APP — Partners in Care campaign. Our panel of rheumatologists and experienced advanced practice providers share insights into hiring, onboarding, training, compensation, and more.Panelists:Philip Mease, MDCayla Alexander, DNP, ARNPKori Dewing, DNP, ANP-BC, ARNPJack Cush, MD, Moderator
Dr. Jack Cush reviews the news and reports from this past week on RheumNow.com, including reports on FDA resurrections, FM seasonal worsening, and do you fight switch or swap biologics in PsA TNFi nonresponders?
GU infxnhttps://t.co/2qa7O2v6fm5. No risk of MACE seen w/ initiation of IL-17(R)A inhib. French study of 34 241 ipts Rx IL-17(R)Ai and 381 MACEs. MACE risk was not elevated (OR, 1.25 [95% CI, 0.75-2.08] vs TNF-α inhibitors. https://t.co/WcjgRhr8mj6. Genetic Risks and Severe Cutaneous Reactions to Allopurinol A matched cohort study shows that HLA-B58:01 and HLA-A34:02 are strongly associated with allopurinol-induced severe cutaneous adverse reactions (SCARs), these alleles were absent in more than one-third of those https://t.co/NLpHVhr9Ww7. Western Australia study of 1854 SLE pts (median 40 yrs old). Interstitial lung disease was seen in in 3.8% of SLE, 26 fold more than controls. Risk factors for ILD included older age, smoking and serositis. SLE-ILD pts had higher mortality rates (MR 52.0, CI 37.0–71.1).8. 25-Hydroxyvitamin D levels and Lupus Outcomes Lupus patients entering a prospective cohort study with low vitamin D levels faced doubled all-cause mortality risk and tripled risk for major cardiovascular events during follow-up averaging 6 years, researchers said. https://t.co/CYwVy7ls7y9. ACR2025 Non-Renal Lupus Guidelines – from ACR Convergence 202510. 900,000 vs 9 It takes about 900,000 minutes to become a board-certified dermatologist. At that point, you might be very skilled and well-informed. It takes less than nine minutes to make your patient feel seen, understood and reassured. If you skip the 9 minutes, you wasted the 900,000 https://t.co/o7BaWjS4HB
Replay of RheumNow Live 2025 - VasculitisFeaturing: - Dr. Michael Wechsler: Management of EGPA in 2025- Dr. Rennie Rhee: Imaging in Vasculitis- Dr. Richard Conway: Modern Treatment of PMR
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.Check out: RNL 2026 – Feb 7 8 2026 DFWRheumNow.live
Replay of RheumNow Live 2025 - SpondyloarthritisSponsored by AbbVieFeaturing: Dr. Desiree van der Heidje - Advances in Treatment of Spondyloarthritis Dr. Jennifer Cather - Progress in Hidradenitis SupprativaDr. Catherine Bakewell - Imaging Evaluation of Spondyloarthritis
Dr. Jack Cush reviews the journal articles, news and guidelines from this past week on RheumNow.com
Replay of RheumNow Live 2025 - Psoriatic ArthritisSponsored by AbbVieFeaturing: Dr. Alexis Ogdie - Can Aggressive Treatment of Psoriasis Prevent PsA?Dr. Artie Kavanaugh - Combination Biologic Therapies in PsADr. Kenneth Gordon - Head-to-head Studies in Psoriatic Disease – What have we learned?
Featuring: Dr. Jeffrey Curtis: AI applied to Rheumatoid Arthritis Care: Practically (Not) Perfect Dr. Una Makris: Key Considerations When Managing Older Adults with RADr. Bryant England: Who will manage multimorbidity in RA
A JAKi in GCA- Phase 3 Results Through 2 YearsSponsored by AbbVie Medical Affairs + Health Impact
A focused discussion on updates in spondyloarthritis, including emerging data, treatment strategies, and real-world care considerations. Hear expert perspectives and practical takeaways shaping SpA management today.
A focused conversation on the latest in CAR-T from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what’s shaping CAR-T practice right now.
A focused conversation on the latest in psoriatic arthritis care — from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what’s shaping PsA practice right now.
A focused conversation on the latest in psoriatic arthritis care - from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what's shaping PsA practice right now.
Stay plugged into the conversations, discoveries, and breakthroughs moving rheumatology forward. Real updates. Real context. For clinicians who never stop learning.
Dr. Jack Cush recaps ACR2025 with suggestions on how to best learn ACR25 content from RheumNow.com and our Videos and podcasts.
https://www.youtube.com/watch?v=kIEN39XRsSMWhy do patients stay in clinical trials?https://www.youtube.com/watch?v=pVIBoN0jO2oWhat to do after first TNR failure in axSpA?https://www.youtube.com/watch?v=PVSyq_Y5-PE
From Pain to Wellness in PsASecukinumab vs Ustekinumab in PsAIzokibep: still enthused about enthesitis?Using Digital Apps to Modify Pain in axSpA
Secukinumab vs Ustekinumab in PsARA ILD Prediction: simple as a dipstick?Sjogren's Disease: PROs as a Filter for Precision MedicineWhy do patients stay in clinical trials?Using Digital Apps to Modify Pain in axSpAIgG4: Rare but Treatable!
Join panelists Drs. Brian Jaros, Akhil Sood and Michael Putman as they recap highlights from Day 4, the final day of the 2025 ACR Convergence meeting in Chicago.
Join RheumNow Faculty Drs. Shelia Reyes, Mike Putman, Bella Mehta, and Jack Cush as they discuss highlights and key takeaways from the Day 3 Recap, at the 2025 ACR Convergence meeting in Chicago.
Screen RA ILD ProperlyRheumatoid Arthritis HighlightsPredicting Rheumatoid ArthritisGDF-15: How Depression is Related to Lung Disease in RA
Another Specialized Biomarker in PsASecrets and Pearls in RheumatologyWhat's the latest in PsA?
GDF-15: How Depression is Related to Lung Disease in RAWhat Can we do About Chronic Pain?What's the latest in PsA?What to do after first TNR failure in axSpA?
Secrets and Pearls in RheumatologyAddressing Lupus Nephritis TimelyFake Rheum Diagnostic DilemmasRheumatoid Arthritis HighlightsRestoring B Cell Compartments with CAR T: Molecular Data is HerePredicting Rheumatoid ArthritishWhat Causes Infection in Vasculitis?Is it All About the Weight Loss?Izokibep: still enthused about enthesitis?T Cell Engagers: Are we engaged?Fiber and Methotrexate
NeuroImmune Modulation in RA: Results of the RESET RA TrialChange it or Keep it? TNF in Axial SpAPerspectives on CAR T TherapyAddressing Lupus Nephritis EarlyAddressing Lupus Nephritis AggressivelyCAR-T: The FutureBiomarker Discovery in axSpAAnother Specialized Biomarker in PsARevised Classification Criteria in axSpA
Off the Shelf: CAR-TCombining CAR-T with CAR-Treg All in OneCAR-T Therapy: Where is it Heading?Safety of CAR-TNew Paradigms in RA TreatmentPerspectives on CAR T Therapy
Wired for Success: Vagal Nerve Therapy in RARA: Does upfront TNFi save heartache?New Paradigms in RA Treatment
Cellular Biomarkers of Rheumatoid ArthritisDay 2 Recap: ACR Convergence 2025 Highlights
Serologic PredictorsRheumatoid Arthritis: Inject the SteroidsIs Low Disease Activity Low Enough?
PsA and Brain FogGLP-1 Receptor Agonists in PsA: Mortality and MACEPsA PredictorsWhen the Back Hurts: uncovering BASDAI drivers in PsAThe Upper Hand in PsA? Not the Dominant One
Diagnostic Delays in PsA: A Radiographic PerspectiveLate-Breaking Trials in axSpA and PsANew Approaches to Therapy in PsA
Psoriatic Arthritis ImagingSpecialized Biomarkers in PsAPsA: Impact of SexGLP-1 and SGLT-2: Treatments Too Good to Ignore?
NSAID Addition Helps the Spine but not the HipsDurability and Safety of BimekizumabProgressive BiTE in SLE 2Hydroxychloroquine Reduces Autoantibody LevelsWhen the Back Hurts: uncovering BASDAI drivers in PsAThe Upper Hand in PsA? Not the Dominant OneAirway Disease in GPAWired for Success: Vagal Nerve Therapy in RAGLP-1 in Knee OsteoarthritisDisparities in Physical Function in SLE
Putting Steroid Tapering into Practice in SLETocilizumab Beats Methotrexate in GCAGLP-1 Receptor Agonists in PsA: Mortality and MACESafety of CAR-TILD in Patients with Connective Tissue DiseaseSLGT-2 and GLP-1 in RA: More than Weight LossPsA PredictorsIanalumab: Breakthrough Therapy in Sjogren's
Off the Shelf: CAR-TCombining CAR-T with CAR-Treg All in OneTapering in SELECT GCA: Steroids are the ProblemDiagnostic Delays in PsA: A Radiographic PerspectiveLate-Breaking Trials in axSpA and PsANew Approaches to Therapy in PsAPRED-SAFE: Chronic Prednisone UsePsA and Brain FogCAR-T Therapy: Where is it Heading?
Join RheumNow Faculty Drs. David Liew, Antoni Chan, Mrinalini Dey, and Jack Cush as they discuss highlights and key takeaways from the Day 2 Recap on Monday, October 27th, at the 2025 ACR Convergence meeting in Chicago.
an Infection?Upadacitinib is a Double Edged Vascular Sword in GCARheumatoid Arthritis: Inject the SteroidsCatching AxSpA Early: Closing the Diagnostic GapIs Low Disease Activity Low Enough?Early Peripheral SpA: Is it okay to stop treatment sometimes?Difficult to Manage axSpA
Serologic PredictorsIs AI Smarter than a Doctor?Lung Disease in ANCA-associated Vasculitis Older Adults Underrepresented in RCTs Next Generation T-Cell Engager: The FutureLupus in Focus: 2025 ACR Treatment Guidelines for SLE Psoriatic Arthritis Imaging
Big takeaways, standout moments, and what set the tone for this year’s conference. We break down the key insights, early trends, and conversations shaping Day 1.
enthesitis ever (OR 2) https://t.co/wqtSbeQ2vz6. Mediterranean Diet Efficacy in Psoriasis 7. Gender Complexities in Psoriatic Arthritis Treatment Outcomes
Dr. Jack Cush reviews the news and journal reports, discusses pediatric reports, pregnancy data, diet and nutrition and more.
Dr. Jack Cush reviews the news, journal reports and important associations in rheumatology from the past week on RheumNow.com.
Our final webinar in this month's Rheum to Breathe: ILD campaign brings together ILD experts to discuss best practices in diagnosis, screening, and monitoring, covering: tools, labs, and imaging; timing and frequency of screening; ILD screening in RA; and, referral strategies.
Panelists:
Shane Shapera, MD
Elana Bernstein, MD
Bryant England, MD
Moderator: Jack Cush, MD
Experts Dr. Jeffrey Curtis and Dr. Kevin Winthrop discuss best practices for shared decision-making, how to talk with patients about the risks of poorly controlled RA, and ways to use a new tool for visualizing the long-term safety of a JAKi.
QD clinics on ILD - lessons from the Clinic; brought to during the "Rheum to Breathe" ILD campaign
ILD QD Clinic #4
ILD QD Clinics - Worsening Breathlessness in SSc ILD: The Pressure Is On
ILD QD clinics on ILD #1 - Be Careful What you Look For
Rheum to Breathe Rx Update ILD Treatment and Guidelines Part 4: Rheum + Pulm Collaborations in ILD including The Rheumatologist and Pulmonologist: Different approaches to the same patient (Dr. Paul Dellaripa and Dr Rachel Putman).
Rheum to Breathe Rx Update ILD Treatment and Guidelines Part 3: ILD Assessment and Management including: Biomarkers in ILD (Dr. Elena Joerns), How to Assess ILD in Patients (Dr. Janet Pope) and Management of SSc ILD (Dr. Alicia Hinze)
Rheum to Breathe Rx Update ILD Treatment and Guidelines Part 2: ILD Treatment including: RA-ILD Treatment Update (Dr. Bryant England), Do DMARDS Affect CTD-ILD Outcomes? (Dr. Elizabeth Volkmann), Non-pharmacologic Treatment of ILD (Dr. Jon Giles) and Transplantation: A real option! (Dr. John Joerns)
Rheum to Breathe Rx Update ILD Treatment and Guidelines Part 1: ILD Guidelines including: ACR/CHEST Guidelines for SSc ILD (Dr. Sindhu Johnson), ERS/EULAR Clinical Practice Guidelines (Dr. Anna-Maria Hoffman-Vold) and ILD Guideline Caveats and Concerns (Dr. Jeffrey Sparks).
Dr. Jack Cush reviews the news and journal articles from RheumNow.com. Pool therapy, Fibrosis, NSIE's and whats best for knee OA.
QD clinics on ILD - lessons from the Clinic; brought to during the "Rheum to Breathe" ILD campaign
ILD QD Clinic #3
ILD QD Clinic: Application of the ACR CHEST Guidelines to Two Cases
ILD QD Clinic: Progressive RA-ILD Management
ILD QD Clinic: Beyond the Numbers in Newly Diagnosed ILD
In this journal club, we will discuss two pivotal studies in ILD, the FIBRONEER study and the RECITAL study:
Nerandomilast in Patients with Progressive Pulmonary Fibrosis, Maher, T.M. et al. NEJM. 2025 May 19. doi: 10.1056
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial, Maher T.M., et al. Lancet 2023 Jan;11(1). doi: 10.1016
Panelists:
Toby Maher, MD
Shervin Assassi, MD
Jack Cush, Moderator
Content curated for dermatologists and skin deep HCPs – on Psoriasis, CLE, vasculitis, HS and dermatology drugs use, efficacy and side effects and more.
Features Dr. Jack Cush, Editor at RheumNow.com.
SHOW NOTES:
1. SMILE Study: A randomized, placebo-controlled trial of hydroxychloroquine in incomplete lupus https://t.co/NnrA8ohiGX
2. Equal Safety of JAK Inhibitors and TNF Inhibitors in H2H IMID trials JAMA systematic review. https://t.co/HI1KBKZiXR
3. SMART study - Single vs. Split Dose Methotrexate https://t.co/lizsrtVHwf
4. Vegan diets don’t work in RA - Metanalysis of 7 studies https://t.co/jeh6gN5Byg
5. No association between IL-17 inhibitors & MACEs (vs TNFi Rx) https://t.co/fJuPFYKnSr https://t.co/Vscnsq0DTA
6. Successful Phase 3 UP-AA Trial evaluating Upadacitinib in Alopecia Areata (AA) https://t.co/8p1FvJx0s0
7. Anifrolumab effective & safe in refractory Cutaneous LE - OL Study in 15 CLE https://t.co/umEYz0XDyt
8. "Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it's the only thing that ever has." - Margaret Mead https://t.co/OFGN223bPa
Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com. Today we cover GLP-1 agonists, acupuncture, what JAKs wont do & an FDA Pink Slip.
This deep dive into controversies in interstitial lung disease explored complex topics including IPAF, methotrexate, systemic autoimmune rheumatic disease vs. connective tissue disease distinctions, and the evolving role of anti-fibrotic therapy.
Panelists: Jeffrey Sparks, MD, Janet Pope, MD, Elena Joerns, MD
Jack Cush, MD - Moderator
Dr. Peter Nash, Australia, reports highlights from a range of sessions presented at the APLAR 2025 Congress in Fukuoka, Japan.
Hot Topics in AxSpA
Precision Medicine in PsA
PSA Therapeutic Update
CAR T Therapy with Immunomediated Diseases
Imaging Use of Micro CT Low Radiation for PsA
"QD clinics on ILD - lessons from the Clinic; brought to during the "Rheum to Breathe" ILD campaign.
Here are the individual video titles and links:
ILD QD Clinic: Stick or twist (when not to change treatment) https://youtu.be/sdGPsvcfyzQ
ILD QD Clinic: Interstitial Lung Disease with Positive SSA and Rash https://youtu.be/1H10_VR8t_0
ILD QD Clinic Video: RA and Bronchiectasis https://youtu.be/-StSi3v8ew8
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Are their benefits to Diet/vegan diets? Whats the effect of menopause on CTD? Ro52 makes a big entrance with all our ILD coverage this month.
Rheum to Breathe “ILD and Autoimmune Disease”:
RA ILD Complications (Scott Matson): https://youtu.be/xTLvKLwlF-E
ILD and Mortality (Bryant England): https://youtu.be/Ew9OW2o43Bg
ILD in Sjorgen's (Nancy Cateron):https://youtu.be/BLVF2qvoR7E
Truth of Fake: Idiopathic Interstitial Pneumonia with Autoimmune Features (Janet Pope): https://youtu.be/4Jk7nVeLIR8
This webinar will review the ACR and EULAR guidelines on interstitial lung disease, with a focus on ‘where are we now and where are we going?’ in regards to treatment strategies and emerging therapies in ILD care.
Panelists: Sindhu Johnson, MD Shane Shapera, MD Scott Matson, MD Jack Cush, MD - Moderator
https://youtube.com/live/Viexwyv0sxs?feature=share
"QD clinics on ILD #1 - lessons from the Clinic; brought to during the "Rheum to Breathe" ILD campaign
Dr. Jack Cush reviews the news and journal reports from RheumNow. This week - unemployment, diagnosing Sjogrens and alot of ILD.
Join panelists as they discuss rheumatologist impressions, knowledge and practices over the last 20 years when treating rheumatoid arthritis. Experts will unpack the results of a nationwide, three-part survey — covering treatment milestones, changing practices, and what the future holds for RA therapy. Don't miss this opportunity to hear what your peers are saying — and where the field is headed.
Panelists:
Katherine Liao, MD, MPH
Stanley B. Cohen, MD
Jeff Curtis, MD, MS, MPH
Jack Cush, MD - moderator
Sponsored by: Bristol Myers Squibb
Dr. Jack Cush reviews the news and journal reports from RheumNow.com. This week news on vaccines, safety of acetaminophen and more.
Content curated for dermatologists and skin deep HCPs – on Psoriasis, CLE, vasculitis, HS and dermatology drugs use, efficacy and side effects and more. Features Dr. Jack Cush, Editor at RheumNow.com.
Dr. Jack Cush reviews the news, journal reports and press clippings from the past week on RheumNow. Positive results in a Sjogrens trial, to PT or not to PT, and aphorisms to live by.
Dr. Jack Cush reviews the news, reports, pipeline and drug repurposing on this weeks podcast.
Rheumatologists Dr Anca Askanase and Dr Cristina Arriens discuss their clinical perspectives on how to target and achieve DORIS remission in clinical practice.
Sponsored by AstraZeneca Medical Affairs
Dr. Jack Cush reviews the news, journal reports and a new treatment for RA from the FDA.
Dr. Jack Cush reviews the news, journal and FDA updates from this past week on RheumNow.com
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com
Interesting case questions from "Ask Cush Anything"
Dr. Jack Cush reviews the news and journal reports from this past week - some obvious, other new thoughts and some - hmmm, reallly?
Join rheumatology experts Dr. John J. Cush and Dr. Arthur Kavanaugh for the EULAR Rheumatology RoundUp — a dynamic, fast-paced discussion capturing the most impactful highlights, late-breaking data, and clinical takeaways from EULAR 2025.
Trends and Innovations from Barcelona (6.20.2025)
AI Advances axSpA Diagnosis with Multimodal MRI
IL-17 Inhibitors in Psoriatic Arthritis
IL-17 Inhibitors for Axial Spondyloarthritis
New IL-17 Inhibition New Molecular Constructs
Resilience or Resignation? Rethinking Pain, Aging, and Quality of Life
Spondyloarthritis Panel: Eular 2025
Leading rheumatology experts discuss the latest research, treatment advances, and clinical insights in axial spondyloarthritis. Hear what’s new from EULAR 2025 and what it means for improving patient outcomes.
Digital Behavioural Therapy for Persistent Pain in Axial Spondyloarthritis
There's an App for That (and it works): the AXIA RCT
Eular 2025 PsA Topic Panel
Assessment of Peripheral Arthritis in Spondyloarthritis
IL-17 inhibitors - Novel Drugs
IL17 inhibitors - Long-term Extensions and Uveitis
IL17 inhibitors - STAMP T2T and Combinations
Using AI for Reading PET/CT in Rheumatoid Arthritis
Leading experts in rheumatology dive into the latest advances, treatment strategies, and emerging research in rheumatoid arthritis. Don’t miss this in-depth panel as they unpack key findings from EULAR 2025 and discuss what’s next for RA care.
Efficacy and Safety of Xeligekimab in AS
Sonelokimab in PsA
Seronegative Arthritis Breakthroughs
Novel Therapies in Axial Spondyloarthritis
JAK Inhibitors: The Latest from the JAK-pot Study
Does Abatacept Buy You Time Off RA?
How to Properly Use Steroids in Early RA: Oral vs Parenteral
All Rheumatoid Arthritis is Not the Same
Jekyll and Hyde: which RA-ILD is it?
RA treatment: A Constant State of Evolution
Who/When to Treat Clinically Suspect Arthralgia
Thoughtful, Effective RA Care Should be Guided by Need —Not Age
The Impact of Biologics on Methotrexate Adherence
Jokes Aside: The Impact of Laughter in RA
JAK Safety Update
Why is RA Difficult to Treat?
DMARD Combinations in RA Treatment
Increased Risk of VTE in RA: Lessons Learned from 40 Years of Data
ALTO: Long-term Outcomes of APIPPRA
Efficacy and Safety of Xeligekimab in AS
Lessons on Uveitis and AxSpA
Difficult to Treat Axial Spondyloarthritis
MRI Lesions in Early axSpA vs Non-axSpA
Emerging Therapies in Axial Spondyloarthritis
Chronic Pain in AxSpA Beyond Fibromyalgia
Novel Therapies in Axial Spondyloarthritis
GLP 1 Receptor Agonists in axSpA Patients
Difficult to Treat Psoriatic Arthritis
Less or more frequent dosing in PsA?
Complex-to-Manage PsA: The GRAPPA Framework and Definition
Biologic Switching in PsA
Decoding Difficult to Treat PsA
Deucravacitinib in Psoriatic Arthritis: A New Oral Option with Dual Impact
EULAR 2025 - Day 1 podcasts
Sonelokimab in PsA
Seronegative Arthritis Breakthroughs
Using Combination csDMARDs in PsA
Deucravacitinib's Place in the PsA Treatment Algorithm?
Biologic Switching in PsA
Decoding Difficult to Treat PsA
Deucravacitinib in Psoriatic Arthritis: A New Oral Option with Dual Impact
GLP 1 Receptor Agonists in axSpA Patients
Jekyll and Hyde: which RA-ILD is it?
RA treatment: A Constant State of Evolution
Difficult to Treat Psoriatic Arthritis
Less or more frequent dosing in PsA?
Complex-to-Manage PsA: The GRAPPA Framework and Definition
Emerging Therapies in Axial Spondyloarthritis
Chronic Pain in AxSpA Beyond Fibromyalgia
Novel Therapies in Axial Spondyloarthritis
JAK Inhibitors: The Latest from the JAK-pot Study
Does Abatacept Buy You Time Off RA?
How to Properly Use Steroids in Early RA: Oral vs Parenteral
All Rheumatoid Arthritis is Not the Same
Catch up on the biggest breakthroughs, standout sessions, and expert insights from the fourth day of EULAR 2025. Join us live as we break down the key highlights and what they mean for the future of rheumatology.
Deucravacitinib's Place in the PsA Treatment Algorithm?
Lessons on Uveitis and AxSpA
Difficult to Treat Axial Spondyloarthritis
MRI Lesions in Early axSpA vs Non-axSpA
JAK Safety Update
Why is RA Difficult to Treat?
DMARD Combinations in RA Treatment
Increased Risk of VTE in RA: Lessons Learned from 40 Years of Data
ALTO: Long-term Outcomes of APIPPRA
Catch up on the biggest breakthroughs, standout sessions, and expert insights from the third day of EULAR 2025. Join us live as we break down the key highlights and what they mean for the future of rheumatology.
Seronegative Arthritis Breakthroughs
Jokes Aside: The Impact of Laughter in RA
The Impact of Biologics on Methotrexate Adherence
Thoughtful, Effective RA Care Should be Guided by Need —Not Age
Sonelokimab in PsA
Using Combination csDMARDs in PsA
Catch up on the biggest breakthroughs, standout sessions, and expert insights from the first day of EULAR 2025. Join us live as we break down the key highlights and what they mean for the future of rheumatology.
Efficacy and Safety of Xeligekimab in AS
Who/When to Treat Clinically Suspect Arthralgia
New Steroid Rules for Lupus - Dr. Michelle Petri
Management of CKD in Lupus Nephritis - Dr. HJ Anders
HCQ Levels and Adherence - Dr. Nathalie Costedoat-Chalumeau
Lupus Nephritis Guidelines - a debate - Drs. Michelle Petri and Maria Dall'Era
Nephrologists Approach to Lupus Nephritis - Dr. Brad Rovin
Voclosporin and Steroids in Lupus Nephritis - Dr. Jack Cush
In this webinar, panelists discussed issues such as congenital heart block, lupus nephritis treatment, teratogenic risks including conception on mycophenolate, antiphospholipid syndrome, hypertension management including the differential diagnosis of preeclampsia, practical guidance on pregnancy planning, and optimizing outcomes for patients with lupus.
Panelists: Dr. Megan Clowse, Dr. Lisa Sammaritano, Dr. Jill Buyon, Dr. Jack Cush
- QD286: Early Lupus (Dr. Jack Cush) https://youtu.be/zzpC397FhZ0
- QD287: A Different Strategy to Tackle Non-adherence (Dr. Megan Clowse) https://youtu.be/28fhFVM7QRc
- QD288: Tackling Lupus Pregnancies (Dr. Bella Mehta) https://youtu.be/zZiGyUTaEF0
- QD289: All Swells that Ends Well (Dr. Sheila Reyes) https://youtu.be/ipnSRchKLqY
- QD282: SLE Get Ready (Dr. Jack Cush) https://youtu.be/UWNAxiuwZro
- QD283: Rhupus (Dr. Jack Cush) https://youtu.be/OJUfylWJf4c
- QD284: The Dilemma of MMF Without Birth Control (Dr. Megan Clowse) https://youtu.be/Q1yJrQXyJSU
- QD285: Young SLE (Dr. Jack Cush) https://youtu.be/KigLAeOZciY
- QD279: Hyperpigmentation in Lupus (Dr. Jack Cush) https://youtu.be/xA9nvuadhCg
- QD280: Polar Opposite Approaches for Lupus (Dr. Eric Dein) https://youtu.be/zCnF1rgAapk
- QD281: Refractory Renal SLE (Dr. Jack Cush) https://youtu.be/dHS8etnZsRw
Dr. Jack Cush reviews the news and journal reports from RheumNow.com - including views on the vagus nerve, NPSLE and CAR-T mania.
In this one-hour webinar, panelists discussed antiphospholipid syndrome, including diagnosis, labs, treatment approaches and more. Panelists Dr. Shruti Chaturvedi, Dr. Jason Knight, Dr. Cassy Sims and Dr. Jack Cush
Dr. Jack Cush reviews the news, journal and regulatory reports from this week on RheumNow.com. Interesting trends and results with prednisone in lupus, cannabis in RA and opioid deaths too!
Discussion of the diagnosis, management, and latest insights into cutaneous manifestations of SLE. Panelists: Dr. Victoria P. Werth, Dr. Matilda Nicholas; Dr. Anthony Fernandez; and, Dr. Christopher Richardson.
Dr. Jack Cush reviews the news, journal reports and lupus highlights from the past week on RheumNow.com. Triple positivity, the gut and CRPS, and hope for better outcomes with Vitamin D therapy.
In this first webinar of RheumNow's Lupus Unlocked campaign, Journal Club discussed two articles:
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. Furie R, et al. NEJM. 2025 Feb 7. doi: 10.1056
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1) Rovin BH. Lancet. 2021 May 29;397(10289)
Speakers:
Brad Rovin, MD
Richard Furie, MD
Jack Cush, MD
Dr. Jack Cush reviews the news, articles and drug approvals from the past week on RheumNow.com. This podcast marks the beginning of our Lupus Campaign called "Lupus Unlocked: Keys to Mastery". This months campaign on Lupus is sponsored by Aurinia.
Listen as coinvestigator and rheumatologist Dr. Andrea Rubbert-Roth reviews this Phase 3 trial of a JAKi in patients with giant cell arteritis. Dr. Rubbert-Roth discusses the latest results, including efficacy and safety outcomes.
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Should we believe the reviews and metanalyses?
Dr. Jack Cush reviews the news and Journal reports from this week on RheumNow.com. Osteoarthritis patients have unique risks and synovial fluid WBC numbers can tell you when to worry about septic arthritis in gout and pseudogout patients.
Dr. Jack Cush reviews the news, journal reports and regulatory approvals from this past week on RheumNow.com
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.
**Correction: a Tweet from 3/18 podcast, had incorrect information. Late Breaking abstract from 2025 Amer. Acad. Dermatology (AAD) on the Phase 3 ICONIC-LEAD study showed J&J's oral IL-23 inhibitor (icotrokinra) was superior to PLACEBO (not deucravacitinib as reported) in skin clearance (65% vs 8%) & PASI90 (50% v 4%) at Wk 16 (NOT 15) in 684 moderate-to-severe plaque PsO pts https://buff.ly/dMbTbML
Rheumatologist Dr. Walter Maksymowych discusses the role of biomarkers in RA care, with a focus on 14-3-3eta as a modifiable marker for diagnosis and monitoring disease progression.
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. Listen in for 2 new case questions - Ask Cush Anything.
Dr Jack Cush and his podcast friends are out to change the world. Here is his weekly review of the news and journal reports from the past week on RheumNow.com
Hear from rheumatologist Stanley J. Naides MD, FACP, FACR, as he details the clinical features of autoimmune myositis, the associated phenotypes and autoantibodies, plus the methodologies and testing options to support a myositis diagnosis.
Two leading rheumatologists share insights into why RF levels are important to consider when identifying treatment options for patients with RA.
Dr. Jack Cush reviews the news, journal reports and regulatory actions from the past week on RheumNow.com
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Opioid deaths are down, IL-33 levels are up and Weight loss is in the news again this week!
Dr. Jack Cush reviews highlights from RheumNow Live 2025 held in Dallas, TX on Feb. 8-9, 2025
Dr. Jack Cush reviews the news, regulatory and journal reports from the past week on RheumNow.com
QD276 - New Palmoplantar Psoriasis and PsA https://youtu.be/GJmY27xA1MMQD277 - dsDNA without Lupus https://youtu.be/daL70sBh8ssQD278 - Recurrent Acute Oligoarthritis https://youtu.be/Xp2ZNBPN1o8Features Dr. Jack Cush. QD Clinics - lessons from the clinic, sponsored by RNL2025 in Dallas, TX; Feb 8 & 9, 2025 Register at RheumNow.live
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.We have two call-in cases on "Ask Cush Anything"Be sure to join in the fun at RNL 2025 next weekend - Gong Show Karaoke; what will you sing?
QD Clinic 273 - ANA Negative Lupus https://youtu.be/g0W9aBRuDcQ Pregnant ANA negative SLE (?) patients with Sjogrens and FM - what to do?QD274 - Undiagnosed Autoinflammatory https://youtu.be/hUkYi1gKJOMAutoinflammatory or Still's disease - does this matter?QD275 - Past DIagnoses https://youtu.be/1f4HYhvVGNA When patients cling to a past diagnosis.QD Clinics - lessons from the clinic, sponsored by RNL2025 in Dallas, TX; Feb 8 & 9, 2025Register at RheumNow.live
Dr. Jack Cush reviews the news and journal reports from RheumNow.com.He features Dr. Charity Dean, the Keynote speaker at RheumNow Live 2025 and why she is an inspiration.Register for RheumNow Live 2025 and hear Keynote Speaker, Dr. Charity Dean -- RheumNow.live
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com; and pays homage to colleagues who passed away in 2024.
QD clinics - lessons from the Clinic brought to you by RheumNow Live 2025QD 269 CREST or More? https://youtu.be/GSBfr2S9iL4Is this CREST or Diffuse PSS?Features Dr. Jack Cush. QD270 Acute Neck & Back Pain https://youtu.be/qWTGvqL9-wYAcute onset febrile, polyarthritis, neck and low back painFeatures Dr. Jack Cush. QD271 - Treating Overlap with ILD https://youtu.be/eR7O-oy_O_gPolyarthritis, ILD, Dermatomyositis - how to treat?Features Dr. Jack Cush. QD272 - Natural RA https://youtu.be/Ie1u-_KqxVEPsO/PsA patient avoiding DMARDs and Biologics, and wants Natural therapiesFeatures Dr. Jack Cush. QD Clinics - lessons from the clinic, sponsored by RNL2025 in Dallas, TX; Feb 8 & 9, 2025 Register at RheumNow.live
Dr. Jack Cush reviews the journal reports from the past week on RheumNow.com. Highlights are summarized by three songs: "Stairway to Heaven", "Youre No Good", and "How Long (has this been going on)". From 2.9.2024
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.comRheumNow Live 2025: Register now! RheumNow.live
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.comJoin us at RheumNow Live February 8 & 9 in Dallas, TX! https://t.co/7WawLxwBLP
This year at ACR24, the RheumNow faculty and reporters were prolific, generating 800 Tweets, 56 written articles, 117 Videos and 28 podcasts – all in 4 days! You can best review and learn ACR 2024 by A) Rheumatology Roundup; b) TOPIC Panel podcasts; and c) Topic podcasts.This weeks notable citations on RheumNow.com
Discover the latest advancements in targeting the IL-17 pathway from the ACR Annual Meeting! This expert-led panel will delve into groundbreaking research and therapeutic strategies for managing rheumatic diseases.
Join us for an in-depth discussion about the ACR Annual Meeting! This expert panel will explore the latest research and clinical applications of JAK and TYK inhibitors in managing rheumatic diseases.Stay informed about the cutting-edge therapies shaping the future of rheumatology care.Dr. Janet PopeLondon, OntarioDr. David LiewMelbourneDr. Michael PutmanMilwaukee
Tune in for an engaging discussion at the ACR Annual Meeting! This expert panel will explore the latest breakthroughs and trends in Psoriatic Arthritis(PsA) research and management, providing actionable insights for clinicians and researchers.
Highlight presentations from ACR 2024 in Washington, DCCovered abstracts include:- Dr. Kavanaugh1679 Amplified & biomarkers0082 Enthesitis Pathology & IL-231553 TLR 7/8 inhibitors in SLE995 Carbon footprint to injectablesL20 ARTHUR DIANA Automated US1132 VEGA (Combo Rx – see also 2640, 1460, 1393)1745 Statin use in Oral Surveillance- Dr. Cush458 Seronegative RA fateL19 Emapalumab in Stills diseaseACR 2024 updated guidelines on lupus nephritis2580 Ianalumab in SLE2259 Anti-Obesity Meds in RA2657 Mortality with starting/stopping steroids0774 TAPIR study in GCA1697 PMR MODE study
Join us as we dive into expert insights from the ACR Annual Meeting! This special panel will focus on the latest research and advancements in Spondyloarthritis (SpA), featuring thought leaders in the field.Dr. Marina MagreyClevelandDr. Lihi EderTorontoDr. Sheila ReyesPhillipinesDr. Adela CastroMemphis
A New ACRCancer Survival in RA"Changing Mindsets about Methotrexate Side Effects"Control RA, Build Stronger BonesCumulative Steroid Use and Cardiovascular EventsDisease Activity in RA-ILDDo TNFis and JAKis Prevent Cancer!?Estimating Inflammation, Damage and Patient DistressFinding the Right Combination Therapy in RAImplantable Vagus Nerve Stimulator for RAIs Frequent Lab Monitoring Necessary?Long Term Follow up from APIPPRAMetabolic Dysregulation and RA Interstitial Lung DiseaseNative Americans with RA Die YoungParaoxonase-1: Possible Biomarker for Progression to RAPred Softly: SteroidsPredicting Flares in Rheumatoid ArthritisRA Roundup: Is LDA Inappropriate? What about Statins for JAKs?RA Treatment Adherence: Is decision making really shared?RA: One JAK to Rule Them All?Sonelokimab in PsA: Phase 2 DataTreat-to-Target Improves Fertility in Women with RATreatment Considerations for RA-ILDTreatment Strategies in RAUse of AI in Hand Ultrasound ScoringVaccine Responses:The DMARD CountsWhat's New in Relapsing Polychondritis?What's The State of Biosimilars?
A New ACRAnti IL-17 on Entheseal Biopsy in PsAaxSpA: Impact of TNF and IL-17 in Patients with Prior TNF ExposureBest Things I Saw Today in PsACycling vs Switching after TNFi Failure in axSpAImprovements in Pain and Fatigue in BimekizumabLong-term Safety Profile of Bimekizumab in axSpA and PsASonelokimab in PsA: Phase 2 DataTreating SpA
A New ACRBest Things I Saw Today in PsADo TNFis and JAKis Prevent Cancer!?Hold or continue JAKi and IL-17 when receiving COVID boosters?JAK-pot! How fast do DMARDs work?JAKi Studies at ACRPoly-treatment of Polymyalgia Rheumatica?RA Roundup: Is LDA Inappropriate? What about Statins for JAKs?RA: One JAK to Rule Them All?SELECT-GCA: Efficacy and Safety of Upadacitinib"SELECT-GCA: Upadacitinib in Giant Cell Arteritis"SELECTing the right patients: upadacitinib in GCASo really, are JAKs Safe?Summary of JAKi StudiesThe Case for JAKi in PMRThe Real Value of JAKi is Beyond RAWhen, What and How Long to Treat GCA & PMRWorried about CV Risk and JAKi? What about the Steroids?
A Fibroblast RenaissanceA New ACRA useful urinary biomarker for lupus nephritisANA+ and no Autoimmune Disease? Check the liverCAR-T Therapy and LupusCyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus NephritisEvaluating ANA Patterns and Titers with AINeuropsychiatric Lupus: The Forgotten SymptomsThe 2024 ACR Guidelines for Lupus NephritisVaccine Responses:The DMARD CountsWhat is MCTD? The Great Debate
A New ACRAssessing ASAS Criteria: CLASSIC Study ResultsAssessment and management of axSpAAssessment of axSpACarotid Doppler Ultrasound Screening in Axial SpACycling vs Switching after TNFi Failure in axSpADefining Difficult to Manage axSpADifficult to manage AxSpADISH in SpAGender Differences in AxSpAHighlights in axSpAHot Topics in axSpALong-term Safety Profile of Bimekizumab in axSpA and PsAMachine Learning for Predicting Flares in axSpAPrecision Immunotherapy in Axial SpAPREDICT-SpA: Evaluating the influence of gender on disease assessment toolsTreating SpAWhat is a Positive MRI in Spondyloarthritis?axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure
A New ACRApremilast Benefits and Risks in PsABest Things I Saw Today in PsABimekizumab in PsA Showed Sustained Reductions in Disease ImpactBiologic Monotherapy vs Combination with cDMARDs in PsADo TNFis and JAKis Prevent Cancer!?Improvements in Pain and Fatigue in BimekizumabLong-term Safety Profile of Bimekizumab in axSpA and PsAPotential Impact of Weight Loss Drugs in Rheumatic DiseasesProposed ACR Guidance for Use of MSUS in Psoriatic ArthritisPsA PotpourriPsA Ultrasound UpdatesPsA: Impact of SexSex Differences in Psoriatic ArthritisThe Psoriatic March: PsA before PsOApremilast in PsA: Results from Mosaic TrialAnti IL-17 on Entheseal Biopsy in PsA
Is Frequent Lab Monitoring Necessary?:Dr. Bella MehtaThe Case for JAKi in PMR:Dr. David LiewTreatment Strategies in RA:Dr. Victoria KonzettWhat's New in Relapsing Polychondritis?:Dr. Bella Mehta Worried about CV Risk and JAKi? What about the Steroids?:Dr. David Liew
ANCA Vasculitis "Eye": Can rituximab help?:Dr. Janet PopeApremilast in PsA: Results from Mosaic Trial:Dr. Guillermo Valenzuela Implantable Vagus Nerve Stimulator for RA:Dr. Guillermo Valenzuela Treat-to-Target Improves Fertility in Women with RA:Dr. Richard Conway
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.Join us live and stay at the forefront of rheumatology!
ACR 24: What I learned in Sjogren's, Takayasu's and CAR-T:Dr. Janet PopeAnti IL-17 on Entheseal Biopsy in PsA:Dr. Eric Dein axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure:Dr. Brian JarosCan We Make Clinical Trials Better?:Dr. Janet PopeCumulative Steroid Use and Cardiovascular Events:Dr. Mrinalini Dey IL 6 Inhibitors, Frailty and Polymyalgia Rheumatica:Drs. Trish Harkins and Sebastian SattuiIVIG Treatment in Immune-mediated Necrotizing Myopathy:Drs. Caoilfhionn Connolly interviews Dr. Asim Mohamed Machine Learning for Predicting Flares in axSpA:Dr. Sheila ReyesSo really, are JAKs Safe?:Dr. Janet PopeTackling the Workforce Crisis: A shared dilemma:Drs. Mrinalini Dey, Louise Pollard and Bharat KumarThe 2024 ACR Guidelines for Lupus Nephritis:Dr. Sheila Reyes The Real Value of JAKi is Beyond RA:Dr. David Liew Vaccine Responses:The DMARD Counts:Dr. David Liew
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.Join us live and stay at the forefront of rheumatology!
Best Things I Saw Today in PsA:Dr. Catherine Bakewell Do TNFis and JAKis Prevent Cancer!?:Dr. Richard ConwayEfficacy and Safety of Nipocalimab for Sjogren's Syndrome:Dr. Mike PutmanEvaluating ANA Patterns and Titers with AI:Dr. Bella MehtaImprovements in Pain and Fatigue in Bimekizumab:Dr. Philip Mease Long Term Follow up from APIPPRA:Dr. Antoni Chan talks with Dr. Andrew CopeRace Neutral PFTs in Scleroderma Improves Equity:Dr. Caoilfhionn Connolly talks with Dr. Kamini Kuchinad Summary of JAKi Studies:Dr. Peter NashThe Psoriatic March: PsA before PsO:DR. Antoni ChanUse of AI in Hand Ultrasound Scoring:Dr. Bella Mehta What is MCTD? The Great Debate:Drs. Caoilfhionn Connolly & Lisa Christopher-StineWhat's The State of Biosimilars?:Drs. Eric Dein and Jonathan KayPred Softly: Steroids:Dr. Jiha Lee talks with Dr. Beth Wallace
Control RA, Build Stronger Bones:Dr. Jiha Lee talks with Dr. Rachel Elam Hold or continue JAKi and IL-17 when receiving COVID boosters?:Dr. Bella MehtaLong-term Safety Profile of Bimekizumab in axSpA and PsA:Dr. Philip MeaseNavigating Rheumatology Care in Humanitarian Crisis Settings:Dr. Antoni Chan talks with Dr. Martha DhzhusRA Roundup: Is LDA Inappropriate? What about Statins for JAKs?:Dr. Eric Dein Sex Differences in Psoriatic Arthritis:Dr. Catherine BakewellSingle v Double Lung Transplants for Disease-related ILD:Dr. Eric Dein talks with Dr. Harry HurleySonelokimab in PsA: Phase 2 Data:Dr. Philip MeaseTreating SpA:Dr. Marina Magrey
Control RA, Build Stronger Bones:Dr. Jiha Lee talks with Dr. Rachel Elam
Hold or continue JAKi and IL-17 when receiving COVID boosters?:Dr. Bella Mehta
Long-term Safety Profile of Bimekizumab in axSpA and PsA:Dr. Philip Mease
Navigating Rheumatology Care in Humanitarian Crisis Settings:Dr. Antoni Chan talks with Dr. Martha Dhzhus
RA Roundup: Is LDA Inappropriate? What about Statins for JAKs?:Dr. Eric Dein
Sex Differences in Psoriatic Arthritis:Dr. Catherine Bakewell
Single v Double Lung Transplants for Disease-related ILD:Dr. Eric Dein talks with Dr. Harry Hurley
Sonelokimab in PsA: Phase 2 Data:Dr. Philip Mease
Treating SpA:Dr. Marina Magrey
Assessment of axSpA:Dr. Antoni Chan
Defining Difficult to Manage axSpA:Dr. Lihi
DISH in SpA:Dr. Sheila Reyes
Generative AI in Rheumatology: The Good, The Bad, The Ugly:Dr. Akhil Sood
Native Americans with RA Die Young:Dr. Eric Dein
Precision Immunotherapy in Axial SpA:Dr. Marina Magrey
When, What and How Long to Treat GCA & PMR:Dr. Janet Pope
A Fibroblast Renaissance:Dr. Andrea Fava
A useful urinary biomarker for lupus nephritis:Dr. Andrea Fava
ACR Advocacy Update:Dr. Eric Dein talks with Dr. Christina Downey, ACR Government Affairs Committee, and Dr. Kaitlyn Brittan, RheumPAC
Carotid Doppler Ultrasound Screening in Axial SpA:Dr. Trish Harkins discussed with Dr. Barry O'Shea
Enhanced Detection of Myocarditis in Idiopathic Inflammatory
Myopathies:Dr. Caoilfhionn Connolly talks with Dr. Julie Paik
PsA: Impact of Sex:Dr. Arthur Kavanaugh
Rethinking Lupus Care: Early Biologics, Less Steroids:Dr. Akhil
Treatment Considerations for RA-ILD:Dr. Jeff Sparks with Dr. Scott Matson
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.
Join us live and stay at the forefront of rheumatology!
JAKi Studies at ACR:Dr. Peter Nash
Palliative Care in Rheumatology:Dr. Jiha Lee talks with Dr. Shannon Herndon
Estimating Inflammation, Damage and Patient Distress:Dr. Jack Cush talks with Dr. Ted Pincus
Methotrexate and the Gut Microbiome:Dr. Jonathan Kay talks with Dr. Rebecca Blank
Poly-treatment of Polymyalgia Rheumatica?:Dr. Janet Pope
Predicting Flares in Rheumatoid Arthritis:Dr. Jonathan Kay interviews Dr. John Isaacs
"Changing Mindsets about Methotrexate Side Effects":Dr. Mrinalini Dey
Biologic Monotherapy vs Combination with cDMARDs in PsA:Dr. Adela Castro
Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis:Dr. Mike Putman
ANA+ and no Autoimmune Disease? Check the liver:Dr. Janet Pope
SELECTing the right patients: upadacitinib in GCA:Dr. Brian Jaros
Neuropsychiatric Lupus: The Forgotten Symptoms:Dr. Mrinalini Dey talks with Dr. Chris Wincup
Bimekizumab in PsA Showed Sustained Reductions in Disease Impact:Dr. Eric Dein talks with Dr. Ana-Marie Orbai
CAR-T Therapy and Lupus:Dr. Akhil Sood talks with Dr. Chris Wincup
Cycling vs Switching after TNFi Failure in axSpA:Dr. Lihi Eder
Difficult to manage AxSpA:Dr. Sheila Reyes talks with Dr. Denis Poddubnyy
Gender Differences in AxSpA:Dr. Adela Castro
Metabolic Dysregulation and RA Interstitial Lung Disease:Dr. Mrinalini Dey
PsA Ultrasound Updates:Dr. Catherine Bakewell and Dr. Lihi Eder
SELECT-GCA: Efficacy and Safety of Upadacitinib:Dr. Richard Conway
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.
Join us live and stay at the forefront of rheumatology!
Aging Gracefully in Managing Rheumatic Diseases:Dr. Mrinalini Dey interviews Dr. Elena Myasoedova
Apremilast Benefits and Risks in PsA:Dr. Akhil Sood
Assessing ASAS Criteria: CLASSIC Study Results:Dr. Adela Castro
Assessment and management of axSpA:Dr. Antoni Chan
Disease Activity in RA-ILD:Dr. Richard Conway
Finding the Right Combination Therapy in RA:Dr. Jonathan Kay interviews Dr. Ernest Choy
Highlights in axSpA:Dr. Marina Magrey
Hot Topics in axSpA:Dr. Marina Magrey
Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis:Dr.
Antoni Chan interviews Dr. Catherine Bakewell
PsA Potpourri:Dr. Arthur Kavanaugh
RA Treatment Adherence: Is decision making really shared?:Dr. Jonathan
Kay interviews Dr. Cécile Gaujoux-Viala
RA: One JAK to Rule Them All?:Dr. Brian Jaros
What is a Positive MRI in Spondyloarthritis?:Dr. Sheila Reyes interviews Dr. Walter Maksymowych
JAK-pot! How fast do DMARDs work?:Dr. Mike Putman and Dr. Kim Lauper
Paraoxonase-1: Possible Biomarker for Progression to RA:Dr. Jonathan Kay
Potential Impact of Weight Loss Drugs in Rheumatic Diseases:Dr. Arthur Kavanaugh
PREDICT-SpA: Evaluating the influence of gender on disease assessment tools:Dr. Sheila Reyes
SELECT-GCA: Upadacitinib in Giant Cell Arteritis:Dr. Mike Putman
Too Many CAR-Ts for Horses?:Dr. Pope
Transplant-free Survival Predictors in Idiopathic Inflammatory Myopathies-ILD:Dr. Gaby Martinez
A New ACR:Dr. Cush
Are we under-monitoring in scleroderma ILD?:Dr. Janet Pope
Cancer Survival in RA:Dr. Eric Dein interviews Joshua Hsieh
Continuing or Stopping Low Dose Glucocorticoids in GPA:Dr. Mike Putman
COVID Associated Immune Disease:Dr. Len Calabrese
How to Master ACR Meetings:Dr. Cush
ACR 2024 starts tomorrow; here are a few previews of Abstracts to be presented. Along with my recommendations of sessions you don’t want to miss.
Dr. Jack Cush reviews the news and journal reports from this past week from RheumNow.com
Minimizing steroid use in patients with SLE. Learn more about when, why, and how to taper steroids and listen to experts, Dr Michelle Petri and Dr Leanna Wise, discuss key data and their clinical perspectives on these topics.
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.comRegister now for RheumNow.live 2025
This week, Jonathan is joined by John J Cush, from Dallas, Texas, USA. The two doctors explore novel treatment avenues for rheumatic diseases, and discuss the exciting potential of AI and telemedicine.
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. Todays reports suggest where to look for help, especially with regard to pain.
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com -- This weeks rants include the microbiome, PsA treatment choices and fishing for P-values in research.
Rheumatologists Dr. Jeffrey Curtis and Dr. Jon Giles discuss the risk of comorbidities that can occur as a consequence of uncontrolled inflammation in RA
Rheumatologists Dr. Jeffrey Curtis and Dr. Jon Giles discuss the risk of comorbidities that can occur as a consequence of uncontrolled inflammation in RA
https://mcdn.podbean.com/mf/web/4745yqmm83ac2bw5/Which_One_is_the_Loneliest_Number_9272071vci.mp3
Dr. Jack Cush reviews the news, journal articles and a new FDA approval for EGPA, this week on the Podcast.
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.This week with a focus on fingers and better prescriptive follow through.
Sponsored by GSK US Medical Affairs Learn about the importance of reducing organ damage and corticosteroid-associated toxicity in SLE, and how biologics may help to change the course of the disease by targeting its underlying mechanisms.
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com - including tips on steroids, MAS, and myositis testing.
Dr. Jack Cush picks highlight reports from the past week on RheumNow.com, with reports on the challenge of lupus nephritis, perplexing skin issues, you don't know JAK (about Tyk) and the value of a good family history.
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com, noting his concerns about diet, cancer, ILD, death and dosing challenges.
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com - leading with lupus because everyone wants to know about lupus!
RA Experts (Drs. Alvin Wells, Orrin Troum, Grace Wright, Aaron Broadwell) discuss dose response differences in this podcast sponsored by Genentech. Full Prescribing Information including BOXED WARNING. Portions of this recording have been edited using AI technology for clarity.
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Location matters; Geo-rheumatology?
This week on the RheumNow Podcast, Dr. Jack Cush reviews the news and journal reports of interesting, including irAE, pollution and Psoriasis, microwave therapy, scleroderma without scleroderma that only the best rheumatologists could discern.
Dr. Jack Cush reviews the terms in rheumatology that should no longer be used in the field of rheumatology. This lecture is part of the RheumNow Live 2024 meeting, being held January 27-28, 2024 in Dallas, TX (and virtually).
Dr. Jack Cush reviews the news, journal articles and regulatory announcements from the past week on RheumNow.com
Moderated by Dr. Jack Cush and featuring Drs. Aurelie Najm, David Liew and Jonathan Kay
Moderated by Dr. Jack Cush and Featuring Drs. Eric Ruderman, Antoni Chan, and Peter Nash
Featuring Drs. Artie Kavanaugh and Jack Cush Discussion of highlights from the EULAR 2024 Meeting in Vienna
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria:
OP0195 Sonelokimab IL 17 A/F nanobody inhibitor
LB0005 Izokibep IL17A nanobody inhibitor
POS0803 Vunakizumab, another IL17A inhibitor
OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib
Giant Cell Arteritis and Polymyalgia Rheumatica Update
Dr. Janet Pope discusses abstracts LBA0001, OP0233, OP0261 and POS0280 at Eular 2024 in Vienna, Austria.
JAK Inhibitors for New Indications
Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.
Pain in RA: Different Drugs for Different Mechanisms
Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.
Top 3 Messages About JAK Inhibitor Safety
Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.
DMARDs and Herpes Zoster Vaccination: To Stop or Not To Stop
Dr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria.
Has JAK POT Hit the Spot About Infection Risk?
Dr. Yuz Yusof discusses abstract OP0092 presented at Eular 2024 in Vienna, Austria.
Select your GCA Therapy
Dr. David Liew discusses LBA0001 presented at Eular 2024 in Vienna, Austria.
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria:
OP0195 Sonelokimab IL 17 A/F nanobody inhibitor
LB0005 Izokibep IL17A nanobody inhibitor
POS0803 Vunakizumab, another IL17A inhibitor
OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib
Do MRI changes at the Spine and SI Joints in Treatment of AxSpA Matter?
Dr. Eric Ruderman discusses abstracts OP0046 and POS0058 presented at Eular 2024 in Vienna, Austria.
OP0046 Effect on SI joint structural lesions with ixekizumab
POS0058 Effect on SI joint structural lesions with bimekizumab
Does Telemonitoring in SpA Work?
Dr. Antoni Chan reports on abstract OP0120 from Eular 2024 in Vienna, Austria.
Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA
Dr. Bella Mehta interviews Dr. Vincenzo Venerito about abstract POS0236 at Eular 2024 in Vienna, Austria.
Treat to Target Outcomes in Early AxSpA
Dr. Antoni Chan discusses abstract OP0132 presented at Eular 2024 in Vienna, Austria.
Early Diagnosis of Axial Spondyloarthritis
Dr. Antoni Chan reports on abstract OP0310 presented at Eular 2024 in Vienna, Austria.
Imaging in Axial Spondyloarthritis
Dr. Antoni Chan reviews abstracts OP0222 and OP0303 presented at Eular 2024 in Vienna, Austria.
Does B Cell Depletion Matter?
Drs. Yuz Yusof and Ed Vital discuss abstract OP0077 at Eular 2024 in Vienna, Austria.
3 Big Lupus Themes from EULAR 2024
Dr. Janet Pope discusses three hot topics in lupus at Eular 2024 in Vienna, Austria.
POS0732
OP0255
Voclosporin and Steroids in Lupus Nephritis
Dr. Jack Cush reports on abstract OP0059 presented at Eular 2024 in Vienna, Austria.
JAK Inhibitors for New Indications
Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.
Cognitive Function in Older Adults with Lupus
Dr. Mrinalini Dey discusses abstract POS0730 presented at Eular 2024 in Vienna, Austria.
Does Withdrawing Steroids Increase Flares in SLE?
Dr. Janet Pope reports on abstract OP0180 presented at Eular 2024 in Vienna, Austria.
Tapering Treatment for Lupus
Dr. Andrea Fava at Eular 2024 in Vienna, Austria, shares his perspectives on several sessions that addressed tapering treatment in lupus.
The Crossroads of Autoinflammation and Autoimmunity
Dr. Andrea Fava shares his perspectives on autoinflammation and autoimmunity at Eular 2024 in Vienna, Austria.
We've Got to Talk about CAR T cells
Dr. Yuz Yusof discusses abstract OP0017 presented at the Eular 2024 meeting in Vienna, Austria.
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria:
OP0195 Sonelokimab IL 17 A/F nanobody inhibitor
LB0005 Izokibep IL17A nanobody inhibitor
POS0803 Vunakizumab, another IL17A inhibitor
OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib
JAK Inhibitors for New Indications
Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.
PsA Treatment: is Earlier Better?
Dr. Aurelie Najm discusses abstract OP0184, presented at Eular 2024 in Vienna, Austria.
Transition from Psoriasis to PsA: Can we Prevent It?
Dr. Aurelie Najm discusses abstract OP0010 presented at Eular 2024 in Vienna, Austria.
Depression and Anxiety Associated with Inability to Achieve Remission in RA and PsA
Dr. Aurelie Najm reports on abstract POS0946 presented at Eular 2024 in Vienna, Austria.
PsA Switch or Cycle, the Eternal Question
Dr. Aurelie Najm reports on abstracts POS0278 and POS0266 presented at Eular 2024 in Vienna, Austria.
Axial & Psoriatic Disease
Dr. Peter Nash at Eular 2024 in Vienna, Austria.
Difficult to Treat Psoriatic Arthritis
Dr. Peter Nash reports at Eular 2024 in Vienna, Austria.
Predictors of Treatment Response in Psoriatic Arthritis
Dr. Janet Pope reviews three abstracts presented at Eular 2024 in Vienna, Austria. Abstracts discussed:
POS 0990
POS 0992
POS 0266
Prevention of Psoriatic Arthritis
Dr. Peter Nash sharing his perspectives on preventing psoriasis from turning into PsA at Eular 2024 in Vienna, Austria.
Mechanistic Promise in RA Doesn’t Always Mean Actual Gain
Dr. David Liew reports on abstracts OP0007 and OP0069 at Eular 2024 in Vienna, Austria.
The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis
Dr. Mrinalini Dey reports from Eular 2024 in Vienna, Austria about an abstract she will present during the meeting, POS0309.
A Step Closer to Identifying Phenotypes of RA ILD
Dr. Mrinalini Dey discusses abstract OP0202 presented at Eular 2024 in Vienna, Austria.
Pain in RA: Different Drugs for Different Mechanisms
Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.
Predicting Palindromic Prognosis
Dr. David Liew discusses abstract OP0127 at Eular 2024 in Vienna, Austria.
Top 3 Messages About JAK Inhibitor Safety
Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.
Abatacept Misses on Shingrix Response
Dr. David Liew discusses abstract POS0620 at Eular 2024 in Vienna, Austria.
Artificial Intelligence Detection of CPPD on Hand Radiographs
Dr. Antoni Chan interviews Dr. Thomas Hugle about abstract OP0112 presented at Eular 2024 in Vienna, Austria.
Cognitive Function in Older Adults with Lupus
Dr. Mrinalini Dey discusses abstract POS0730 presented at Eular 2024 in Vienna, Austria.
Difficult-to-treat Rheumatoid Arthritis Validation of the EULAR Definition
Dr. Mrinalini Dey discusses abstract OP0156 presented at Eular 2024 in Vienna, Austria.
DMARDs and Herpes Zoster Vaccination To Stop or Not To Stop
Dr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria.
Has JAK POT Hit the Spot About Infection Risk?
Dr. Yuz Yusof discusses abstract OP0092 presented at Eular 2024 in Vienna, Austria.
Inspirations About RA-ILD
Dr. Jonathan Kay discusses abstracts POS0070, POS0043 and POS0022 presented at the Eular 2024 meeting in Vienna, Austria.
Depression and Anxiety Associated with Inability to Achieve Remission in RA and PsA
Dr. Aurelie Najm reports on abstract POS0946 presented at Eular 2024 in Vienna, Austria.
Digital Rheumatology
Dr. Jonathan Kay reviews abstracts POS0451 and POS0607 presented at Eular 2024 in Vienna, Austria.
Drug-resistant RA Does Blinatumomab BiTE?
Dr. Yuz Yusof reports on abstract OP0193, presented at Eular 2024 in Vienna, Austria.
Axial & Psoriatic Disease
Dr. Peter Nash at Eular 2024 in Vienna, Austria.
Difficult to Treat Psoriatic Arthritis
Dr. Peter Nash reports at Eular 2024 in Vienna, Austria.
Predictors of Treatment Response in Psoriatic Arthritis
Dr. Janet Pope reviews three abstracts presented at Eular 2024 in Vienna, Austria. Abstracts discussed:
POS 0990
POS 0992
POS 0266
Prevention of Psoriatic Arthritis
Dr. Peter Nash sharing his perspectives on preventing psoriasis from turning into PsA at Eular 2024 in Vienna, Austria.
Depression and Anxiety Associated with Inability to Achieve Remission in RA and PsA
Dr. Aurelie Najm reports on abstract POS0946 presented at Eular 2024 in Vienna, Austria.
Digital Rheumatology
Dr. Jonathan Kay reviews abstracts POS0451 and POS0607 presented at Eular 2024 in Vienna, Austria.
Drug-resistant RA Does Blinatumomab BiTE?
Dr. Yuz Yusof reports on abstract OP0193, presented at Eular 2024 in Vienna, Austria.
Early Diagnosis of Axial Spondyloarthritis
Dr. Antoni Chan reports on abstract OP0310 presented at Eular 2024 in Vienna, Austria.
Imaging in Axial Spondyloarthritis
Dr. Antoni Chan reviews abstracts OP0222 and OP0303 presented at Eular 2024 in Vienna, Austria.
Dr. Janet Pope reviews three abstracts presented at Eular 2024 in Vienna, Austria. Abstracts discussed:
POS 0990
POS 0992
POS 0266
Moderated by Dr. Jack Cush and featuring Dr. Aurelie Najm and Dr. David Liew Recorded June 15, 2024
Dr. Antoni Chan reviews abstracts OP0222 and OP0303 presented at Eular 2024 in Vienna, Austria.
EULAR 2024 RECAP DAY 3 Moderated by Dr. Jack Cush with Drs. Bella Mehta and Antoni Chan.
EULAR 2024 RECAP DAY 3 Moderated by Dr. Jack Cush with Drs. Bella Mehta and Antoni Chan.
EULAR 2024 RECAP DAY 3 Moderated by Dr. Jack Cush with Drs. Bella Mehta and Antoni Chan.
Dr. Jonathan Kay reviews abstracts POS0451 and POS0607 presented at Eular 2024 in Vienna, Austria.
Dr. Aurelie Najm reports on abstract POS0946 presented at Eular 2024 in Vienna, Austria.
Dr. Peter Nash sharing his perspectives on preventing psoriasis from turning into PsA at Eular 2024 in Vienna, Austria.
Dr. Peter Nash sharing his perspectives on preventing psoriasis from turning into PsA at Eular 2024 in Vienna, Austria.
Dr. Jonathan Kay reviews abstracts POS0451 and POS0607 presented at Eular 2024 in Vienna, Austria.
Dr. Aurelie Najm reports on abstract POS0946 presented at Eular 2024 in Vienna, Austria.
Select your GCA Therapy
Dr. David Liew discusses LBA0001 presented at Eular 2024 in Vienna, Austria.
DMARDs and Herpes Zoster Vaccination: To Stop or Not To Stop
Dr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria.
Has JAK POT Hit the Spot About Infection Risk?
Dr. Yuz Yusof discusses abstract OP0092 presented at Eular 2024 in Vienna, Austria.
Depression and Anxiety Associated with Inability to Achieve Remission in RA and PsA
Dr. Aurelie Najm reports on abstract POS0946 presented at Eular 2024 in Vienna, Austria.
PsA Switch or Cycle, the Eternal Question
Dr. Aurelie Najm reports on abstracts POS0278 and POS0266 presented at Eular 2024 in Vienna, Austria.
DMARDs and Herpes Zoster Vaccination To Stop or Not To Stop
Dr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria.
Difficult-to-treat Rheumatoid Arthritis Validation of the EULAR Definition
Dr. Mrinalini Dey discusses abstract OP0156 presented at Eular 2024 in Vienna, Austria.
Has JAK POT Hit the Spot About Infection Risk?
Dr. Yuz Yusof discusses abstract OP0092 presented at Eular 2024 in Vienna, Austria.
Cognitive Function in Older Adults with Lupus
Dr. Mrinalini Dey discusses abstract POS0730 presented at Eular 2024 in Vienna, Austria.
Artificial Intelligence Detection of CPPD on Hand Radiographs
Dr. Antoni Chan interviews Dr. Thomas Hugle about abstract OP0112 presented at Eular 2024 in Vienna, Austria.
Abatacept Misses on Shingrix Response
Dr. David Liew discusses abstract POS0620 at Eular 2024 in Vienna, Austria.
Inspirations About RA-ILD
Dr. Jonathan Kay discusses abstracts POS0070, POS0043 and POS0022 presented at the Eular 2024 meeting in Vienna, Austria.
We've Got to Talk about CAR T cells
Dr. Yuz Yusof discusses abstract OP0017 presented at the Eular 2024 meeting in Vienna, Austria.
Does Withdrawing Steroids Increase Flares in SLE?
Dr. Janet Pope reports on abstract OP0180 presented at Eular 2024 in Vienna, Austria.
Tapering Treatment for Lupus
Dr. Andrea Fava at Eular 2024 in Vienna, Austria, shares his perspectives on several sessions that addressed tapering treatment in lupus.
The Crossroads of Autoinflammation and Autoimmunity
Dr. Andrea Fava shares his perspectives on autoinflammation and autoimmunity at Eular 2024 in Vienna, Austria.
Cognitive Function in Older Adults with Lupus
Dr. Mrinalini Dey discusses abstract POS0730 presented at Eular 2024 in Vienna, Austria.
Dr. Aurelie Najm reports on abstract POS0946 presented at Eular 2024 in Vienna, Austria.
Dr. Aurelie Najm reports on abstracts POS0278 and POS0266 presented at Eular 2024 in Vienna, Austria.
Dr. Andrea Fava at Eular 2024 in Vienna, Austria, shares his perspectives on several sessions that addressed tapering treatment in lupus.
Dr. Andrea Fava shares his perspectives on autoinflammation and autoimmunity at Eular 2024 in Vienna, Austria.
Dr. Mrinalini Dey discusses abstract POS0730 presented at Eular 2024 in Vienna, Austria.
Dr. Jonathan Kay discusses abstracts POS0070, POS0043 and POS0022 presented at the Eular 2024 meeting in Vienna, Austria.
Dr. Antoni Chan interviews Dr. Thomas Hugle about abstract OP0112 presented at Eular 2024 in Vienna, Austria.
Dr. Mrinalini Dey discusses abstract POS0730 presented at Eular 2024 in Vienna, Austria.
Dr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria.
Dr. Jack Cush moderates EULAR 2024 RECAP for days 1 & 2 with Drs. Mrinalini Day and Yuz Yusof in Vienna, Austria.
OP0156
Dr. Jack Cush moderates EULAR 2024 RECAP for days 1 & 2 with Drs. Mrinalini Day and Yuz Yusof in Vienna, Austria.
Dr. Mrinalini Dey discusses abstract OP0156 presented at Eular 2024 in Vienna, Austria.
Dr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria.
Dr. Yuz Yusof discusses abstract OP0017 presented at the Eular 2024 meeting in Vienna, Austria.
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria:
OP0195 Sonelokimab IL 17 A/F nanobody inhibitor
LB0005 Izokibep IL17A nanobody inhibitor
POS0803 Vunakizumab, another IL17A inhibitor
OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib
Transition from Psoriasis to PsA: Can we Prevent It?
Dr. Aurelie Najm discusses abstract OP0010 presented at Eular 2024 in Vienna, Austria.
JAK Inhibitors for New Indications
Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.
PsA Treatment: is Earlier Better?
Dr. Aurelie Najm discusses abstract OP0184, presented at Eular 2024 in Vienna, Austria.
Do MRI changes at the Spine and SI Joints in Treatment of AxSpA Matter?
Dr. Eric Ruderman discusses abstracts OP0046 and POS0058 presented at Eular 2024 in Vienna, Austria.
OP0046 Effect on SI joint structural lesions with ixekizumab
POS0058 Effect on SI joint structural lesions with bimekizumab
Does Telemonitoring in SpA Work?
Dr. Antoni Chan reports on abstract OP0120 from Eular 2024 in Vienna, Austria.
Treat to Target Outcomes in Early AxSpA
Dr. Antoni Chan discusses abstract OP0132 presented at Eular 2024 in Vienna, Austria.
Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA
Dr. Bella Mehta interviews Dr. Vincenzo Venerito about abstract POS0236 at Eular 2024 in Vienna, Austria.
Pain in RA: Different Drugs for Different Mechanisms
Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.
Top 3 Messages About JAK Inhibitor Safety
Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.
Giant Cell Arteritis and Polymyalgia Rheumatica Update
Dr. Janet Pope discusses abstracts LBA0001, OP0233, OP0261 and POS0280 at Eular 2024 in Vienna, Austria.
Does B Cell Depletion Matter?
Drs. Yuz Yusof and Ed Vital discuss abstract OP0077 at Eular 2024 in Vienna, Austria.
3 Big Lupus Themes from EULAR 2024
Dr. Janet Pope discusses three hot topics in lupus at Eular 2024 in Vienna, Austria.
Voclosporin and Steroids in Lupus Nephritis
Dr. Jack Cush reports on abstract OP0059 presented at Eular 2024 in Vienna, Austria.
The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis
Dr. Mrinalini Dey reports from Eular 2024 in Vienna, Austria about an abstract she will present during the meeting, POS0309.
Mechanistic Promise in RA Doesn’t Always Mean Actual Gain
Dr. David Liew reports on abstracts OP0007 and OP0069 at Eular 2024 in Vienna, Austria.
Pain in RA: Different Drugs for Different Mechanisms
Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.
Top 3 Messages About JAK Inhibitor Safety
Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.
A Step Closer to Identifying Phenotypes of RA ILD
Dr. Mrinalini Dey discusses abstract OP0202 presented at Eular 2024 in Vienna, Austria.
Predicting Palindromic Prognosis
Dr. David Liew discusses abstract OP0127 at Eular 2024 in Vienna, Austria.
Dr. Mrinalini Dey discusses abstract OP0202 presented at Eular 2024 in Vienna, Austria.
Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.
Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.
Dr. Janet Pope discusses abstracts LBA0001, OP0233, OP0261 and POS0280 at Eular 2024 in Vienna, Austria.
Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.
Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.
Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.
Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.
Dr. Bella Mehta interviews Dr. Vincenzo Venerito about abstract POS0236 at Eular 2024 in Vienna, Austria.
Dr. Aurelie Najm discusses abstract OP0184, presented at Eular 2024 in Vienna, Austria.
Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.
Dr. David Liew reports on abstracts OP0007 and OP0069 at Eular 2024 in Vienna, Austria.
Dr. Mrinalini Dey reports from Eular 2024 in Vienna, Austria about an abstract she will present during the meeting, POS0309.
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria:
Dr. Eric Ruderman discusses abstracts OP0046 and POS0058 presented at Eular 2024 in Vienna, Austria.OP0046 Effect on SI joint structural lesions with ixekizumabPOS0058 Effect on SI joint structural lesions with bimekizumab
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria:OP0195 Sonelokimab IL 17 A/F nanobody inhibitorLB0005 Izokibep IL17A nanobody inhibitorPOS0803 Vunakizumab, another IL17A inhibitorOP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria:OP0195 Sonelokimab IL 17 A/F nanobody inhibitorLB0005 Izokibep IL17A nanobody inhibitorPOS0803 Vunakizumab, another IL17A inhibitorOP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib
Dr. Jack Cush reviews FDA approval, news and journal articles -- Its the week before EULAR 2024 in Vienna!!
Dr. Jack Cush reviews the journal reports and articles from this past week on RheumNow.com. The ACR (and Cush) address their new website designed to educate PCPs and APP's - what do you think?
Dr. Jack Cush reviews the journal reports and news from the past week on RheumNow.com. This week blockbuster drugs, opioids in rheumatology and nontreatment of inflammatory arthritis?
Dr. Jack Cush reviews the news and journal reports from the past 2 weeks. This weeks question - Can we prevent gout, ILD or psoriasis?
In lieu of this weeks podcast, Dr. Jack Cush records his "Life Lessons (that keep changing) in Rheumatology Lecture.A lecture recently cancelled because some of this content was objectionable? (I dont think so!)
The 2023 EULAR recommendations for the management of lupus advocate for a treat-to-target approach, aiming for remission or low-level disease activity state.3 In this video, Dr. Michelle Petri summarizes the clinical criteria to attain these targets, and their association with reducing organ damage accrual.
The 2023 EULAR recommendations for the management of lupus advocate for a treat-to-target approach, aiming for remission or low-level disease activity state.3 In this video, Dr. Michelle Petri summarizes the clinical criteria to attain these targets, and their association with reducing organ damage accrual.
Dr. Jack Cush muses on the news, journal reports, FDA announcements and the 2024 BSR abstracts just released.
Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A:
Rethinking Pre-Clinical Disease in Lupus
David Karp, MD
Biology and Rx of Lupus Flares
Michelle Kahlenberg, MD
Current/Future Biomarkers in SLE
Andrea Fava, MD
Join us for session highlights from RheumNow Live 2023. This webinar will feature highlights from these lectures followed by live audience Q & A:
Nonradiographic Axial Spondyloarthritis
Eric Ruderman, MD
Enthesitis in Spondyloarthritis
Lihi Eder, MD
Future Therapy of Axial Spondyloarthritis
Lianne Gensler, MD
Dr. Jack Cush reviews regulatory reports, news and novel journal articles - this week focusing on Sjogrens, ILD, Gout and Uveitis.
Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A:
Vasculitis & Pregnancy
Catherine Sims, MD
GPA Management in 2024
Anisha Dua, MD, MPH
Treat to Target in Vasculitis
Philip Seo, MD
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. Is it time to worry about burnout and those who are leaving healthcare?
Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A:
EULAR vs ACR vs GRAPPA Guidelines
Alexis Ogdie, MD
Choosing Systemic Therapies for Psoriatic Disease
April Armstrong, MD
Gender Differences in PsA Outcomes & Management
Lihi Eder, MD
Dr. Jack Cush reviews the news and Journal reports from this past week on RheumNow.com - including problems w/ falls, pain and treatment of Dupuytrens contractures.
Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A:
Lessons from Cardio-Rheumatology Clinic RA
Brittany Weber, MD
Nutrition in RA
Monica Guma, MD
Prevention of RA
Hani El Gabalawy, MD
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com, including on where you should sit in clinic and why you should worry about secondary Sjogrens in RA.
Dr. Jack Cush reviews the news and journal reports from the past week - including a few contrary reports on infection, seropositivity and plasmapheresis.
Dr. Jack Cush has advise for Cesar and the superstitious and covers pregnancy, platelets, dialysis and vaccinations in Lupus.
Dr. Jack Cush reviews the news, journal reports and regulatory approvals from the past week.
Hear Dr. Richard Furie and Dr. Leanna Wise discuss clinical considerations related to the 2023 EULAR treatment recommendations for SLE. US-85292 last updated 2/24.
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Are these associations with infection, biomarkers and weather real or imaginary? Linked or luck? Causal or casual? You decide....
Dr. Jack Cush reviews the news and journal reports from the past 2 weeks on RheumNow.com; but begins with a discussion of what constitutes "immunosuppression" and how it applies to our patients.
Dr. Jack Cush answers audience clinical case questions sent by email or "ask Cush anything". Cases and questions from:
Dr. William Hong - RA management in the setting of active TB or latent TB (LTBI)
Dr. Vrishali Dalvi - relapsing polychondritis monitoring
Dr. Ken Stark - ICI induced RA; management and breast cancer considerations
Dr. Nada Skaf - Sarcoidosis in the maxilla
Dr. Cush - acute onset (knee) monarthritis
Dr. Jack Cush reviews the journal reports from the past week on RheumNow.com. Highlights are summarized by three songs: "Stairway to Heaven", "Youre No Good", and "How Long (has this been going on)".
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week we discuss hipsters undergoing hip replacement, pregnancy outcomes in RA and the future of academic clinicians.
Tune in to Dr. Spiera and Dr. Lebovics to learn about ear, nose, and throat manifestations in granulomatosis with polyangiitis (GPA) and gain insights into daily life of a person living with severe active GPA. USA-569-80515.
Dr. Jack Cush reviews the terms in rheumatology that should no longer be used in the field of rheumatology. This lecture is part of the RheumNow Live 2024 meeting, being held January 27-28, 2024 in Dallas, TX (and virtually).
QD264 - To Aspirate or Not https://youtu.be/ek25MJ0dI7g?si=SKLnw92gkJeFw0BM
QD265 - Suspend MTX How Long https://youtu.be/N6-m-IDrnFc
QD266 - GCA & Steroid Weaning https://youtu.be/Vyzd5_lMi_k
QD267 - RA, SSZ, & MI https://youtu.be/p9uzqk6VO1s
QD268 - ISR Management https://youtu.be/tztFzdA_oog
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. How good (or not) are rheumatologists and what to do about MTX nodulosis?
Dr. Jack Cush reviews highlights, advances and hot topics in rheumatology from 2023 and the RheumNow website.
2023 was a year of growth and new horizons while returning to operational and practice standards (in care and education) established before the pandemic.
Below is my top 10 list (in no particular order) of 2023 advances, game-changers, and developments that changed or will soon change rheumatologic practices.
QD260 - Do I have Arthritis? https://youtu.be/trnVWysh9cY
QD261 - A Non-Textbook Patient https://youtu.be/fePbSt_u6W4
QD262 - Rituximab Dosing in RA https://youtu.be/mG61Xk9skyc
QD263 - ANA Positivity in RA https://youtu.be/I8pKp52Lk1w
Dr. Jack Cush imparts his new New Years Resolutions for 2024 and also reviews the news and journal reports from the past week on RheumNow.com.
Drs. Liebowitz and Mehta review the diagnostic concepts, risk factors, pathophysiology, and management of monogenic autoinflammatory diseases.
Dr. Jack Cush reviews selected AOSD & systemic JIA abstracts from the ACR 2023 Annual meeting held in San Diego, November 12th thru 16th.
QD255 - The ANA Positive Consult https://youtu.be/My4zfWNB8g0
QD256 - Great Rheum Meetings https://youtu.be/1WxBzQQ0jgE
QD257 - Assessing Lupus Activity https://youtu.be/xK04eaP8rBc
QD258 - Unmet Need in Gout https://youtu.be/fcB-WQjhxlc
QD259 - Hospitalized JAK Patient https://youtu.be/i8Fiq56Jcbs
QD250 - RA & Pleuritis https://youtu.be/t4xxK6wH9iU?si=z1XoXMhA33lhWviE
QD251 - Eosinophilia in RA https://youtu.be/Qft9RGE2sBs?si=lLAL-sZRmjFIEKES
QD252 - Uh oh, Scleroderma https://youtu.be/v5A5NSNk5wg?si=IdBW51AgVIHaORqr
QD253 - SLE and PsA https://youtu.be/MGWfEiSA7ic?si=F8zU45CRHz4pOTht
QD254 - How to Avoid Knee Arthroplasty https://youtu.be/ZfifWIfHV4E?si=n_XprFQih0FSz8md
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Two major reports on fatigue and fibromyalgia misfired and "ankylosing spondylitis" is sent to the Rheumatology dead word cemetary.
https://rheumnow.com/blog/rheumatology-dead-word-cemetery-2019
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. Be sure to catch the early registration break for 2024 RheumNow Live
Listen as rheumatologist Dr. Kathryn Dao and
gastroenterologist Dr. Amar Naik share similarities and
differences in their clinical perspectives, including a
conversation on some of the benefits and risks of a JAKi in
each patient population.
Dr. Jack Cush reviews this past weeks news and journal reports from RheumNow.com. Good news is that nearly 99% of adult rheumatology positions matched! But the challenge is that 45% of pediatric fellowship programs and 39% of pediatric rheum slots were unfilled in the 2024 NRMP match
In this weeks podcast, Dr. Jack Cush reviews the ACR Convergence 2023 meeting and proposes how to best learn at large medical meetings:
An Interview with Kevin Winthrop_ Three Questions About COVID 19
Assessment and Treatment of Cardiovascular Risks in Rheumatoid Arthritis
Biologics in RA_ Mechanisms of Delivery Over Mechanisms of Action_ (1)
Cannabinoid Receptor in RA Patients
Impact of Tofacitinib on Skeletal Muscle in RA
No Increased Mortality in Patients with RA Receiving Checkpoint Inhibitors
Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD
Older RA Patients Just Aren't Getting Treated
People with RA and Long COVID Had Worse Pre-COVID RA Symptoms
Reproductive History, HPV Vaccination Among Women with SLE and RA
Teledidactic vs On Campus Training in Musculoskeletal Ultrasound
The SMART Study_ Split Dose Oral Methotrexate
Unravelling the Mechanism of Clots with JAK Inhibitors
Upadacitinib for Pain_ Is That Real_
Will CAR T Cells also treat RA_
Another TYK2 Ticks the Boxes
Head to Head Comparison of Tofacitinib and TLL-018 in RA
Impact of Tofacitinib on Skeletal Muscle in RA
Is Point of Care Ultrasound Hocus Pocus_
JAK1 TYK2 in RA
Monitoring the Effect of Therapy with a...Smart Watch_
Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD
Simulated JAK Trials to Counter ORAL Survelliance
Treatments in SpA
Unravelling the Mechanism of Clots with JAK Inhibitors
Upadacitinib for Pain_ Is That Real_
An Interview with Kevin Winthrop_ Three Questions About COVID 19
Does GnRHa Reduce Premature Ovarian Insufficiency in SLE Patients on Cyclophosphamide_
Identifying New Biomarkers in the Pathogenesis of SLE-PAH
Less (Glucocorticoids) is More in Lupus Nephritis
Lupus and the Patient Perspective
Lupus Nephritis Therapy Paradigm Shift
PR3+ in Lupus Nephritis
Racial and Ethnic Differences in Efficacy of Beliumumab in SLE
Reproductive History, HPV Vaccination Among Women with SLE and RA
The Lupus APOL1 Story
Bimekizumab in Active AS_ 5 Year Study
Deep Neural Networks and Radiographic Progression in AxSpA
Difficult to Treat axSpA
From AS Patient to Rheumatologist
Imaging Updates in SpA
INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA
Monitoring the Effect of Therapy with a...Smart Watch_
Overlap of Inflammatory and Degenerative Features in Radiographic axSpA
People with AxSpa Need More Sleep
Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA
SpA Insights_ New Therapies
Teledidactic vs On Campus Training in Musculoskeletal Ultrasound
Treatments in SpA
Undiagnosed IBD in AxSpA
Using Telemedicine to Improve Diagnosis of AxSpA
Another TYK2 Ticks the Boxes
Correlation Between Patient and Physicians Assessments in PsA
Difficult to Treat axSpA
Effects of Apremilast on Cardiometabolic Effects in PsA
EHR Algorithms Identify PsA Patients
Is MSOT the New Ultrasound_
Is Point of Care Ultrasound Hocus Pocus_
SpA Insights_ New Therapies
Teledidactic vs On Campus Training in Musculoskeletal Ultrasound
The FOREMOST Study_ Apremilast in PsA
Ultrasound for PsA Stratification_ Are We There Yet_
Window of Opportunity in PsA
Join Drs. Jack Cush and Arthur Kavanaugh as they discuss highlights and key takeaways from ACR 23.
Featuring panelists Dr. Kathryn Dao, Eric Dein and Sheila Reyes, discussing the best and most interesting lupus studies presented at the 2023 ACR Convergence meeting in San Diego, CA.
Bimekizumab in Active AS_ 5 Year Study
INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA
Overlap of Inflammatory and Degenerative Features in Radiographic axSpA
People with AxSpa Need More Sleep
Does Diet Matter in RA_ ITIS vs Mediterranean diet
EHR Algorithms Identify PsA Patients
JAK1 TYK2 in RA
Older RA Patients Just Aren't Getting Treated
PR3+ in Lupus Nephritis
Racial and Ethnic Differences in Efficacy of Beliumumab in SLE
Steroids and MACE in RA
Unravelling the Mechanism of Clots with JAK Inhibitors
Join our live stream panel discussion as we dive deep into the highlights and key takeaways from day one of ACR 2023.
Cannabinoid Receptor in RA Patients
Cardiac Troponin T and MACE Events in RA
Imaging Updates in SpA
Impact of Tofacitinib on Skeletal Muscle in RA
Teledidactic vs On Campus Training in Musculoskeletal Ultrasound
Treatments in SpA
Identifying New Biomarkers in the Pathogenesis of SLE-PAH
No Increased Mortality in Patients with RA Receiving Checkpoint Inhibitors
Simulated JAK Trials to Counter ORAL Survelliance
The FOREMOST Study_ Apremilast in PsA
The SMART Study_ Split Dose Oral Methotrexate
Upadacitinib for Pain_ Is That Real_
Head to Head Comparison of Tofacitinib and TLL-018 in RA
Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD
People with RA and Long COVID Had Worse Pre-COVID RA Symptoms
Reproductive History, HPV Vaccination Among Women with SLE and RA
Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA
The SMART Study_ Split Dose Oral Methotrexate
Undiagnosed IBD in AxSpA
Using Telemedicine to Improve Diagnosis of AxSpA
Window of Opportunity in PsA
An Interview with Kevin Winthrop_ Three Questions About COVID 19
Biologics in RA_ Mechanisms of Delivery Over Mechanisms of Action_ (1)
Deep Neural Networks and Radiographic Progression in AxSpA
Difficult to Treat axSpA
Does GnRHa Reduce Premature Ovarian Insufficiency in SLE Patients on Cyclophosphamide_
Factors Associated with Discontinuation of TNFs in AxSpA
From AS Patient to Rheumatologist
Join our live stream panel discussion as we dive deep into the highlights and key takeaways from day one of ACR 2023.
Join our live stream panel discussion as we dive deep into the highlights and key takeaways from day one of ACR 2023.
Features presentations by Drs. Jack Cush, Rachel Tate, Sheila Reyes, Yuz Yusof and Robert Chao. Discussing the following abstracts from ACR 2023:
- 0494 Occult IBD in SpA
-0781 Combination therapy and reduced dose prednisone in SLE
-
0723 TRAF5 and PAH in SLE
-
0845 Repeat MRI and testing in LBP patients
-0836 Imposter syndrome
-
0548 ANA+ referral approaches
-
CNS Vasculitis
-
0835 APIPPRA
-
0839 TLL-018 in RA
A Compilation of faculty reports from ACR 2023 in San Diego
Another TYK2 Ticks the Boxes
Is MSOT the New Ultrasound_
Is Point of Care Ultrasound Hocus Pocus_
Less (Glucocorticoids) is More in Lupus Nephritis
Lupus and the Patient Perspective
Lupus Nephritis Therapy Paradigm Shift
Monitoring the Effect of Therapy with a...Smart Watch_
SpA Insights_ New Therapies
The Lupus APOL1 Story
Treatment of VEXAS_
A Compilation of faculty reports from ACR 2023 in San Diego
Another TYK2 Ticks the Boxes
Is MSOT the New Ultrasound_
Is Point of Care Ultrasound Hocus Pocus_
Less (Glucocorticoids) is More in Lupus Nephritis
Lupus and the Patient Perspective
Lupus Nephritis Therapy Paradigm Shift
Monitoring the Effect of Therapy with a...Smart Watch_
SpA Insights_ New Therapies
The Lupus APOL1 Story
Treatment of VEXAS_
Dr. Jack Cush reviews this past weeks news on RheumNow.com and suggests a learning plan for those wanting to consume the upcoming ACR Convergence 2023 meeting.
QD245 - Patients Don't Read Textbooks https://youtu.be/gK18TgDTGyg
QD246 - Neighbor Consults https://youtu.be/D3ffK3l_gbU
QD247 - Habitually Noncompliant https://youtu.be/Vpwue51878c
QD248 - OA and Syncope https://youtu.be/O4v03KL_gOg
QD249 - Hemoptysis https://youtu.be/WbRSPBsfec8
Dr. Jack Cush reviews the news, journal reports and regulatory approvals from the past week on RheumNow.com.
- QD242: Fever of Unknown Origin - Dr. Sebastian Sattui https://youtu.be/-ftg4-LAQJQ?si=Ad2Vx-OPqfa56hT3
- QD243: Looks like PMR - But is it? - Dr. Sebastian Sattui https://youtu.be/atHtTlyeVqI?si=PcS_XoF3FE3FpVyW
- QD244 PMR TNR Pearls - Dr. Jack Cush https://youtu.be/pYiWP8RRTsM?si=edTIUy2QHoTADIzP
- Steroid Tapering in PMR: What's the Gold Standard? Dr. Anisha Dua https://youtu.be/7tYNlKpGzoA?si=xNbwVDlv8NknxqoC
- Should We be Giving IL-6 Inhibitors Late in PMR, or Early? Dr. Robert Spiera https://youtu.be/Ms7VDp5_MEc?si=JtDoxioB8rXslsRh
- Universal Imaging for GCA in PMR? Not so fast! Dr. Michael Putman https://youtu.be/VNCdiG7aaJ8?si=O2Dp4z6BI0WtDrLZ
- Advancing PMR. Dr. Eric Matteson https://youtu.be/A1uNGBMp8Lk?si=-HOV1hpW0s4p7qUj
- PMR is Only Proximal - Drs. Sarah Mackie and David Liew https://youtu.be/7VpoLT1pXt4?si=zoK96ctYtzKBVrw2
- PMR Needs an Elevated ESR or CRP - Drs. Robert Spiera and David Liew https://youtu.be/WD8c7HARZig?si=UdJGZkzrlPyvYlrt
- PMR Gets 100% Better Within 72 hours - Drs. Eric Matteson and David Liew https://youtu.be/WxzluNI5gFg?si=zDh6pr2KEWKcjIuG
- Role of the PCP in PMR Diagnosis and Care - Dr. Toby Helliwell https://youtu.be/EuuSqhNFM6Y?si=DX7M2Epq6_T-eWf6
- Which PMR Patients Should Rheumatologists See? - Dr. Sebastian Sattui https://youtu.be/_Bq5iXxUOic?si=rlDzD_8cCgndZ4ya
- Epidemiology of PMR - Dr. Max Yates https://youtu.be/EGJeLShhUrA?si=rPwf3AL_vGwElUdd
- ESR/CRP in PMR – Valued or Overvalued? - Dr. Stephen Paget https://youtu.be/1hJzb7Ek6pA?si=U4SomWDHgsYBwtsY
- The Differential Diagnosis of PMR - Dr. Ken Warrington https://youtu.be/qfONs2ixit8?si=eWT6txu95i-LUeZv
- PMR Mimics: PMR vs RA? - Dr. Robert Spiera https://youtu.be/s5on34V2YPc?si=pjpSUma_eZ0e9EU6
- PMR: Is There Hidden GCA? - Dr. Anisha Dua https://youtu.be/yRZPp9BbIBw?si=x4s0dkweRr86Y8iq
- PMR Must Rule Outs - Dr. Len Calabrese https://youtu.be/uCXEtF3GkPk?si=3Jpg8b7qX8FytSZ-
- Importance of Diagnostic Imaging in PMR - Dr. Claire Owen https://youtu.be/7KN1Vi2jOz0?si=PP6ozPi3xUvU2RQF
Rheumatologist and dermatologist Dr. Saakshi Khattri and rheumatologist Dr. Shikha Singla discuss what rheumatologists can learn from psoriasis trials when making clinical decisions about psoriatic arthritis.
"Differential Diagnosis of Inflammatory Back Pain" Featuring: Drs. Ethan Craig and Lianne Gensler
Sponsored by Novartis Pharmaceuticals Corporation
Dr. Jack Cush reviews RheumNow's top entries the PMR Campaign, news, journal reports and regulatory actions.
A TNR Panel discussion on controversies in PMR: diagnosis, imaging, PCP roles, Lumping vs. Splitting. Featuring Drs. Sarah Mackie, Wolfgang Schmidt, and Len Calabrese. Moderated by Dr. David Liew. Recorded on 10/24/2023
Dr. Jack Cush discusses the news, journal articles and regulatory actions. This week we discuss JAKne, DLE and SLE and more.
Panel discussion on treatment options beyond steroids in PMR. Featuring Drs. Sebastian Sattui, Sarah Mackie, Anisha Dua, Robert Spiera and David Liew. Recorded on 10/17/2023
Dr. Jack Cush reviews the news, journal reports and regulatory approvals from this past week on RheumNow.com.
- QD240 - Shoulder Arthralgias (Dr. D Liew) https://youtu.be/mgF00jbGKZ4
- QD241 Clinic: Draw Your Arthralgias (Dr. D Liew) https://youtu.be/mTrZuPliupQ
- QD239 Clinic PMR with Cancer (Dr. S Sattui) https://youtu.be/rSqmtsm6nYc
- QD242: Fever of Unknown Origin (Dr. S Sattui) https://youtu.be/-ftg4-LAQJQ
Tuesday Nite Rheumatology webinar on the use of corticosteroids in patients with PMR. Featuring panelists, Drs. Lindsey Lally, Richard Conway and Max Yates.moderated by Dr. David Liew. Recorded 10/10/2023
- QD236: Difficult PMR Considerations (Dr. S Mackie) https://youtu.be/p078Js9B81c
- QD237: Steroid Response for a PMR Diagnosis (Dr. J Cush) https://youtu.be/4EoVNQpVIlc
- QD238 - Difficult PMR Management (Dr. S Sattui) https://youtu.be/GuDYS7jjo_o
Dr. Jack Cush reviews the big PMR reports from this week along with other journal reports from RheumNow.com
This Tuesday Night Rheumatology PMR panel discusses "Diagnosis and Monitoring". This PMR panel that includes Drs. Claire Owen, Anisha Dua, Stephen Paget and Jack Cush. Recorded on 10/3/2023
This week on the podcast, Dr. Jack Cush is joined by special guest, Dr. Kathryn Dao to review the news and journal reports from the past week on RheumNow.com. They discuss unmet needs in gout, obesity and CV disease in PsA and should you check ANCA antibodies in SLE?
- QD232 - Bad Habits with Rheumatoid Factor https://youtu.be/xwGTYYBP6Oc
- QD233 - RA - GI Fast Track https://youtu.be/E6lKWJf7fOM
- QD234 - RA and Breast Cancer https://youtu.be/lyulIohG5F0
- QD235 - RA in Deep Remission https://youtu.be/VzxNnIUnmvU
This Tuesday Night Rheumatology panel discusses "DMARD Choices & Changes", including weaning, biosimilars, and guideline views from a panel that includes Drs. Madelaine Feldman, Alan Matsumoto, Artie Kavanaugh and Jack Cush.Recorded on 9/16/2023
Dr. Jack Cush is joined by Dr. Michael Weinblatt as they discuss this weeks news and journal reports, including difficult RA, HLA typing and abatacept responses and new regulatory decisions.
- QD229: Meet the patient where they are (Dr. E. Dein) https://youtu.be/OWdc6SoHDGo
- QD230: Cardiovascular Risk and RA (Dr. K. Dao) https://youtu.be/gjH1oqDlK2Q
- QD231: RA with Eye Problems (Dr. M. Putman) https://youtu.be/cdopMGbD2ww
- QD232: Enough with the Steroids (Dr. J Cush) https://youtu.be/cHFUNOtN_JQ
This Tuesday Night Rheumatology panel discussion on "Methotrexate Decisions" featured Drs. Michael Weinblatt, Grace Wright, Richard Conway and Joel Kremer. The Panel discussed folate & MTX dosing, side effect management, MTX & lung disease and optimal monitoring, with many audience questions.Recorded on 9/19/2023
- QD225: Rheumatoid Arthritis and VTE (Dr. J Cush) https://youtu.be/K1TzzKmVs5U
- QD226: Older RA Obstacles (Dr. J Cush) https://youtu.be/jHKPEwcqa0M
- QD227: RA and medication induced ulcers (Dr. B. Mehta) https://youtu.be/4QUtyz1WGJY
- QD228: Clinic: Induced inflammatory arthritis (Dr. D. Liew) https://youtu.be/3LkJKp-iGgk
- QD221: RA & Vaccination (Dr. J. Cush) https://youtu.be/6qsz0TPVKLU
- QD222: Goal of the First Visit (Dr. J Cush) https://youtu.be/EwsO9LCywzI
- QD223: MTX Pearls (Dr. J Cush) https://youtu.be/fktKlc0Pk-o
- QD224: RA on MTX with Progressive Dyspnea (Dr. R. Conway) https://youtu.be/g1Q_uG9zZ0g
- Hard Decisions - Debate: Triple DMARD Therapy (Drs. Pope & Wells) https://youtu.be/22NDkYnIUS0
- Hard Decisions: Perspectives: The Future of RA (Drs. McInnes & Burmester) https://youtu.be/HoxrZk5FG14
- Hard Decisions - Perspectives: Steroid Use in RA (Drs. Landewe, England, Nash) https://youtu.be/tcX8GA6xzQw
- Hard Decisions: HSV and RSV Update for Rheumatology (Dr. Winthrop) https://youtu.be/TZVcZW4DvQo
- Hard Decisions Debate: Imaging in RA (Drs. Troum & Ruderman) https://youtu.be/mFDZRmhPOPk- Hard Decisions: Import of Seropositivity (Dr. Cush) https://youtu.be/jePnI49K2u4
- Hard Decisions: MTX Dosing and Monitoring Issues (Dr. Weinblatt) https://youtu.be/XKAFe-xMkyU
- Hard Decisons - Perspectives: Difficult to Treat RA (Drs. Kavanaugh & Cush) https://youtu.be/Lmc6u9wFJU8
This week, Dr. Jack Cush reviews the news with special guest, Dr. Peter Nash. They discuss COVID Autoantibodies, SpA life expectancy, HCQ, extraarticular RA and our approach to Early RA referrals and pre-clinical RA.
This Tuesday Night Rheumatology was an hour long panel discussion featuring Drs. Jack Cush, Vivian Bykerk, Glenn Hazelwood and Martin J. Bergman. The Panel discussed Rheumatologists views on Early RA referral and intake, initial treatment preferences and views on diagnosing and treating pre-clinical RA. Recorded on 9/12/2023
This week, Dr. Jack Cush reviews the news with special guest, Dr. Janet Pope. They discuss "Not-non-Inferior", large scale genetic screening, Zoster risk w/ newer lupus drugs, Tapering, RA referral problems and the TNR webinar session on "Oral Surveillance Revisited"
This Tuesday Nite Rheumatology was an hour long panel discussion featuring Drs. Janet Pope, Jeff Curtis, Jon Giles and Roy Fleischmann. They reviewed the results and interpretations of the Oral Surveillance Study, Rheumatologists responses to a survey on this study and fielded questions from a Rheumatologist audience. Recorded 9/5/23.
Rheumatologists Dr. Roy Fleischmann and Dr. Janet Pope discuss treatment options for patients with RA who have failed a TNFi. The experts consider switching to an alternate MOA vs cycling to another TNFi.
Dr. Jack Cush Reviews the news and journal reports from this past week on RheumNow; and introduces September campaign - "Hard Decisions in RA".
As part of RheumNow's Hard Decisions in RA campaign, running throughout the month of September 2023, Dr. Eric Ruderman, Chicago and Dr. Orrin Troum, Santa Monica debate imaging in RA.
Dr. Jack Cush comments on the news and journal articles from the past week on RheumNow.com. This VEXAS scoring, scleroderma sine scleroderma and head scratchers from southeast Asia.
Dr. Jack Cush reviews the news and journal reports from the wonderful wide world of Rheumatology.
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. This week highlights Veterans, Vegetarians and Antenatal Corticosteroids.
Listen as rheumatologists Dr. Philip Mease and Dr. Saakshi Khattri share their insights on using composite measures to manage patients with psoriatic arthritis. In this podcast, they discuss four composite measures used in trials of an IL-23 inhibitor.
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week COVID persists, mortality stems from misdiagnosis, and cervical pain is more than a pain in the neck.
Dr. Jack Cush reviews the news and journal reports and this week, takes on 5 cases/questions from "Ask Cush Anything"
Dr. Jack Cush Reviews the news, journal articles and regulatory decisions from the past week from RheumNow.com. This week focuses on parodoxical psoriasis, scleroderma outcomes and subsets, and alopecia areata therapy.
Dr. Jack Cush reviews the news and reports from the past week on RheumNow.com. This week a new colchicine FDA approval, rising rate of IgG4 related disease and what's the safest biologic?
Effect of Ancestry on Therapeutic Outcomes in SLE Dr. Yuz Yusof https://youtu.be/QqthOjDxePE De Novo Renal Nephritis Flares During Belimumab Trials Drs. Yuz Yusof and Iaonnis Parodis https://youtu.be/BYORFgYOdcI Update on CAR T Cell Therapy in SLE & Autoimmune Diseases Dr. Peter Nash https://youtu.be/KnHRgaEcqGc We should put the CART before the T in SLE! Dr. Janet Pope https://youtu.be/carHG-5mFmQ Changes in the Causes and Predictors of Lupus Mortality in Spain Dr. Bella Mehta https://youtu.be/Yzm4twLAWfI JAK/TYK Inhibitors in SLE Dr. Janet Pope https://youtu.be/3wy5pOpbyPY Upadacitinib in SLE Dr. Peter Nash https://youtu.be/eqnXUrgpWdM SLE Trial: Dual BTK JAK Blockade compared Upadacitinib Monotherapy Dr. Yuz Yusof https://youtu.be/yTmQTA7yU8U Efficacy and Safety of Baricitinib in Lupus Nephritis Dr. Yuz Yusof https://youtu.be/DgTIdAlhK_s Baricitinib in Lupus Nephritis Dr. Peter Nash https://youtu.be/qyhMHyYKuTU
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com, including new drug approval, a new SpA variant and new rules for methotrexate (MTX) monitoring and depression screening.
Dr. Jack Cush reviews highlight abstracts and sessions from last weeks EULAR 2023 Congress held in Milan
Join Drs. Jack Cush, David Liew and Bella Mehta as they recap data presented on Day 4 at EULAR 2023 in Milan, Italy.
June 2, 2023RheumNow faculty and reporters provide a daily recap of conference content coverage.
Dr. Jack Cush reviews the news, journal articles and RNL highlights from this past week on RheumNow.com
This is a replay from the live RNL 2023 meeting and session on SPONDYLOARTHRITIS INNOVATIONS held on March 19, 2023.
This POD (session) devoted to advances in Spondyloarthritis and featured three excellent lectures:
- Dr. Atul Deodhar – Five Advances in SpA
- Dr. Denis Poddubnyy - Evaluation of the SI Joint
- Dr. John Reveilee – A Family Hx of AS – what does it mean
This Spondyloarthritis Innovations session was sponsored by Lilly
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. This week we delve into some odd associations, repeat drug warnings and the consequences of antirheumatic therapies.
Audience questions from the live RNL 2023 meeting and the session on EVOLUTION AND ADVANCES IN VASCULITIS held on March 18, 2023.
These sessions were sponsore by Sanofi.
This POD (session) featured three excellent lectures:
-
Dr. Robert Spiera: Therapies for GCA and PMR
-
Dr. Anisha Dua: Assessment of GCA and PMR
-
Dr. Carol Langford: GPA Treatment Choices
This week on the Podcast Dr. Jack Cush reviews the news and journal articles, including the risks of dying, developing RA or autoimmune disease!
Join us for session highlights from RheumNow Live 2023. This webinar will feature highlights from these lectures followed by live audience Q & A:
Remission in Psoriatic Arthritis
Laura Coates, MBBS
University of Oxford
JAK inhibitors in Psoriasis and PsA
Eric Ruderman, MD
Northwestern University Feinberg School of Medicine
Pregnancy in PsA
Christina Chambers, PhD, MPH
Join us for session highlights from RheumNow Live 2023. This webinar will feature highlights from these lectures followed by live audience Q & A:Preclinical RA – To Treat or Not To TreatKevin Deane, MDUniversity of ColoradoYear of the JAKiStanley Cohen, MD, University of TexasSouthwestern Medical SchoolFibroblast/Stromal CellsMichael Brenner, MDBrigham and Women’s HospitalHarvard Medical School
Tune in as rheumatologists Dr. Christina Charles-Schoeman and Dr. Roy Fleischmann discuss how you can help mitigate cardiovascular risk in your patients with rheumatoid arthritis. Listen as they share their perspectives on the rheumatologist’s role in cardiovascular risk assessment, patient education, and maintaining a primary focus on patient disease control.
This podcast presented by Dr. Michelle Petri, Professor of Medicine at the Hopkins Lupus Center,describes how estimated glomerular filtration rate slope may be a valid surrogate endpoint formonitoring renal damage accrual in lupus nephritis. 11. Levey AS et al. Am J Kidney Dis. 2020;75(1):84–104.
Dr. Jack Cush reviews the news and journal reports and addresses 3 viewer case questions.
Town Hall - Creating Change
Join us as we conclude our Women in Rheumatology campaign by focusing on what's next. Our panelists will recap the major challenges addressed this month and discuss a strategy to continue supporting women in rheumatology.
Speakers:
Dr. Kathryn H. Dao, MD
Dr. Rachel Tate, DO
Dr. Gwenesta B. Melton, MD
Moderator: Jack Cush, MD
This week on the podcast Dr. Jack Cush reviews the news, regulatory announcements and novel journal reports including a profile on pseudogout, the safety of immune checkpoint inhibitors in RA patients and the diagnostic importance of neutrophils.
Private Practice & Academia
In this session, our panelists will address the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?". Strategies for self-promotion, networking, finding a mentor, and engaging in research will be discussed with opportunities for you to ask the panelists questions about how you can advance in your career.
Speakers:
Dr. Priya Reddy, MD, FACR
Dr. Grace C. Wright, MD
Dr. Sheetal Desai, MD
Dr. Maio Danila, MD
Moderator:
Dr. Kathryn H. Dao, MD
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com, including Rheumatology success in the NRMP MATCH, Cocaine vasculitis and worrisome safety risks with Biologics and tsDMARDs.
April 11, 2023
Contract Negotiations
Our panelists are joined this week by Andrea Liberatore, JD, to discuss contract negotiations. Join us to learn more about initial contracts, renegotiating contracts, and working with pharma. You will have a chance to ask our panelists questions and learn how to approach your next contract negotiation.
Speakers:
Gwenesta B. Melton, MD, FACR
Andrea Liberatore, JD, is a member of the Litigation team. Her practice encompasses litigation matters for businesses, individuals, and local government
Moderator:
Dr. Kathryn H. Dao, MD
Dr. Jack Cush reviews the news and highlights from our "Women in Rheumatology" Campaign from last week on RheumNow.com
Dr. Jack Cush reviews the news and highlights from our "Women in Rheumatology" Campaign from last week on RheumNow.com
Tuesday - April 4, 2023
Straddling career and family obligations can be challenging at all stages of your career and family life. Our panelists will discuss the challenges they have faced and provide advice and strategies for managing competing priorities and obligations.
Speakers:
Dr. Marcela Ferrada
Dr. Yvonne Sherrer
Dr. Una Makris
Moderator:
Dr. Rachel Tate
Dr. Jack Cush reviews the CV advantage to walking, the OA risk with running and the eczema-OA connection; these articles and journal reports from the past week on RheumNow.com
Dr. Jack Cush reviews the news and journal articles from the past 2 weeks on RheumNow.com. This week reviews clinical associations with SS-A, a new biomarker for SSc-ILD and cancer screening for myositis patients.
Dr. Jack Cush reviews the news and journal articles from the past 2 weeks on RheumNow.com. This week reviews clinical associations with SS-A, a new biomarker for SSc-ILD and cancer screening for myositis patients.
This week on the podcast, Dr. Jack Cush recalls what life was like early on during COVID, March 2020, when his close friend, Larry, contracted COVID-19 and was hospitalized, intubated and put on mechanical ventilation in the ICU. This is the preamble to the "Miracle Larry" story that will be told by Larry Kelly himself, the keynote speaker at RheumNow Live 2023 on Saturday March 18th.
Come here Miracle Larry at RNL23. https://rheumnow.live/rheumnow/
You can also read about Miracle Larry here:
Faith https://rheumnow.com/blog/faith
NY Times: "51 Days on a Ventilator: How ‘Miracle Larry’ Survived" https://www.nytimes.com/2020/07/17/nyregion/coronavirus-ventilator-survivor.html
QD213 - My Bum Knee https://www.youtube.com/watch?v=zJWMlNjwvLEQD214 - New PMR Paradigm https://www.youtube.com/watch?v=chMOQb1FDUYQD215 - Abdominal Pain, Arthralgias, and a Poor Diet https://www.youtube.com/watch?v=XpYZ75aEt6oQD216 - Gottrons Without Weakness https://www.youtube.com/watch?v=S8ObCFHCtpwQD217 - Weight Loss & PsA https://studio.youtube.com/video/P9wsdrEURmQ/editQD218 - RheumNow Live 2023 Preview https://youtu.be/gVJ1XxsQ2WQ
Dr. Jack Cush Reviews the News and Journal articles from the past week on RheumNow. This weeks highlights includes insights on scleroderma, myositis, vasculitis and answers the question - does aggressive biologic treatment of psoriasis prevent future psoriatic arthritis?
QD209 - Recurrent Fevers; 3 Days at 103F https://youtu.be/whOxV89bKoQQD210 - Double Positive, but Few Joints https://youtu.be/HxW012E4K2UQD211 Managing Septic Arthritis in RA https://youtu.be/K39sPOBTSIIQD212 - I Wanna Get Pregnant https://youtu.be/52ydswdTvG8
Dr. Jack Cush reviews the lastest journal articles, news, and FDA announcements from the past week on RheumNow. This week, the importance of IFNa, Subclinical PsA and NSAID safety during Pregnancy.
QD205 - Chest Pain & Fever https://youtu.be/uw3V5NQTYTMQD206 - Arthralgia, Raynaud's & Anemia https://youtu.be/PUmQYDXayBcQD 207 - Molly's in trouble https://youtu.be/vIFTTqIxwsEQD 208 - VTE Options https://youtu.be/ZPyioVr7RQE
Dr. Jack Cush reviews the news and tries to stump the expert panel this week on the podcast.
Dr. Jack Cush reviews the news, journal articles and the numbers, from the past week on RheumNow.com
Dr. Jack Cush reviews this weeks journal articles, focuses on studies that should not have been done and responds to viewer questions in Ask Cush Anything
Dr. Jack Cush reviews the notable standouts in the news since the 1st of January. Surprising reports on ferritin, alcohol benefits, cannabis for pain and a lower dementia risk with hydroxychloroquine.
Dr. Jack Cush Reviews the highlight from 2022 in Rheumatology Check out the full podcast at RheumNow.com
Dr. Jack Frost reviews the news and journal reports with a bonus audience question at the end.
Dr. Jack Frost reviews the news and journal reports with a bonus audience question at the end.
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com
Leading experts from the SLE Educators’ Network discuss how biologic therapies may help address key unmet needs in lupus, while highlighting how clinicians can identify the most appropriate patients for biologic treatment.
ACR22 Year in Review Report Deucravacitinib in PsA JAK inhibitors in rheumatic diseases JAK vs TNF inhibitor Infections in RA New Treatments for SLE? Prelude to a Meeting (ACR22) (11.11.2022) Switching Between JAK Inhibiters in RA Tapering Methotrexate with Biologics or JAK Inhibitors in RA Tofacitinib and RA-ILD Upadacitinib vs Adalimumab in PsA using RAPID3
Addressing Sexual Health and STD Prevention in Lupus Patients CAR-T Therapies in Antiphospholipid Antibody Syndrome Copays Reduce Adherence to SLE Medications Diffuse alveolar hemorrhage in antiphospholipid syndrome Hydroxychloroquine Update from ACR22 Low-grade Proteinuria in Non Renal Lupus: Should We be Worried? Photovoice: A New Visual Research Method in Lupus Stop Ordering Repeat ANAs! Timely Fetal Screening Important in Positive Anti-Ro Antibody Pregnancies Life or Organ Threatening SLE: What To Do? Is There Anything New?
A Novel Treatment Response Measurement Tool for Lupus ACR22 Year in Review Report Breakthrough COVID infection in SLE during Omicron era Effect of voclosporin in class V lupus nephritis Lupus, Sex and STDs Poor Medication Adherence in SLE and How to Improve It Prelude to a Meeting (ACR22) (11.11.2022) Should You Repeat the ENA Panel? Urinary Biomarkers in Lupus Urine Proteomics in SLE with Dr. Michelle Petri
ACR 2022 Appraisal, Praise & Critique (11.18.2022) Best of ACR Day Two in PSA Efficacy and Safety Results from BE OPTIMAL in PsA JAK inhibitors in rheumatic diseases Oligoarticular PsA: FOREMOST Study Opioid use in PsA and SpA PET CT Imaging to Define Risk of Progression from PSO to PsA PsA and SPA: Cyclers, Switchers, Who is the Winner? Switch vs Cycle in PsA Women vs. Men: Response to Treatment in Seronegative Arthritis
Best of PsA on Day 1 Can computers tell the difference between RA & PsA? Deucravacitinib in PsA Differences in Presentation and Outcomes of Early vs Late Onset PsA Opioids and Health Care Utilization in PsA and AS Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor PsA Cycling or Switching MOAs The Dietary Intervention in PsA (DIPSA) Study Ultrasound in PsA Upadacitinib vs Adalimumab in PsA using RAPID3
Bouncebackability portends increased risk of adverse outcomes in RA Can I stop Methotrexate in RA? Fat and bone are never alone: osteoporotic fracture in RA JAK inhibitors in rheumatic diseases RA: Steroids are bad, again Reproductive health in a post-Roe world Sensor-engineered glove evaluates hand function in RA Tapering Methotrexate with Biologics or JAK Inhibitors in RA Tofacitinib and RA-ILD
ACR22 Daily Recap: Saturday Recap JAK vs TNF inhibitor Infections in RA Opioid and Neuropathic Use After Initiating btsDMARDs in RA Pre-RA Pharmacological Interventions: Delaying is not Enough PreRA to Treat or Not! Prescribing Methotrexate in Post-Roe Era The Great Debate: To Treat or Not to Treat Pre RA To Switch or Not: Biosimilars in Inflammatory Arthritis
ACR22 Year in Review Report Can computers tell the difference between RA & PsA? NSAIDs and CV risk in Inflammatory Arthritis Prelude to a Meeting (ACR22) (11.11.2022) QD205 - RA Activity During Pregnancy (abstract #0955) Sputum anti-CCP the new diagnostic test in at-risk RA? Switching Between JAK Inhibiters in RA Treatment Choices and Mortality in RA ILd
Treatment Considerations in Axial Spondyloarthritis What Happens after you stop biologics? What lifestyle factors affect TNF inhibitor efficacy in AxSpA? Which is better for AxSpA? IL-17i or TNFi? Women vs. Men: Response to Treatment in Seronegative Arthritis
Opioids and Health Care Utilization in PsA and AS Reproductive health in a post-Roe world Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression Sunday (Day 2): ACR 22 Daily Recap Tapering TNFi in nonradiographic AxSpA The CONSUL Trial: Ankylosing Spondylitis
Comorbidities in Ankylosing Spondylitis Early Diagnosis of Axial Spondyloarthritis Fertility issues in SpA Gender in AxSpa Inadequate Dosing of Hydroxychloroquine Leads to Hospitalizations in SLE JAK inhibitors in rheumatic diseases Opioid use in PsA and SpA
ACR22 Daily Recap: Saturday Recap AI Future of Sacroiliitis Assessment Artificial Intelligence in Detecting Sacroiliitis Axial Spondyloarthritis: gender differences Can we alter neonatal gut microbiome to prevent spondyloarthritis? Comorbidities in Axial Spondyloarthritis Do Disease Activity Measures Really Capture AS in Women?
Dr. Jack Cush and Dr. Arthur Kavanaugh discuss, dissect and deliberate the sessions and data presented at the ACR22 meeting in Philadelphia.
Wednesday - SpA Panelists: Drs. Lianne Gensler, Antoni Chan, Akhil Sood, Eric Dein, Sheila Reyes, Catherine Sims
Get the Skinny on Bimekizumab in PsA Dr. Janet Pope discusses abstract presented at ACR22 Convergence in Philadelphia, PA. L02: Bimekizumab Treatment in Biologic DMARD-Naïve Patients with Active Psoriatic Arthritis: 52-Week Efficacy and Safety Results from a Phase 3, Randomized, Placebo-Controlled, Active Reference Study
Low dose steroids can negatively impact bone healthDr. Janet Pope discusses abstract L01 presented at ACR22 Convergence in Philadelphia, PA. L01: Impact of Glucocorticoid Dosing and Anti-Osteoporotic Treatment on Bone Health in Patients with Inflammatory Rheumatic Musculoskeletal Diseases: A Longitudinal Cohort Study
The First Head to Head trial in Axial Spondyloarthritis Dr. Lianne Gensler discusses abstract L15 presented at ACR22 Convergence in Philadelphia, PA. L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis: A Randomized Phase IIIb Study
Why Clinical Trials? Dr. Guillermo Valenzuela talks about the importance of clinical trials from ACR22 Convergence in Philadelphia, PA.
RheumNow faculty to recap the best and most interesting data presented at ACR2022 in the area of PsA. Tuesday - PsA (7pm ET) Panelists: Drs. Rachel Tate, Robert Chao, Olga Petryna, Elaine Husni, Patricia Harkins
RheumNow faculty recap the best and most interesting data presented at ACR22 in RA. Panelists: Drs. Richard Conway, Aurelie Najm, David Liew, Janet Pope, Julian Segan
Autoimmunity Following COVID-19 Infection Dr. Akhil Sood discusses abstract 0795 at ACR22 Convergence. Abstract 0795: Post-Acute COVID-19 Sequalae (PACS) with New-onset Rheumatological Complications
Best of ACR22 in PsA: Day Three Dr. Rachel Tate discusses the best PsA content presented on day three (Monday) at ACR22 Convergence in Philadelphia, PA.
Medication Adherence intervention in SLE Dr. Bella Mehta speaks with Dr. Kai Sun abstract 0063 at ACR22 Convergence in Philadelphia, PA. Abstract 0063: Implementability of a SLE Medication Adherence Intervention
Peresolimab for RA: Phase 2a Results Dr. Jonathan Kay abstract L03 at ACR22 Convergence in Philadelphia. L03: A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
Breakthrough COVID infection in RMD patients treated with Evusheld Dr. Yuz Yusof talks with Dr. Chris Podgorski at ACR22 Convergence.
Lung Involvement in VEXAS Dr. Yuz Yusof and Dr. Marta Casal Moura discusses abstract 1569 presented at ACR22 Convergence. Abstract 1569: Lung Involvement in VEXAS Syndrome
Reproductive health in a post-Roe world Dr. Robert Chao discusses abstract 1673 and L09 presented at ACR22 Convergence. Abstract 1673: Preconceptional NSAID Treatment Exposure Is Associated with a Significantly Longer Time-to-conception in Women with Spondyloarthritis: Analysis of the Prospective GR2 Cohort Abstract L09: Impact on Access to Methotrexate in the Post-Roe Era
Stop Ordering Repeat ANAs! Dr. Kathryn Dao reviews abstracts 1278, 0228, and 0058 presented at ACR22 Convergence.
Ultrasound in PsA Dr. Arthur Kavanaugh discusses abstract 2206 presented at ACR22 in Philadelphia. Abstract 2206: Understanding Inter-rater Variability in Scoring of Entheseal Lesions: Results from the Diagnostic Ultrasound Enthesitis Tool (DUET) Study
What Happens after you stop biologics? Dr. Robert Chao discusses abstract 0427 presented at ACR22 convergence. Abstract 0427: Recapture Rates with Ixekizumab After Withdrawal of Therapy in Patients with Axial Spondyloarthritis: Results at Week 104 from a Randomized Placebo-controlled Withdrawal Study
Which is better for AxSpA? IL-17i or TNFi? Dr. Robert Chao discusses abstract L15 presented at ACR22 Convergence.
Bouncebackability portends increased risk of adverse outcomes in RA Dr. Richard Conway discusses Abstract 2218 at ACR22 Convergence. Abstract 2218: Frailty Is Associated with Serious Infections in Biologic and Targeted-synthetic DMARD Treated Patients with Rheumatoid Arthritis
Deucravacitinib in PsA Dr. Arthur Kavanaugh discusses abstract 1598 at ACR22 Convergence in Philadelphia. Abstract 1598: Safety and Efficacy of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients with Psoriatic Arthritis: 52-Week Results from a Randomized Phase 2 Trial
Efficacy and Safety Results from BE OPTIMAL in PsA Dr. Arthur Kavanaugh discusses abstract L02 ACR22 Convergence in Philadelphia, PA. L02: Bimekizumab Treatment in Biologic DMARD-Naïve Patients with Active Psoriatic Arthritis: 52-Week Efficacy and Safety Results from a Phase 3, Randomized, Placebo-Controlled, Active Reference Study
Hydroxychloroquine Update from ACR22 Dr. Michelle Petri reviews several abstracts presented at ACR22 Convergence. Abstracts 0343, 0538, 0976, 0983, 0981, 0980
RA: Steroids are bad, again Dr. Richard Conway discusses Abstract 2219 at ACR22 Convergence Abstract 2219: Time-Dependent Evaluation of Glucocorticoid Exposure Duration and Major Adverse Cardiovascular Events in a Cohort of Veterans with Rheumatoid Arthritis
Tapering TNFi in nonradiographic AxSpA Dr. Peter Nash at ACR22 Convergence in Philadelphia, PA.
Tofacitinib and RA-ILD Dr. Richard Conway discusses Abstract 2251 at ACR22 Convergence. Abstract 2251: Reduction in Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk in Patients Treated with Tofacitinib
Life or Organ Threatening SLE: What To Do? Is There Anything New? Dr. Michelle Petri discusses Abstracts 1651, 1677 at ACR22 Convergence in Philiadelphia, PA.
Comorbidities in Axial Spondyloarthritis Dr. Antoni Chan discusses Abstract 1609 at ACR22 Convergence.
Diffuse alveolar hemorrhage in antiphospholipid syndrome Dr. Eric Dein discusses Abstract 0675 at ACR22 Convergence. Abstract 0675: Clinical Characteristics and Factors Associated with Relapse and Mortality in Diffuse Alveolar Hemorrhage Among Patients with Antiphospholipid Syndrome: A Multi-Center Retrospective Cohort
Eosinophilia in systemic JIA patients after exposure to biologics Dr. Bella Mehta discusses Abstract 0872 at ACR22 Convergence. Abstract 0872: Incidence, Risk Factors, and Outcomes of Eosinophilia on IL-1 and IL-6 Inhibitors in Systemic and Non-Systemic Juvenile Idiopathic Arthritis
Gender differences in Axial Spondyloarthritis Dr. Antoni Chan covered abstracts 0497 and 1614 at ACR22 Convergence in Philadelphia, PA.
Inadequate Dosing of Hydroxychloroquine Leads to Hospitalizations in SLE Dr. Sheila Reyes discusses abstract 1654 at ACR22 Convergence. Abstract 1654: Hydroxychloroquine Dosing Less Than 5 Mg/kg/day Leads to Increased Hospitalizations for Systemic Lupus Erythematosus Flares
Oligoarticular PsA: FOREMOST Study Dr. Peter Nash discusses abstract 1018 at ACR22 Convergence. Abstract 1018: Characterization of Joint Distribution and Disease Burden in Patients with Early Oligoarticular Psoriatic Arthritis: Results from the Ongoing FOREMOST Study
Sensor-engineered glove evaluates hand function in RA Dr. David Liew discusses abstract 0904 at ACR22 Convergence. Abstract 0904: Testing the Hand Function with a Sensor-engineered Glove in Patients with Rheumatoid Arthritis
Best of ACR Day Two in PSA Dr. Rachel Tate, discusses abstracts 1018, 1159 at ACR22 Convergence.
Comorbidities in Ankylosing Spondylitis Dr. Akhil Sood discusses Abstract 1609 at ACR22 Convergence.
Fat and bone are never alone: osteoporotic fracture in RA Dr. David Liew discusses Abstract 889 at ACR22 Convergence. Abstract 889: Serum Adipokines Predict Incident Osteoporotic Fracture in Patients with Rheumatoid Arthritis
GCA: What we feel and what we can't Dr David Liew discusses Abstracts 0483 and 0486 at ACR22 Convergence.
Hydroxychloroquine: Cumulative Doses and Thresholds Dr. Sheila Reyes discusses Abstracts 0982 and 0344 at ACR22 Convergence.
JAK inhibitors in rheumatic diseases Dr. Antoni Chan discusses abstracts 0510 and 0404 at ACR22 Convergence in Philadelphia, PA. Abstract 0510: MACE and VTE Across Upadacitinib Clinical Trial Programs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Abstract 0404: Site-Specific Responses of Joint and Entheses to Tofacitinib in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of a Phase 3 Trial
Low-grade Proteinuria in Non-Renal Lupus: Should We be Worried? Dr. Yuz Yusof discusses Abstract 1463 presented at ACR22 Convergence in Philadelphia, PA.
PET CT Imaging to Define Risk of Progression from PSO to PsA Dr. Peter Nash discusses Abstract 1018 at ACR22 Convergence.
Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression Dr. Lianne Gensler discusses the following abstracts presented at ACR22 Convergence. Abstracts 1597, 1598, 1599 (treatment) and 1613, 1609 and 1614 (diagnosis and outcomes)
Tapering TNF Inhib in non Radiolgraphic AxSpA Dr. Peter Nash, Philadelphia
Vaccines Work! Dr. Eric Dein and Dr. Caoilfhionn Connolly discuss abstracts 2275 & 0797 at ACR22 Convergence.
Join RheumNow faculty to recap the best and most interesting data presented at ACR22 in the area of SLE. Sunday - SLE Panelists: Drs. Kathryn Dao, Bella Mehta, Yuzaiful Yusof, Eric Dein, Michael Putman, Sheila Reyes, Janet Pope
AI Future of Sacroiliitis Assessment Dr. Rachel Tate speaks with Dr. Fabian Proft about Abstract 0383 at ACR22 Convergence.
Can I stop Methotrexate in RA? Dr. Janet Pope and Dr. Charis Meng discuss Abstract 0916 at ACR22 Convergence. Abstract 0916: Should RA Patients with Controlled Disease Taper Methotrexate from Targeted Therapy or Continue It? Risk Differences in Sustaining Remission from a Systematic Review and Meta-analysis
CAR-T Therapies in Antiphospholipid Antibody Syndrome Dr. Michael Putman and Dr. Maximilian Konig discuss abstract 1677 at ACR22 Convergence. Abstract 1677: Chimeric Autoantigen-T Cell Receptor (CATCR)-T Cell Therapies to Selectively Target Autoreactive B Cells Copays Reduce Adherence to SLE Medications Dr. Michael Putman reports on abstract 1115 at ACR22 Convergence in Philadelphia, PA.
Copays Reduce Adherence to SLE Medications Dr. Michael Putman reports on abstract 1115 at ACR22 Convergence in Philadelphia, PA.
Does Race play a role in Mycophenolate Response in Scleroderma? Dr. Eric Dein speaks with Dr. Lauren Smith about abstract 0521 at ACR22 Convergence in Philadelphia, PA. Abstract 0521: Examination of Differential Response to Treatment with Mycophenolate Mofetil in Black and White Patients with Systemic Sclerosis
Fertility issues in SpA Dr. Sheila Reyes speaks with Dr. Sabrina Hamroun about abstract 1673 at ACR22 Convergence. Abstract 1673: Preconceptional NSAID Treatment Exposure Is Associated with a Significantly Longer Time-to-conception in Women with Spondyloarthritis: Analysis of the Prospective GR2 Cohort
Opioid use in PsA and SpA Dr. Eric Dein discusses Abstract 1012 at ACR22 Convergence
PsA and SPA: Cyclers, Switchers, Who is the Winner? Dr. Aurelie Najm discusses abstracts 1499 and 1600 at ACR22 Convergence in Philadelphia, PA.
Remibrutinib in Sjogren's Syndrome Dr. Michael Putman reports on abstract 1113 presented at ACR22 Convergence meeting in Philadelphia, PA. Abstract 1113: Remibrutinib (LOU064) in Sjögren’s Syndrome: Safety and Efficacy Results from a 24‑Week Placebo-controlled Proof-of-Concept Study
Advancing Telehealth in Rheumatology Dr. Cush at ACR22 Convergence in Philadelphia, PA.
Artificial Intelligence in Detecting Sacroiliitis Dr. Akhil Sood discusses Abstract 0383 at ACR22 Convergence. Abstract 0383: Analysis of the Performance of an Artificial Intelligence Algorithm for the Detection of Radiographic Sacroiliitis in an Independent Cohort of axSpA Patients Including Both Nr-axSpA and r-axSpA
COVID Highlights Dr. Leonard Calabrese and Dr. Cassandra Calabrese share highlights on COVID data being presented at ACR22 Convergence. Abstract 0793: Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation Abstract L08: Breakthrough Acute COVID-19 Infection During the US Omicron Surge Following Administration of Tixagevimab/Cilgavimab in Immunocompromised Patients with Rheumatologic Disorders
Impact of COVID 19 on Pregnancies in Women with RMD Dr. Cassy Sims discusses abstract 0950 at ACR22 Convergence. Abstract 0950: Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status: Data from the COVID-19 Global Rheumatology Alliance Registry
Photovoice: A New Visual Research Method in Lupus Dr. Bella Mehta talks with Dr. Candace Feldman about Abstract 1099 at ACR22 Convergence. Abstract 1099: Empowering Patients with Lupus Through Their Photographs: Application of the Photovoice Method to Understand Social Determinants of Health
PreRA to Treat or Not! Dr. Janet Pope discusses the Great Debate at ACR22 Convergence in Philadelphia.
Prescribing Methotrexate in Post-Roe Era Dr. Cassy Sims reports live from ACR22 Convergence in Philadelphia, PA. L09: Impact on Access to Methotrexate in the Post-Roe Era
To Switch or Not: Biosimilars in Inflammatory Arthritis Dr. Jonathan Kay reports on abstract 1112 at ACR22 Convergence.
Women vs. Men: Response to Treatment in Seronegative Arthritis Dr. Janet Pope discusses abstracts 1614 and 1601 at ACR22 Convergence in Philadelphia, PA
Advancing Telehealth in Rheumatology Dr. Cush at ACR22 Convergence in Philadelphia, PA.
Artificial Intelligence in Detecting Sacroiliitis Dr. Akhil Sood discusses Abstract 0383 at ACR22 Convergence. Abstract 0383: Analysis of the Performance of an Artificial Intelligence Algorithm for the Detection of Radiographic Sacroiliitis in an Independent Cohort of axSpA Patients Including Both Nr-axSpA and r-axSpA
COVID HighlightsDr. Leonard Calabrese and Dr. Cassandra Calabrese share highlights on COVID data being presented at ACR22 Convergence Abstract 0793: Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation Abstract L08: Breakthrough Acute COVID-19 Infection During the US Omicron Surge Following Administration of Tixagevimab/Cilgavimab in Immunocompromised Patients with Rheumatologic Disorders
Impact of COVID 19 on Pregnancies in Women with RMD Dr. Cassy Sims discusses abstract 0950 at ACR22 Convergence. Abstract 0950: Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status: Data from the COVID-19 Global Rheumatology Alliance Registry
Photovoice: A New Visual Research Method in Lupus Dr. Bella Mehta talks with Dr. Candace Feldman about Abstract 1099 at ACR22 Convergence. Abstract 1099: Empowering Patients with Lupus Through Their Photographs: Application of the Photovoice Method to Understand Social Determinants of Health
Prescribing Methotrexate in Post-Roe Era Dr. Cassy Sims reports live from ACR22 Convergence in Philadelphia, PA.3 L09: Impact on Access to Methotrexate in the Post-Roe Era
Treatment Persistence and Switching Patterns of an Adalimumab Biosimilar Dr. Julian Segan discusses Abstract 1425 at ACR22 Convergence. Abstract 1425: Treatment Persistence and Switching Patterns of ABP 501 (AMGEVITA®) in German Patients with Rheumatic Diseases
Can we alter neonatal gut microbiome to prevent spondyloarthritis? Dr Chao discusses Abstract 0868 at the ACR22 Convergence meeting. Abstract 0868: Spondyloarthritis and Neonatal Factors Affecting the Gut Microbiome
JAK vs TNF inhibitor Infections in RA Dr. David Liew discusses abstract 0302 at ACR22 Convergence. Abstract 0302: Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis
Opioid and Neuropathic Use After Initiating btsDMARDs in RA Dr. Julian Segan discusses Abstract 0925 at the ACR22 Convergence meeting.
The Dietary Intervention in PsA (DIPSA) StudyDr. Patricia Harkins talks with Professor Lihi Eder about abstract 1007 at the ACR22 Convergence meeting. Abstract 1007: Metabolic Disorders and Abnormal Dietary Patterns and Their Association with Psoriatic Arthritis Activity: The Dietary Intervention in PsA (DIPSA) Study
Treatment Considerations in Axial Spondyloarthritis Dr. Lianne Gensler discusses treatment considerations in Axial SpA. Abstract 0402: Opioid Use and Healthcare Utilization in Adults with PsA and AS Abstract 0388: Incidence Rate and Factors Associated with Fractures Among Older Adults with Ankylosing Spondylitis in the United States Abstract 0544: Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients with Active Non-Radiographic Axial Spondyloarthritis: 24-Week Efficacy & Safety from a Phase 3, Multicenter, Randomized, Placebo Controlled Study Abstract 0545: Continuing (Full or Reduced Treatment) versus Withdrawing from Golimumab Treatment in Patients with Non-radiographic Spondylarthritis Who Achieved Inactive Disease: Efficacy and Safety Results from a Placebo-Controlled, Randomized Withdrawal and Retreatment Study (GO-BACK)
What lifestyle factors affect TNF inhibitor efficacy in AxSpA? Dr Chao discusses Abstract 1510 at ACR22 Convergence. Abstract 1510: Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis – Data from 14 European Countries
2023 RWCS Meeting Dr. Arthur Kavanaugh invites you to join him for the 2023 RWCS meeting in February 2023.
Dr David Liew JAK inhibitor VS TNF inhibitor, Infections in East Asian Patients. Abstract 302
Early Diagnosis of Axial Spondyloarthritis Dr. Antoni Chan talks with Dr. Nelly Ziade at ACR22 Convergence in Philadelphia, PA. Abstracts 1512: What Is the Best Referral Strategy for Axial Spondyloarthritis? A Prospective Multicenter Study of 515 Patients with Suspicious Chronic Low Back Pain Abstract 1517: Value of the Anti-CD74 Antibodies for the Diagnosis of Axial Spondyloarthritis: Results of a Prospective Study in Patients with Suspicious Low Back Pain
New Treatments for SLE? Dr. Michelle Petri discusses abstract 1117 presented at ACR22 Convergence meeting in Philadelphia, PA. Abstract 1117: Efficacy and Safety of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Patients with Active Systemic Lupus Erythematosus: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Breakthrough COVID infection in SLE during Omicron era Dr. Yusof talks with Dr. Amit Saxena about abstract 2081 at ACR22 Convergence. Abstract 2081: COVID-19 Infections, Morbidity, and Seroreactivity in SLE Patients Following Initial Vaccination Series and Additional Dose Through the New York City Omicron BA.1 Wave
Differences in Presentation and Outcomes of Early vs Late Onset PsA Dr. Olga Petryna discusses abstract 0377 presented at ACR22 Convergence. Abstract 0377: Differences in Early-onset vs. Late-onset Psoriatic Arthritis: Data from the RESPONDIA and REGISPONSER Studies
A Year in Review Dr. Jack Cush, Philadelphia
Differences in Clinical Presentation and Outcomes of Early vs Late Onset PsA Dr. Olga Petryna, New York Abstract 0377
mTORC1 as a Driver of Inflammation in sJIA Connecting Pathogens of sJIA and MAS Dr. Olga Petryna, New York Abstract 0004
Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor Dr. Sims discusses abstract 0199 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0199: Izokibep, a Novel IL-17A Inhibitor, Improves Patient-reported Outcomes – 16-Week Results from a Placebo-controlled Phase 2 Study in Patients with Active Psoriatic Arthritis
The CONSUL Trial Dr. Sheila Reyes, The Phillipines Abstract 0526
Best of PsA on Day 1 Dr. Rachel Tate discusses the best PSA data presented Saturday, November 12, 2002 at ACR22 Convergence. Abstract 0387: Sleep Quality in Patients with Psoriatic Arthritis and Its Relationship with Activity and Comorbidity Abstract 0377: Differences in Early-onset vs. Late-onset Psoriatic Arthritis: Data from the RESPONDIA and REGISPONSER Studies
Can computers tell the difference between RA & PsA? Dr. David Liew discusses Abstract 0242 presented at ACR22 in Philadelphia, PA. Abstract 0242: Neural Networks for Distinguishing Rheumatoid Arthritis from Psoriatic Arthritis by Using Magnetic Resonance Imaging
Can you use the BASDAI in Pregnancy? Dr. Eric Dein discusses abstract 0374 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0374: The BASDAI Index During Pregnancy
Drs Tate and Worthing What's going on on the Hill Session # 12S119.
Effect of voclosporin in class V lupus nephritis Dr. Yusof discusses abstract 0355 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0355: Long-term Use of Voclosporin in Patients with Class V Lupus Nephritis: Results from the AURORA 2 Continuation Study
Microbiome and AxSPA Dr. Akhil Sood discusses abstract 1162 presented at ACR22 Convergence in Philadelphia, PA. Abstract 1162: Improvement of Gut Microbiota Dysbiosis in Patients with Axial Spondyloarthritis After One Year of Biological Treatment
Opioids and Health Care Utilization in PsA and AS Dr Aurelie Najm discusses Abstract 0402 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0402: Opioid Use and Healthcare Utilization in Adults with PsA and AS
Switching Between JAK Inhibiters in RA Dr. Janet Pope discusses abstract 0274 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0274: Real-world Utilisation and Switching Between Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in the Australian OPAL Dataset
Treatment Choices and Mortality in RA ILd 2 Dr. Julian Segen, Philadelphia Dr. Bryant England, Philadelphia
Upadacitinib vs Adalimumab in PsA using RAPID3 Dr. Catherine Sims discusses abstract 0192 presented at ACR22 Convergence. 0192: Upadacitinib versus Adalimumab on Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Psoriatic Arthritis
Frailty in Vasculitis Dr. Patricia Harkins sits down with Professor Sebastian Sattui to discuss Abstract 0444, Prevalence of Frailty and Associated Factors in Patients with Vasculitis, being presented on Saturday at ACR22 Convergence.
Lupus, Sex and STDs Dr. Kathryn Dao discusses abstract 0939 presented at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 0939: Pilot Study: A Novel Method for Cervical Health Monitoring in African American Women with Systemic Lupus Erythematosus (SLE) Using a Self- Sampling Brush to Assess Cervical HPV Infection and Cervical Cytology
Much gusto for GUSTO: Efficacy of Tocilizumab Monotherapy for Giant Cell Arteritis Dr. Richard Conway discusses abstract 0470, being presented during Poster Session A on Saturday, November 12, 2022 at the ACR 2022 meeting. Abstract 0470: Long-term Efficacy of Tocilizumab Monotherapy After Ultra-short Glucocorticoid Administration to Treat Giant Cell Arteritis – One Year Follow-up of the GUSTO Trial
NSAIDs and CV risk in Inflammatory Arthritis Dr. Richard Conway discusses abstract 1207, being presented during Poster Session C on Sunday, November 13, 2022 at the ACR 2022 meeting. Abstract 1207: Risk Factors for Major Cardiovascular Events (MACE) in Inflammatory Arthritis: A Time-dependent Analysis on the Inflammatory Burden, Use of DMARDs, NSAIDs, and Steroid
Should You Repeat the ENA Panel? Dr. Kathryn Dao discusses abstract 0725, presented at ACR22 Convergence. Abstract 0725: Utility of Repeat Extractable Nuclear Antigen Antibody Testing- a Retrospective Audit
To Beta Block or Not in GCA and Large Vessel Vasculitis Dr. Patricia Harkins discusses abstract 0477 presented on Saturday, November 12, 2022, at ACR22 Convergence. Abstract 0477: Can Beta-blockers Prevent Aortic Dilation in Patients with Giant Cell Arteritis and Large Vessel Vasculitis?
A Novel Treatment Response Measurement Tool for Lupus Dr. Kathryn Dao discusses abstract 2054 with Dr. Eric Morand at the ACR22 Convergence meeting. Abstract 2054: Towards a Novel Clinician-Reported Outcome Measure for SLE – Outcomes of an International Consensus Process
Sarilumab in Polymyalgia Rheumatica: Results from Phase 3 Trial Dr. Michael Putman interviews Dr. Robert Speira about abstract 1676 presented at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 1676: Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)
Welcome to ACR 2022 Dr. Jack Cush, Executive Editor of RheumNow, welcomes you to Philadelphia for ACR22 Convergence!
2022 ACR/EULAR Classification Criteria for GCA Dr. Michael Putman discusses interesting take-home messages from the Vasculitis Investigators Meeting at ACR22 Convergence regarding the 2022 ACR/EULAR Classification Criteria for GCA.
Gender in AxSpa Dr. Peter Nash, Philadelphia
Do Disease Activity Measures Really Capture AS in Women? Dr. Rachel Tate interviews Dr. Sinead Mcguire about Abstract 0406, presented at ACR22 Convergence in Philadelphia, PA. Abstract 0406: https://acrabstracts.org/abstract/are-the-basdai-basfi-capturing-the-full-impact-of-disease-activity-on-quality-of-life-in-women-with-axial-spondyloarthritis/
Dr Aurelie Najm Opoids and health care utilization in PsA and AS Abstract 402
Poor Medication Adherence in SLE and How to Improve It Dr. Janet Pope discusses three abstracts presented at the ACR22 Convergence meeting in Philadelphia, PA. 0343: Severe Non-adherence to Hydroxychloroquine Is Associated with Flares, Early Damage, and Mortality in Systemic Lupus Erythematosus: Data from 660 Patients from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort 0115: Facilitators of Immunosuppressive Medication Adherence in Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers and Clinic Staff 0063: Implementability of a SLE Medication Adherence Intervention
Sputum anti-CCP the new diagnostic test in at-risk RA? Dr. Aurelie Najm discusses abstract 0533 at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 0533: Sputum RA-Associated Autoantibodies Independently Associate with Future Development of Classified RA in an At-Risk Cohort of Individuals with Systemic Anti-CCP Positivity
Drs Cush and Fava: Urinary Biomarkers in Lupus Dr. Jack Cush interviews Dr. Andrea Fava about Abstract 536 at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 0536: Change in Urinary Biomarkers at Three Months Predicts 1-year Treatment Response of Lupus Nephritis Better Than Proteinuria
Social Media in Rheumatology Academia Dr. Kathryn Dao, Dallas Jorena Lim, third-year medical student, UTSW, Dallas Abstract 0220
Treatment Choices and Mortality in RA ILd Dr. Julian Segen, Philadephia Dr. Bryant England, Philadephia
Dr Tate PsA Cycling or Switching MOAs with Dr Ogdie Abstracts 1600 and 402.
Dr Cassy Sims The Impact of Upacitinib vs Adalimumab in Psoriatic Arthritis using RAPID Abstract 192.
Urinary Biomarkers in Lupus Dr. Jack Cush interviews Dr. Andrea Fava about Abstract 536 at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 0536: Change in Urinary Biomarkers at Three Months Predicts 1-year Treatment Response of Lupus Nephritis Better Than Proteinuria
Dr Janet Pope Switching from a JAK Inhibiter Abstract 0274.
Dr Yusof Effect of voclosporin in Class 5 lupus nephritis Abstract 0355.
Best of PsA Dr. Rachel Tate
Drs Yusof and Sexena Breakthrough COVID infection in a lupus cohort during Omicron era Session # 12S119.
PsA Cycling or Switching MOAs Dr. Rachel Tate interviews Dr. Alexis Ogdie at ACR22 Convergence in Philadelphia, PA. Abstract 1600: The Impact of Second-Line Therapeutic on Disease Control After Discontinuation of First Line TNF Inhibitor in Patients with PsA: Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry Abstract 402: Opioid Use and Healthcare Utilization in Adults with PsA and AS
Urine Proteomics in SLE with Dr. Michelle Petri Dr. Michelle Petri discusses abstract 0536, Change in Urinary Biomarkers at Three Months Predicts 1-year Treatment Response of Lupus Nephritis Better Than Proteinuria, being presented Saturday at ACR22 Convergence.
Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com and looks forward to highlight sessions in the next few days at ACR Convergence 2022.
QD201 - Seropositive Arthralgia (abstract #1604) https://youtu.be/uQt_IV3FmZc QD202 -1st Line Anakinra (abstract #L12) https://youtu.be/QyDVQBnYqn4 QD203 - When to Worry About Malignancy and Myositis (abstract #002) https://youtu.be/qt-debWfSrY QD204 How to Treat Erosive OA (abstract #L05) https://youtu.be/5-atRyBsCn4 QD205 - RA Activity During Pregnancy (abstract #0955) https://youtu.be/wavTWqZbhq4
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com. New regulatory decisions about JAK inhibitors and why do women with rheumatic diseases have unfair outcomes?
Dr. Nimesh Dayal (Orlando Health-Health Central Hospital, Orlando, FL) discusses the relevance of clinical endpoints and guidelines for ax-SpA in clinical practice. Sponsored by AbbVie Medical Affairs
Dr. Jack Cush discussess the news and journal reports from the past week on RheumNow.com . This week more lupus nephritis, more drug induced lupus and more lupus infections that may kill.
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Highlighted discussion of implantable stimulators, urine proteomics and gut-immune responses to Prevotella in RA.
Review of Adult-onset Still's Disease by Dr. Jack Cush, Executive Editor of RheumNow.com
Dr. Jack Cush reviews: - Should you do clinical trials? - how to start in clinical trials - Types of studies - Benefits to research
Dr. Jack Cush goes off on "Untitling" (not using proper names/titles) in the clinic, in additon to reports on rheumatologist salaries, new drugs in phase 1-3 development and the range of COVID-19 MSK symptoms -- all from the past week on RheumNow.com.
Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.
Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.
Thanks to all of you for your kind comments and great reviews of our weekly podcast. Please let us know how we can improve by emailing me (jackcush@rheumnow.com) or recording your suggestion using the "Ask Cush Anything" link on our email and website.
Thanks to all of you for your kind comments and great reviews of our weekly podcast. Please let us know how we can improve by emailing me (jackcush@rheumnow.com) or recording your suggestion using the "Ask Cush Anything" link on our email and website.
Dr. Jack Cush reviews the news, journal reports, ACR and FDA announcements from the past week on RheumNow.com
Dr. Jack Cush reviews the news, journal reports, ACR and FDA announcements from the past week on RheumNow.com
Can we predict the bad outcomes? Like when ITP evolves into SLE; or when psoriasis will develop arthritis; or if Sjogens will develop lymphoma? Dr. Jack Cush reviews these journal reports and this past weeks news from RheumNow.com
Can we predict the bad outcomes? Like when ITP evolves into SLE; or when psoriasis will develop arthritis; or if Sjogens will develop lymphoma? Dr. Jack Cush reviews these journal reports and this past weeks news from RheumNow.com
Dr. Jack Cush discusses declining survival rates in the USA, FDA approvals of new COVID subvariant boosters and other odd and possibly true new research reports from the past week on RheumNow.com.
Rainbow Rheumatology (8.26.2022) Dr. Jack Cush delivers this weeks rheumatology "weather report" with the best and least of news and journal articles from the past week on RheumNow.com
“Climate is what we expect, weather is what we get.” – Mark Twain
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow and discusses a case of refractory juvenile dermatomyositis with calcinosis.
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. This week the run down is based on popularity, measured by rheumatologist engagements on the website and social media.
Dr. Jack Cush reviews the news, FDA approvals, journal articles from the past week on RheumNow; plus viewer questions. This week great hopes for vitamin D, the great unknows of CSA and the great big mess that is the gout.
Drs. Jack Cush and Rachel Tate discuss the launch of the updated StillsNow.com website and the new monthly podcast from StillsNow.com. This podcast ends with a Still's disease quiz for rheumatologists.
QD197 - Still's (or Not) NEJM CPC https://youtu.be/_xnCaxeqidw QD198 - Still's (or Not) with Daily Fevers https://youtu.be/J1bezuA-f_s QD199 - Still's (or Not): an FUO Evaluation https://youtu.be/0qDijCAqEpQ QD200 - Still's (or Not): Fever, Joint pain & Itchy Eyes https://youtu.be/utvFA1lx1lc
Dr. Jack Cush reviews the news, journal reports and rheumatologist cases from the past week on RheumNow.com. This podcast is brought to you by StillsNow.com - be sure to sign up for our monthly StillsNow email and Monthly StillsNow Podcast.
This week's Stills disease Journal Club features expert discussants Drs. Olga Petryna, Daniel Lovell, Hermine Brunner and Jack Cush. Journal articles reviewed includes: - CONSIDER Trial. Canakinumab for Treatment of Adult-Onset Still's Disease. Kedor C. Ann Rheum Dis 2020 Aug;79:1090-1097 https://bit.ly/3coPFg0 - TENDER Trial. Tocilizumab in systemic juvenile idiopathic arthritis. De Benedetti F. N Engl J Med. 2012 Dec 20;367:2385-95 https://bit.ly/3uXFq8Q
Join Dr. Michael Weisman, Dr. Bella Mehta and Dr. Jack Cush in this live, one-hour Journal Club to discuss:
- Still's disease in the adult. EGL Bywaters. Annals of Rheumatic Disease 1971
- Juvenile rheumatoid arthritis presenting in the adult as fever of unknown origin. J Bujak, et al. Medicine 1973
Dr. Jack Cush reviews the new studies and drug approvals and new insights into febrile disorders from the past week on RheumNow.com
QD193 - Stills (or Not) MAS off of Tocilizumab https://youtu.be/xIco2Xdxf68 QD194 - Stills (or Not) with Widespread Pain https://youtu.be/50BXYafkVZM QD 195 - Stills (or Not) with Hives https://youtu.be/f4tPMylrnpQ QD 196 - Stills (or Not); A Wifes Letter https://youtu.be/eRnisH0Hjhw
Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021.
My Top 10 list 1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod 2. New FDA Indications 3. New Biologics for Lupus 4. Super "H" Hydroxychloroquine 5. Zoomatology 6. Avacopan 7. Tocilizumab 8. FDA & JAK inhibitor warnings 9. New Biologics for GCA 10. IL-23 Inhibitors
https://rheumnow.com/news/2021-rheumatology-year-review-172022
Still's disease is the most common rheumatic cause of unknown fever in adults. This series by Dr. Jack Cush covers the definition, history, epidemiology, key manifestations and labs, diagnostic criteria, pathogenesis and the management of adult-onset Still's disease.
Dr. Cush is the executive editor of StillsNow.com - a new medical education site focused on Still's disease and other febrile autoinflammatory disorders. You can subscribe to the website's monthly email with updated social media, news articles, videos and podcasts for physicians, patients and healthcare providers caring for patients with febrile disorders.
Dr. Jack Cush reviews recent news, regulatory and guideline updates from the past week on RheumNow.com. Studies on methotrexate use, COVID vaccination, Supplements and vitamins, and arthrocentesis despite anticoagulation are discussed.
A tutorial on podcasting - what works and what does not. Featuring Dr. Jack Cush of RheumNow.com
- David Liew: Can We Get Rid of RA? https://www.youtube.com/watch?v=Dc0X6k2e1NU&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=54
- Jonathan Kay: Rheumatoid Arthritis Comorbidities https://www.youtube.com/watch?v=1UUKeVWLVAs&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=29
- Richard Conway: Major Consequences of Depression In RA https://www.youtube.com/watch?v=WwLUL0zYZ58&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=17&t=36s
- Eric Dein: Incident Depression Major Risk Factor for Death in Rheumatoid Arthritis https://www.youtube.com/watch?v=7JyEPiY6K68&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=7
- Aurelie Najm: Treatment of Pre-RA: Is Early Already Too Late? https://www.youtube.com/watch?v=3Cznh59mgPQ&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=9&t=8s
- David Liew: Not Your Kind of RA https://www.youtube.com/watch?v=lQt7ymAIEx0&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=11
- Richard Conway: No Glory in GLORIA https://www.youtube.com/watch?v=VOMeRIjbdCc&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=19
- Aurelie Najm: Demystifying Synovial Tissue Biology https://www.youtube.com/watch?v=jxePzDtEYpg&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=20
- Richard Conway: Golden Window in Pre-RA https://www.youtube.com/watch?v=f9m0_-7MIhg&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=18
- Kathryn Dao: Methotrexate And The Sperm https://www.youtube.com/watch?v=JK-Jqzwxpvw&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=27
- Maxime Dougados: Residual Pain in RA https://www.youtube.com/watch?v=sJBbbU2WoNU&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=30
- Eric Dein: RA-ILD Lung Transplantation: Who Gets it and how do they do? https://www.youtube.com/watch?v=4Uo_18gdTpY&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=46
- David Liew: Low-dose steroids: can we get rid of them? https://www.youtube.com/watch?v=RibcAv2jpcI&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=51
- Eric Dein: EULAR Recommendations for ANCA Vasculitis https://www.youtube.com/watch?v=yy-3rllQ3UU&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=4
- David Liew: Getting Real on PMR https://www.youtube.com/watch?v=du_Lh_hcUt8&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=10
- David Liew: Vessels Glowing in the Dark - Does it Matter? https://www.youtube.com/watch?v=eAzm31Iy2SM&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=24
- Janet Pope: Updates in Polymyalgia Rheumatica and GCA https://www.youtube.com/watch?v=vrqSLYrq0xM&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=59
- Yuz Yusof: Sarilumab + Tapered Steroid Effective in Relapsing Polymyalgia Rheumatica https://www.youtube.com/watch?v=ynYKRvjONnw&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=57
- Janet Pope: Lower Dose Rituximab in ANCA Vasculitis https://www.youtube.com/watch?v=ykMGjJMVono&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=60
- Janet Pope: Vasculitis Abstracts from EULAR 2022 https://www.youtube.com/watch?v=Ursw_upv1g0&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=61
- Kathryn Dao: What Patients Want and Are Willing to Risk with SLE https://www.youtube.com/watch?v=lytObQy_UdQ&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=13
- Yuz Yusof: What Symptoms or Targets Mattered Most to People with Lupus? https://www.youtube.com/watch?v=EJKPsegnpS0&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=8&t=6s
- Kathryn Dao: AURORA-2 Two-year Results Voclosporin For Lupus Nephritis https://www.youtube.com/watch?v=HZOFQi559S4&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=14
- Kathryn Dao: Severe Hematologic Relapse Risk in SLE https://www.youtube.com/watch?v=j3S-BOhNhDE&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=15
- Eric Dein: Let’s Talk about Sex and Autoimmune Disease https://www.youtube.com/watch?v=hi_DqRiLPUw&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=21
- Kathryn Dao: DMARDS, Prednisone, Pregnancy, OH MY! https://www.youtube.com/watch?v=kwzKrzFjIWM&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=25
- Kathryn Dao: Belimumab Use in Pregnancy https://www.youtube.com/watch?v=14MUTorltoU&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=26
- Peter Nash: Deucravacitinib at EULAR 2022 https://www.youtube.com/playlist?list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP
- Yuz Yusof: Interview with Dr. Lucy Carter on RNA-Seq analysis to determine who's at risk for SLE https://www.youtube.com/watch?v=PhQvt6IVPfY&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=50
- Peter Nash: 2022 ASAS/EULAR Recommendations on the Management of Axial Spondyloarthritis https://www.youtube.com/watch?v=yp0AWs45hHo&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=34
- Robert Chao: Tapering TNFi in Psoriatic Arthritis and Axial Spondyloarthritis https://www.youtube.com/watch?v=P-naoLl_oA8&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=40
- Peter Nash: Increasing Secukinumab Dose in Ankylosing Spondylitis Nonresponders https://www.youtube.com/watch?v=SqBBRuirXsQ&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=35
- Janet Pope: Axial PsA: Is it for Real? https://www.youtube.com/watch?v=AqrKxnup2LQ&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=36
- Antoni Chan: Axial PsA vs. Axial SpA https://www.youtube.com/watch?v=t23KQvanKvQ&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=38
- Sophia Ramiro: New 2022 ASAS/EULAR Recommendations on the Management of Axial Spondyloarthritis https://www.youtube.com/watch?v=L0ehBOrVhEw&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=1&t=15s
- Antoni Chan: Update in Spondyloarthritis https://www.youtube.com/watch?v=WfNIP8vI93k&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=39
- Robert Chao: Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients https://www.youtube.com/watch?v=wiHZQQNLGQ8&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=41
- Aurelie Najm: TNFi in PsA and AxSpA: To Taper or Not? https://www.youtube.com/watch?v=6bYtgJ0BfxQ&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=47&t=62s
- Antoni Chan: Novel Imaging Studies in Psoriatic Arthritis https://www.youtube.com/watch?v=Te4_JwmfHrw&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=48&t=21s
- Antoni Chan: Gender Differences in Axial Spondyloarthritis https://www.youtube.com/watch?v=Jd3FN7F0F-I&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=58
- Antoni Chan: New Developments in Imaging in Spondyloarthritis - interview with Fabian Proft https://www.youtube.com/watch?v=aU4CcZwVa7o&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=65&t=1s
- Jeff Sparks: New 2022 EULAR RA Treatment Guidelines https://www.youtube.com/watch?v=31nddXtAuK4&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=31
- Peter Nash: Another Take on the 2022 EULAR RA Treatment Guidelines https://www.youtube.com/watch?v=RclHQAqqaL8&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=32
- Eric Dein: EULAR Recommendations for Rheumatoid Arthritis https://www.youtube.com/watch?v=uCV_QpKC1TI&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=6
- Janet Pope: EULAR RA guidelines — More of the same? https://www.youtube.com/watch?v=1iSDV90FJ6E&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=33
- Jonathan Kay: RA Potpourri on Day One EULAR 2022: Not An Ugly Duckling https://www.youtube.com/watch?v=PigUZ4g-UQw&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=28
https://www.youtube.com/watch?v=j31vuQDOomM&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=62&t=3s Featuring: Dr. Richard Conway, Dublin; Dr. Johannes Knitza, Erlangen, Germany; Dr. Sarah Mackie, Yorkshire, UK
https://www.youtube.com/watch?v=_zfS1NBshxI&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=63&t=6s Featuring Drs. Jack Cush, Richard Conway, Eric Dein and Jonathan Kay.
https://www.youtube.com/watch?v=XoJIcGZT58A&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=64&t=4s Featuring Drs. Jack Cush, Kathryn Dao and Yuz Yusof reporting on lupus-related studies and sessions from EULAR 2022.
- Antoni Chan: Telemedicine and Patient Engagement https://www.youtube.com/watch?v=DlmzAXgmKnA&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=66&t=20s
- David Liew: Telemedicine -- It's complicated https://www.youtube.com/watch?v=5s6atL5-0TM&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=52
- Jack Cush: Further Considerations of the ORAL Surveillance Study https://www.youtube.com/watch?v=LXjP5z87wPE&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=2&t=211s
- Janet Pope: Post Hoc Analysis of the ORAL Surveillance Study
- Jonathan Kay: Getting to the Heart of JAK Inhibitors
- David Liew: ORAL Surveillance: The Fallout https://www.youtube.com/watch?v=ps8fgbqR_3o&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=55
Dr. Jack Cush does a 2 week review of RheumNow Tweets on news and journal citations worth noting. Along with some opinions on Telehealth, manpower, monkeypox and the price of drugs.
Join us for session highlights from RheumNow Live 2022. This webinar will feature highlights from these lectures followed by live audience Q & A:
Advances in Psoriasis Management Bruce Strober, MD, PhD
Psoriasis Management Cases Kenneth Gordon, MD
Co-management of Psoriasis and PsA Joseph Merola, MD
ANNOUNCEMENT: Change of topic for tonight's webinar. Instead of 'psoriatic disease for rheumatologists', we are covering 'hot topics in rheumatology'.
Join us for session highlights from RheumNow Live 2022. This webinar will feature highlights from these lectures:
Adults with JIA Jonathan Hausmann, MD
Rethinking Pain and Analgesia Tuhina Neogi, MD
Fatigue and Central Sensitization in Rheumatic Disease Philip Mease, MD
Dr. Jack Cush reviews the news, regulatory updates and journal reports from the past week on RheumNow.com. This week gout worries, mortality risks, measuring anti-drug antibodies and a better way in lupus?
Leading experts from the SLE Educators' Network take us through the pathophysiology of SLE as we understand it today, and discuss the need to change the course of disease as a key treatment goal.
This RheumNow Live 2022 session features lecture highlights the Rheumatoid Arthritis - Best Management Pod followed by live audience Q & A. Featured lectures include: - Drug Cycling Vs Switching in RA - Janet Pope, MD, MPH, FRCPC - Multimorbidity in RA - Elena Myasoedova, MD, PhD - Preventing Rheumatoid Arthritis - Karen Costenbader, MD
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week neuroimmunology leading to therapy, the cold shoulder approach and Regulatory updates from the FDA
This RheumNow Live 2022 session features highlights from lectures on Spondyloarthritis. - Microbiome in Spondyloathritis - Jose Scher, MD - Axial Psoriatic Arthritis - Philip Mease, MD - Juvenile Spondyloathritis - Pamela Weiss, MD
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Bad news for digitial ulcers in Systemic sclerosis, Readmissions in Lupus and Thrombocytopenia in APL patients.
Join us for session highlights from RheumNow Live 2022. This webinar will feature highlights from these lectures followed by live audience Q & A:
Psoriatic Arthritis Guidelines Arthur Kavanaugh, MD
Drug Targeting in PsA Bruce Kirkham, MD PsA Registries and Real World Data Alexis Ogdie, MD
Dr. Jack Cush reviews the news, journal reports, FDA actions, new side effects and changing prevalence of Gout.
Join us for session highlights from RheumNow Live 2022. This webinar will feature highlights from these lectures followed by live audience Q & A:
Treatment Choices in Refractory RA - Dr. Jack Cush Adherence to Rheumatoid Therapies - Dr. Kaleb Michaud Precision Medicine in RA - Dr. Ernest Choy
Dr. Jack Cush reviews the news and journal reports and takes viewer questions this week
QD190 - PsA Sine Psoriasis https://youtu.be/FlhAve8eaXA QD191 - After TNF Inhibitor in PsA https://youtu.be/yoxQPGWpkaw QD192 - IBD or IL-17 induced Colitis? https://studio.youtube.com/video/JQem54VwJ5c/edit
This one-hour live Journal Club will discuss the following two articles:
Safety and efficacy of faecal microbiota transplantation in PsA. Ann Rheum Dis. 2021 Sep;80(9):1158-1167
SPIRIT H@H trial: ixekizumab versus adalimumab in biologic-naive PsA. Ann Rheum Dis. 2020 Oct;79(10):1310
Please note the updated speaker lineup:
Dr. Eric Ruderman Dr. Arthur Kavanaugh Dr. David Liew Dr. Jack Cush
- The Future of PsA Imaging - Dr. Philip Conaghan https://www.youtube.com/watch?v=jdV4u9Jyh7c
- Prevention of PsA - Dr. Alexis Ogdie https://www.youtube.com/watch?v=XAX5kTYx7BM
- The Future of Psoriasis Therapeutics - Dr. Kenneth Gordon https://www.youtube.com/watch?v=RnoA94b_N_Y
- Future Biomarkers in PsA - Dr. Katy Leung https://www.youtube.com/watch?v=y50ukfLuXlk
- Future Discovery in PsA - Dr. Christopher Ritchlin https://www.youtube.com/watch?v=qGVyo7BzU3c
Dr. Jack Cush discusses the news and recent journal reports from last weeks RheumNow.com. Also viewer questions from #ACA Ask Cush Anything
- The Future of PsA - Dr. Jack Cush https://www.youtube.com/watch?v=wzCCwnvoAjw&t=16s
- Future of PsA Care - Dr. Dafna Gladman https://www.youtube.com/watch?v=CYxc30PlPBc&t=11s
- Future Treatments for PsA - Dr. Eric Ruderman https://www.youtube.com/watch?v=s74ONYRCsE0&t=8s
- Precision Medicine in PsA - Dr. Laura Coates https://www.youtube.com/watch?v=FB7sU7uDz78&t=2s
QD189 - Treating PsA with HIV https://www.youtube.com/watch?v=3KRDtG-ML6I&t=27s QD 88 - Managing Comorbidities in Psoriatic Patients https://www.youtube.com/watch?v=1R6J_-WM49Q QD18 - EOA vs PsA https://www.youtube.com/watch?v=PmifY3B11_Y&t=1s QD8 - Enthesopathy-related arthritis https://www.youtube.com/watch?v=gx4EcM2dnvQ&t=4s
The PsA Expert panelists included:
Dr. Dafna Gladman, Toronton Dr. Joseph Merola, Boston Dr. Peter Nash, Brisbane Dr. Christopher Ritchlin, Rochester Dr. Jose Scher, New York Dr. Jack Cush, Moderator
QD186 - When the Going Gets Good QD187 - Loss of Biologic Effect QD188 - PsA & LFTs RheumNow's PsA Campaign with enhanced coverage of Psoriatic Disease is sponsored by Janssen. All content is chosen by RheumNow + its faculty.
Sponsored by Novartis Medical Affairs - Listen to Xenofon Baraliakos discuss secukinumab in patients with Psoriatic Arthritis and Axial Manifestation: results from the double-blind, randomised, phase 3 MAXIMISE trial.
QD183 - Moll & Wright - Right or Wrong? QD184 - What to Do-Do-Do About the DIPs? QD185 - Rheum Comanagement of Psoriasis
RheumNow's PsA Campaign with enhanced coverage of Psoriatic Disease is sponsored by Janssen. All content is chosen by RheumNow + its faculty.
Dr. Jack Cush reviews the news and journal articles from the past week and discusses the use of fibroscan in RA, steroid hip injections in OA and famous quotes from a famous cardiologist.
Tuesday Nite Rheumatology, held on April 5th, 2022 features a Patient Perspectives panel discussion, hosted by Dr. Jack Cush. PsA Panelists included: - Tena Brown - Christine Lindsay - Ashley Krivohlavek
RheumNow's PsA Campaign with enhanced coverage of Psoriatic Disease is sponsored by Janssen. All content is chosen by RheumNow + its faculty.
QD178 - Your Psoriatic Questions from RNL2022 QD179 - Your Rheumatoid Questions from RNL 2022 QD180 - Your Lupus Questions from RNL 2022 QD181 - Your Spondyloarthritis Questions from RNL 2022 QD182 - Your Hot Topic Questions from RNL 2022 RheumNow's PsA Campaign with enhanced coverage of Psoriatic Disease is sponsored by Janssen. All content is chosen by RheumNow + its faculty.
Throughout the month of April 2022, RheumNow is introducing a new approach to education and information sharing – a Campaign devoted to Psoriatic Arthritis (PsA) - PsA All the Way!
QD174 - Who's to Blame QD175 - The Next Revolution QD176 - Muy Rapida Medicina QD177 - Drugs for Pregnancy Hopefuls
QD170 - Shared Decision Making in PsA QD171 What To Do With the NSAID? QD172 - The Differential on Tenosynovitis QD173 - Doctors in the Dark
Long-Term Safety Profile of Secukinumab Analysis of Malignancies Up to 5 Years of Exposure Across Indications Sponsored by Novartis Medical Affairs
QD165 - Referring Psoriasis with Joint Pain https://youtu.be/ioyHELvAzz4 QD166 - Phone calls about labs https://youtu.be/uAvOkahIWiM QD167 - When Labs and Exam are Discordant https://youtu.be/dTLt7VoGubA QD168 - Rheumatoid Arthritis and Eosinophilia https://youtu.be/gIHOohWLWFs QD169 - Another Kind of COVID Discussion https://youtu.be/cVdvvRSh6WA
Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com This podcast is sponsored by RheumNow.live Then great future of rheumatology education is at RNL 2022
Dr. Liya Stolyar – A Rare Presentation of Vasculitis with Muscle Involvement https://www.youtube.com/watch?v=hknRT7Ks-6U Dr. Peter (Ki) Eum – Optic Neuritis in SLE https://www.youtube.com/watch?v=aCJl7UNnrac&t=4s Dr. Dylan Lee – Implementing Target to Treat Strategy in Rheumatoid Arthritis https://www.youtube.com/watch?v=_IhrKnJvfco&t=127s Dr. Smarikat Sapkota – MDA5 Antibody and COVID19 https://www.youtube.com/watch?v=4qvE3WXh8AA Dr. Yoon Qui – Late-onset scleroderma renal crisis https://www.youtube.com/watch?v=89kN9dxPci8 Dr. Rashmi Dhital – Infection-related Hospitalizations in Adolescents and Young Adults with SLE https://www.youtube.com/watch?v=uKpJsjmAeWE Dr. Jaclynn Levine – Beware of Dermatomyositis Mimickers https://www.youtube.com/watch?v=qV2Duhhgne0 Dr. Peta-Gay Ricketts – A Tale of Two Vasculopathies https://www.youtube.com/watch?v=ZYyb-qYkxXs&t=5s Dr. Tiffany Hoang – Kids are not little adults https://www.youtube.com/watch?v=2A1WppLo2Ds&t=13s
QD161 - Enough is Enough https://www.youtube.com/watch?v=NU0Am08ygnM QD162 - Swollen Knee in a Myeloma Patient https://www.youtube.com/watch?v=4Wg7Bo7cSVs&t=12s QD163 - Oligoarthritis in a Hairdresser https://www.youtube.com/watch?v=Ns0WHUfJDVw&t=40s QD164 - Undifferentiated Arthritis https://www.youtube.com/watch?v=VmG_25xDop0&t=27s
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week, rheumatologic problems incited by respiratory infections, air pollution and how you live, now where you live. Sponsored by RheumNow.live March 19-20th -- a great medical meeting for Rheumatologists
Drs. Jack Cush and Artie Kavanaugh review the highlights of the RWCS (Rheumatology Winter Clinical Symposium) from Maui.
QD157 Steroid Weaning QD158 Diagnosing Neuropsychiatric Lupus QD159 - Not the Same Ol’ Lecture QD160 - Your Next Follow-up Visit is When?
Dr. Jack Cush reviews the news and journal articles from this past week in RheumNow.com. Interesting reports this week about dementia, who gets hand OA and a great list of women Heroes and Pillars of Rheumatology.
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. He discusses the GI side effects of IL-17 inhibitors, downstream revenues from rheumatology care and dietary prevention of gout.
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com Check out RheumNow.Live
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com. These reports are about better outcomes in Lupus; Less Gout flares with T2T and the power of belief.
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com RheumNow.Live is March 19, 20th in Dallas, TX
Patients with axial spondyloarthritis (axSpA) commonly experience cardiovascular (CV) comorbidities. There is a need to holistically assess a patient, including considerations for managing disease activity and understanding the safety profile of available therapies as it relates to comorbidities. Join Marina Magrey, MD as she provides insight on this topic for holistic patient-centered care.
Please provide feedback on the session using this link https://bit.ly/3j4pA6u
Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021.
New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields.
In this episode, Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com
A population based Swedish study of birth records shows that antibiotic exposure in first three years of life to be associated with a future risk of JIA, although infections during fetal life or childhood did not increase risk of JIA. #RheumNow https://t.co/Md0zBm5Txl
Alendronate may protect against type 2 Diabetes. Data from National Danish Patient Registry, presented at the EASD meeting compared 160k T2DM & 500k controls, T2DM following alendronate adjusted OR=0.64; 0.62-0.66; ⋗8yrs OR=0.47 https://t.co/RYEZodUZtv
Analysis of 508 #RA pts (over 10 yrs) in the BeST study shows joint swelling at baseline resulted in half w/ re-swelling later and significantly increased risk of same joint swelling during follow-up (OR 2.37, 95% CI 2.30 to 2.43, p⋖0.001) https://t.co/a7zH4YRAkq
Finnish Pop study 939 #RA pts shows highest healthcare costs linked to high Dz activity & comorbidity. Clusters: C1) young w/ low costs & activity, C2) chronic pain, disability, fatigue, C3) high cost/dz activity, less pain, C4)comorbidities w/ $$$ https://t.co/Azc35zyA9J
A longitudinal study from Iceland shows an increasing number of native joint infections (NJI), with iatrogenic, postarthroscopic infections being of particular concern. Read more… https://t.co/j3gzZ9g0QV
Case controlled study suggests that intraarticular steroid injections is associated with increased (HR 8.56; 3.29-22.3) risk of rapidly destructive hip disease (RDHD); at a rate of 5.4% (5.1 mos post injx) w/ JSN, osteolysis, fem head collapse https://t.co/grX5bO4495
Biosimilar update: 31 FDA approved biosimilars, but only 60% made it to market. 2015 to 2019, drug spending grew 6.1%, biologic spending grew 14.6%; biologics are 43% of US drug spending. Most biosimilars at ~30% discount. https://t.co/4paYH8yVLQ
Study Finds U.S. Generic and Biosimilar Savings Totaled a Record $338 Billion in 2020 https://t.co/hPR0nGd6jp
Can I get the INFLUENZA and COVID Vaccines together? The CDC says: "YES...both vaccines can be given at the same visit, people should follow the recommended schedule for either vaccine.... ideally get a flu vaccine by the end of October." https://t.co/T49zm6Cxyc
MMWR shows the safety of a 3rd (booster) dose of the mRNA vaccine to be same as the 2nd dose AEs. V-safe data on 3rd dose (n=12,591) showed local or systemic effects (79% or 74%) to be same as 2nd dose (78% or 76%) https://t.co/LcD0ARlWJ2
CDC Advises COVID-19 Vaccines for Pregnant Women https://rheumnow.com/news/cdc-advises-covid-19-vaccines-pregnant-women
U.S. Preventive Services Task Force (USPSTF) reaffirmed its recommendations that pregnant women at a high risk of preeclampsia should take a daily aspirin regimen at the end of the first trimester https://t.co/DiV7p6g8vL
Is Acetaminophen Potentially Hazardous in Pregnancy? https://rheumnow.com/news/acetaminophen-potentially-hazardous-pregnancy
RA patients had an an increased risk of mortality after CABG (HR 1.50; 1.28-1.77); and a higher risk of MI following CABG (HR 1.61; 1.28-2.04). A retrospective Finnish study comparing RA (n= 378) to nonRA patients (n = 7560) https://t.co/cGGsrLs1V2
Early Diastolic Dysfunction in Premenopausal Women with RA https://rheumnow.com/news/early-diastolic-dysfunction-premenopausal-wom…
108 pts with autoimmune cytopenias (TTP, ITP, AIHA, etc) were given COVID vaccination showing low rate of post-vax flares. Signif HEME decreases in 7.4% of AIHA & ITP; mild decrease in 10% AIHA and 20% ITP, w/ no Rx change https://t.co/OaHILar57z
Global SECURE-IBD trial on IBD drugs and COVID shows that severe COVID-19 outcomes were not associated with the use of biologics and mesalamine/sulfasalazine, AZA, 6MP, MTX combo Rx or biologics (TNFi, IL-12/23, IL-23, integrin inhib) https://t.co/MO4i5ngKkr
Questions & Cases Approach to dental surgery while on bisphosphonate Recurrent shingles while on adalimumab Myositis after COVID-19 vaccine
CONNECT WITH RheumNow ✩ Website - https://rheumnow.com/ ✩ Subscribe @ RheumNow: https://rheumnow.com/user/register ✩ LinkedIn - https://www.linkedin.com/in/john-cush... ✩ RheumNow LinkedIn: https://www.linkedin.com/company/rheu... ✩ Twitter - https://twitter.com/RheumNow Listen | PODCAST Apple Podcasts: https://podcasts.apple.com/us/podcast... Spotify: https://open.spotify.com/show/4Mjzj5j... Stitcher: https://www.stitcher.com/show/the-rhe... TuneIn: https://tunein.com/podcasts/Health--W... Podbean: https://rheumnow.podbean.com/ Got a Rheumatology question or case for Dr. Jack Cush? Record it here and we'll feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. BackTalk: https://rheumnow.com/submit-podcast-q...
Merry Christmas and Happy Holidays from RheumNow. Dr. Jack Cush tells his podcast story - the genesis, keys to success and recommendations on how to get into podcasting - for teaching, practice, fun or influence.
Dr Jack Cush reviews the latest news, journal reports, regulatory approvals, plus 3 new cases from rheumatologists.
A moderated panel of prominent female rheumatologists will discuss the challenges and successes in clinical practice and research that they encountered during the COVID-19 pandemic..
There is a significant burden of disease associated with JPsA and ERA, with patients experiencing structural damage progression, risk of disability, and comorbidities that may persist into adulthood. This presentation led by Hermine Brunner, MD educates on the importance of early recognition and management.
The ACR 2021 meeting has concluded. Dr. Jack Cush recants a few more great abstracts from this past weeks meeting.
Drs. Jack Cush and Martin Bergman gather to review the topic of treat-to-target (T2T) management in rheumatology. Both will debate the pro's and con's of the T2T strategy at the upcoming RWCS meeting on Feb. 17, 2022. You can register and learn more about the meeting at: https://r-w-c-s.com/2022/
Dr. Jack Cush discusses the evolution and future of telemedicine in rheumatology with the telemedicine guru - Dr. Alvin Wells
Dr. Jack Cush interviews Professor Edward Keystone, MD (from the University of Toronto) on the origins and science behind the 60/40/20 benchmark and outcomes in rheumatoid arthritis.
ALPN-303 - Dr. Pedro Castillo Dr. Castillo reports on abstract #1429 presented at the ACR21 annual meeting.
JAK Safety -- The Lowdown on Infection: Drs. Kevin Winthrop and Jonathan Kay Infections in ORAL Surveillance: Drs. Kevin Winthrop and Jonathan Kay Infliximab Drug Monitoring in PsA, RA, AxSpA: Dr. Pedro Castillo Lupus and Pregnancy: Dr. Sheila Reyes Secukinumab Effect on CV Risks in PsA, axSpA: Dr. Sheila Reyes
Giant Cell Arteritis and Polymyalgia Rheumatic Wrapup: Drs. Calabrese, Liew, Conway and Mackie
Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim Potpourri of Biosimilar Trials: Dr. Jonathan Kay Closing a Chapter: Interview with the 84th ACR President 2020-2021, Kathryn Dao
Glucocorticoids and CV risk in RA: Drs. Aurelie Najm and Jon Giles Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay Rheumatic Diseases Can Take your Breath Away: Dr.Janet Pope Best of PsA Day 4 (Tuesday): MACE in PsA: Dr. Rachel Tate Predicting Progression from Psoriasis to PsA: Dr. Robert Chao David Liew Interview Dr. Seoyoung Kim About Tofacitinib and Malignancy Risk. Third Time's the Charm - COVID Vaccination While on Rituximab: Dr. Yuz Yusof Can We Stop Medication in Systemic JIA? Dr. Bella Mehta Day 4 SpA Highlights - Pregnancy in SpA and Drug Monitoring: Dr. Robert Chao
Diagnosing (Bad) VEXAS: The Experts Speak with Drs. Cush, Beck and Ferrada CV Risks and Gout T2T - An Interview with Dr. Seoyoung Kim, Kathryn Dao
Dr. Michelle Petri - Urine Proteome Advances: What Do They Mean? "Doctor, I Can Tell When It's Raining!" - Dr. Aurelie Najm NSAIDS Prevent Heart Attacks in PsA: Dr. Richard Conway Pediatric Psoriatic Arthritis: Dr. Eric Ruderman irAEs: Drs. Cassie Calabrese and David Liew TNFi in axSpA: Dr. Swetha Alexander
Sex, Age and Race/Ethnic Differences in Multimorbidity in Lupus: Drs. Duarte and Mehta Hospitalization Trends in Patients with Psoriatic Arthritis: Dr. Olga Petryna Patient Reported Outcomes in axSpA: Dr. Swetha Alexander Pregnancy Outcomes in PsA, SpA, RA: Dr. Rachel Tate Guselkemab vs. Ustekinumab in PsA: Dr. Richard Conway Medication Preferences in Patients with Psoriatic Arthritis: Dr. Olga Petryna Dr. Michelle Petri - Urine Proteome Advances: What Do They Mean?
Uveitis in AxSpa: Dr. Sheila Reyes ACR Gold Medal Recipient: Dr. Stan Cohen Infection Risk in Offspring Exposed to Biologics: Dr. Rachel Tate Steroids in RA Patients 65 and Older: Dr. Richard Conway Cardiovascular Disease for TNFi vs JAKi: Dr Jon Giles Food for Thought: "ITIS" Diet for Patients with Rheumatoid Arthritis: Dr. Akhil Sood Who gets Methotrexate Induced Nausea and Alopecia? Drs.Ahmad Sherbini and Eric Dein
Dr. Janet Pope: RA Conundrums Drs Kathryn Dao, Una Makris and Raymond Yung: Caring for the Older Patient with Rheumatic Disease Dr. Arthur Kavanaugh: FDA Approvals Predictors of TNF Response with Drs. Pope, Dein and Liew The Gift of Gab with Drs. Dein and Liebowitz and Janet Zeide
Drs Jack Cush, Yuz Yusof, Bella Mehta, Olga Petryna, and Rachel Tate Auto-inflammatory Panel
The Respiratory Tract and RA with Drs. Sparks, McDermott and Kronzer Guselkumab Use Improves Anemia in Treatment of PsA: Dr. Robert Chao Ultra Low Doses of Rituximab in RA: Dr. Eric Dein and Nathan den Broeder Uveitis and Prevalence of Psoriasis in axSpA: Dr. Robert Chao
Long Term Steroid Use in RA - Matters of the Heart: Dr. Mrinalini Dey Data on Existing SLE Medications, Patient Centered Outcomes, and Exercise: Dr. Michelle Petri COVID-19 Vaccination in Autoimmune Disease: Drs. Latika Gupta and Sheila Reyes Pulmonary Hypertension in Adult Onset Still's Disease: Dr. Jack Cush MDA in Psoriatic Arthritis: Dr. Rachel Tate CBD in Hand OA and PsA: Dr. Richard Conway
Real Time Monitoring of Disease Activity? There's An App for That: Dr. Akhil Sood CBD and Opioids in Psoriatic Arthritis: Dr. Eric Ruderman Osteoporosis in PsA: Dr. Rachel Tate Type 1 and Type II Lupus — Patient Perspectives: Drs. Bella Mehta and Megan Clowse JAKi Safety: Dr. Ernest Choy with Dr. Aurelie Najm Herpes Zoster and Rheumatoid Arthritis: Dr. Akhil Sood Frailty in Lupus: Dr. Sheila Reyes Geriatric Rheumatology: Improving care of aging patients
First JAKi Failure: What next? Dr. Aurelie Najm: RAPID3 in Psoriatic Arthritis: Dr. Meral El Ramahi Herpes Zoster and Rheumatoid Arthritis with Dr. Akhil Sood JAKi Safety Through the Lens of an Expert: Interview of Dr. Ernest Choy with Dr. Aurelie Najm Emerging Therapies in Psoriatic Arthritis: Drs. Antoni Chan and Oliver FitzGerald
Vitamin D and Omega-3 Fatty Acids Reduce Risk of Autoimmune Diseases: Dr. Chao Health Information Use by SLE Patients: Dr. Sheila Reyes Best of SpA Abstracts Day 2: Dr. Robert Chao Career Advice for Young Rheumatologists: Drs. Janet Pope and Vivian Bykerk Drs Antoni Chan and Oliver FitzGerald: New Therapies in Psoriatic Arthritis
Poverty and Length of Hospital Stays for Children with Lupus: Dr. Bella Mehta BBB and CNS Dysfunction in SLE: Dr. Jack Cush Twin Studies on Psoriasis Microbiome: Dr. Robert Chao Are you Aware of COPA Syndrome? Dr. Meral El Ramahi Early Rheumatoid Arthritis: Drs. Vivian Bykerk and Janet Pope TNF Inhibitors Rise to the Top: Drs. Janet Pope and David Liew Cytokines & Chemokines Predict Incident MACE in RA Veterans: Dr. El Ramahi
Catching up with Dr. Vivian Bykirk with Dr. Janet Pope Life Lessons with Dr. Vivian Bykirk with Dr. Janet Pope RAPID3 to Monitor Disease Activity in Psoriatic Arthritis, not just RA! with Dr. El Ramahi Several Cytokines & Chemokines Predict Incident MACE in RA veterans! with Dr. El Ramahi Are you Aware of COPA Syndrome? with Dr. El Ramahi TNF Inhibitors Rise to the Top with Drs. Pope and Liew 4
SLE Update: Vitamin D and Hydroxychloroquine: Dr. Michelle Petri Frailty and Lupus with Dr. Sheila Reyes Health Disparities: Dr. Artie Kavanaugh BBB and CNS Dysfunction in SLE: Dr. Jack Cush Twin Studies on Psoriasis Microbiome with Dr. Robert Chao Best of SpA Day 2 with Dr. Robert Chao 1 Vitamin D and Omega-3 Fatty Acids Reduce Risk of Autoimmune Diseases with Dr. Chao
Predictors to Flare in SpA: Dr. Antoni Chan Psoriatic Arthritis: What's with Brepocitinib? Dr. Eric Ruderman Radiographic Progression in SpA: Dr. Antoni Chan Does Obesity Play a Role in Biologic Response? Dr. Eric Dein Radiographic Progression in SpA: Dr. Antoni Chan Does Obesity Play a Role in Biologic Response? Dr. Eric Dein Treat to Target in SLE: Dr. Yuzaiful Yusof Best of PSA from Sunday Sessions: Dr. Rachel Tate
Updates on New Treatments for SpA: Drs. Antoni Chan and Laura Coates
Hypertension in AS: Drs. Swetha Ann Alexander and Jean Liew Depression in Axial Spondyloarthritis: Dr. Mrinalini Dey Predictors of mortality in RA lung disease? Dr. Meral El Ramahi An Exclusive Interview with Dr. Al Kim (#Wowkim): Dr. Kaythryn Dao Dr. Eric Dein: Can we Use Frax Score in RA Patients?
Recognizing and Treating Axial Disease in Psoriatic Arthritis: Dr. Pedro Castillo Best of Spondyloarthritis from Day 1: Dr. Robert Chao Treating RA: Does Where You Live Matter? Dr. Mrinalini Dey To Clot or Not to Clot: Drs. Janet Pope and Jeffrey Sparks Best of PsA Saturday: Dr Rachel Tate NrAxSpA progression to AxSpA: Dr. Rachel Tate Pulse Pressure as a Predictor of Carotid Plaque in RA: Dr. Meral El Ramahi Hydroxychloroquine Levels in Type I and 2 Lupus: Drs. Megan Clowse and Bella Mehta
Does RA Begin in the Gut? with Dr. Jonathan Kay Dr. David Liew: 11 Ways to Stay Away From RA Dr. David Liew: Tired of Doing Nothing About Fatigue Lung Now with Drs. Pope and Sparks Perspectives on TNF and RA Day 1 with Dr. Jon Giles
The PROOF Study in AxSpA: Dr. Sheila Reyes Management of Pain in Spondyloarthritis: Dr. Antoni Chan Pregnancy complications in Ankylosis Spondylitis: Dr.Olga Petryna JAKi For Refractory Still’s Disease: Dr. Olga Petryna Sinusitis and Pharyngitis and RA with Dr. Richard Conway Cognitive Function and Rheumatoid Arthritis: Dr. Akhil Sood Interviews Dr. Elena Myasoedova Serum Biomarkers to Distinguish Radiographic Progression in PsA with Dr. Robert Chao
Preventive Window of Opportunity in RA? Dr. Aurelie Najm Iberdomide for Lupus: Dr. Kathryn Dao Increased Risk of MACE in Lupus After Noncardiac Surgery: Dr. Kathryn Dao Peripheral SpA: Dr. Antoni Chan and Dr. Nelly Ziade Complications of Covid19 in Lupus: Dr. Kathryn Dao Dose Tapering of TNFi in AxSpA: Dr. Antoni Chan Dr. Yuzaiful Yusof: Factors Associated with Poor Vaccine Response in Rituximabe-treated Patients
What's Cool and Hot in Vasculitis: Dr. Janet Pope ARIAA Study - Abatacept Reverses ACPA+ Subclinical Arthritis: Dr. Jack Cush MRI Imaging in RA and SpA: Dr. Sheila Reyes Sick Leave, Work Disability in Patients with AxSpA: Dr. Mrinalini Dey PsA Perspectives - IL-23: Dr. Eric Ruderman Patient Clustering Based on Multimorbidity Patterns in RA: Dr. Mrinalini Dey and Dr. Bryant England
COVID in Rheumatologic Disease Patients: Drs. Sparks, Liew, Yazdany and Dao AxSpA: Geographic Prevalence Association with HLA-B27: Dr. Rachel Tate What I'm Looking Forward to at ACR: Dr. Arthur Kavanaugh Fibromyalgianess Glucocorticoid Persistence in RA Patients: Dr. Sheila Reyes
Opening Ceremony, Keynote Lecture and Year in Review Discussants: Drs. Jack Cush, Sheila Reyes, Rachel Tate & Kathryn Dao
QD153 - Serologically Active, Clinically Quiescent SLE QD154 - Paradoxical Psoriasis QD155 - Scary Steroids QD156 - How I Treat Rheumatoid Arthritis
Dr Cush reviews the news and kicks off ACR21 learning and how to take in the annual meeting
QD148 - Severe Arthritis Numbers and Associations QD149 - The Thyroid Lump QD150 - Alopecia Rules QD151 - Half Baked Blogs QD152 - Who is Immunosuppressed?
Dr. Jack Cush reviews the news and journal articles from the past week and discusses parent-child rheumatologists pairs
Dr. Jack Cush reviews the FDA approvals, news and the latest journal articles from the past week on RheumNow.com
Dr Jack Cush reviews the news and journal reports from this past week on RheumNow.com; plus questions & cases from viewers in (#ACA) Ask Cush Anything.
New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields.
In this episode, Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com
A population based Swedish study of birth records shows that antibiotic exposure in first three years of life to be associated with a future risk of JIA, although infections during fetal life or childhood did not increase risk of JIA. #RheumNow https://t.co/Md0zBm5Txl
Alendronate may protect against type 2 Diabetes. Data from National Danish Patient Registry, presented at the EASD meeting compared 160k T2DM & 500k controls, T2DM following alendronate adjusted OR=0.64; 0.62-0.66; ⋗8yrs OR=0.47 https://t.co/RYEZodUZtv
Analysis of 508 #RA pts (over 10 yrs) in the BeST study shows joint swelling at baseline resulted in half w/ re-swelling later and significantly increased risk of same joint swelling during follow-up (OR 2.37, 95% CI 2.30 to 2.43, p⋖0.001) https://t.co/a7zH4YRAkq
Finnish Pop study 939 #RA pts shows highest healthcare costs linked to high Dz activity & comorbidity. Clusters: C1) young w/ low costs & activity, C2) chronic pain, disability, fatigue, C3) high cost/dz activity, less pain, C4)comorbidities w/ $$$ https://t.co/Azc35zyA9J
A longitudinal study from Iceland shows an increasing number of native joint infections (NJI), with iatrogenic, postarthroscopic infections being of particular concern. Read more… https://t.co/j3gzZ9g0QV
Case controlled study suggests that intraarticular steroid injections is associated with increased (HR 8.56; 3.29-22.3) risk of rapidly destructive hip disease (RDHD); at a rate of 5.4% (5.1 mos post injx) w/ JSN, osteolysis, fem head collapse https://t.co/grX5bO4495
Biosimilar update: 31 FDA approved biosimilars, but only 60% made it to market. 2015 to 2019, drug spending grew 6.1%, biologic spending grew 14.6%; biologics are 43% of US drug spending. Most biosimilars at ~30% discount. https://t.co/4paYH8yVLQ
Study Finds U.S. Generic and Biosimilar Savings Totaled a Record $338 Billion in 2020 https://t.co/hPR0nGd6jp
Can I get the INFLUENZA and COVID Vaccines together? The CDC says: "YES...both vaccines can be given at the same visit, people should follow the recommended schedule for either vaccine.... ideally get a flu vaccine by the end of October." https://t.co/T49zm6Cxyc
MMWR shows the safety of a 3rd (booster) dose of the mRNA vaccine to be same as the 2nd dose AEs. V-safe data on 3rd dose (n=12,591) showed local or systemic effects (79% or 74%) to be same as 2nd dose (78% or 76%) https://t.co/LcD0ARlWJ2
CDC Advises COVID-19 Vaccines for Pregnant Women https://rheumnow.com/news/cdc-advises... U.S. Preventive Services Task Force (USPSTF) reaffirmed its recommendations that pregnant women at a high risk of preeclampsia should take a daily aspirin regimen at the end of the first trimester https://t.co/DiV7p6g8vL
Is Acetaminophen Potentially Hazardous in Pregnancy? https://rheumnow.com/news/acetaminoph... #RA patients had an an increased risk of mortality after CABG (HR 1.50; 1.28-1.77); and a higher risk of MI following CABG (HR 1.61; 1.28-2.04). A retrospective Finnish study comparing RA (n= 378) to nonRA patients (n = 7560) https://t.co/cGGsrLs1V2
Early Diastolic Dysfunction in Premenopausal Women with RA https://rheumnow.com/news/early-diast... 108 pts with autoimmune cytopenias (TTP, ITP, AIHA, etc) were given COVID vaccination showing low rate of post-vax flares. Signif HEME decreases in 7.4% of AIHA & ITP; mild decrease in 10% AIHA and 20% ITP, w/ no Rx change https://t.co/OaHILar57z
Global SECURE-IBD trial on IBD drugs and COVID shows that severe COVID-19 outcomes were not associated with the use of biologics and mesalamine/sulfasalazine, AZA, 6MP, MTX combo Rx or biologics (TNFi, IL-12/23, IL-23, integrin inhib) https://t.co/MO4i5ngKkr
Questions & Cases Approach to dental surgery while on bisphosphonate Recurrent shingles while on adalimumab Myositis after COVID-19 vaccine
CONNECT WITH RheumNow
✩ Website - https://rheumnow.com/
✩ Subscribe @ RheumNow: https://rheumnow.com/user/register
✩ LinkedIn - https://www.linkedin.com/in/john-cush...
✩ RheumNow LinkedIn: https://www.linkedin.com/company/rheu...
✩ Twitter - https://twitter.com/RheumNow
Listen | PODCAST
Apple Podcasts: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/4Mjzj5j...
Stitcher: https://www.stitcher.com/show/the-rhe...
TuneIn: https://tunein.com/podcasts/Health--W...
Podbean: https://rheumnow.podbean.com/
Got a Rheumatology question or case for Dr. Jack Cush? Record it here and we'll feature it on an upcoming podcast. Tell us your name and where you practice rheumatology.
BackTalk: https://rheumnow.com/submit-podcast-q...
New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields.
In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com
Study of 435 #SLE pts seen during the pandemic. Comparing those seen F2F vs telemedicine, there was no significant difference in SLE disease activity (by SLEDAI-2K) or SLE flare rates or steroid prescribing between visit types https://bit.ly/39wWoQ6
Encouraging DBRPCT of Rituximab in #PMR: 116 screened, 49 enrolled, 47 completed: 23 on RTX vs 24 on PBO. Steroid-free remission at 21 wks seen with 11/23 (48%) RTX pts vs 5/24 (21%) on PBO (p=0·049). Infusion Rxns: 10 RTX vs 3 PBO); 1 SAE (PE) on RTX https://bit.ly/3lSI0rj
Pregnancies exposed to ixekizumab (from Eli Lilly Global Safety Database) found 193 pts with psoriasis, PsA, or axSpA who were IXE exposed. Live births reported for 53.8 and 61.1% of known outcomes. No congenital malformations seen. https://t.co/M1rvCH81hT
FDA approves Jakafi for chronic GVHD. Ruxolitinib (Jakafi, Incyte), an oral Janus kinase 1/2 inhibitor, previously received approval for treatment of patients aged 12 years or older with steroid-refractory acute GVHD. https://t.co/isItDebNZ8
Retrosp. review of 10–24 yr olds w/ newly Dx #SLE shows 78% given steroid-sparing DMARDs by year 1; Most (69%) given HCQ & fewer (34%) given other immunosuppressants. Adults less likely to recv immDMARDs @1 yr https://t.co/aLi6FXlMd3
Case controlled study shows CPPD pts have no higher risk for MACE. 23,124 CPPD vs 86,629 non-CPPD, w/ ⋗ 250,000 Pt-Yrs FU. CPPD MACE risk not increased (HR 0.98), but there was incr risk of MI, CVA & acute coronary syndr. https://t.co/pgmZBxTg9O
Trade names: Generic PFIZER = Comirnaty; MODERNA= Spikevax Moderna; J&J (pending) https://t.co/MM7XiSCczl
Prospective study of 77 RA patients in remission -- ⋗ vax w/ BNT162b2 (BioNTech-Pfizer) (w/ temp D/C of DMARDs per ACR) found a vaccine-related flare rate of 7.8% (6 pts) w/ 5/6 flares after 2nd dose (2.6 days), resolved w/in 2 wks https://t.co/YOL3YVS2ne
Dr. Calabrese shares his Delta COVID-19 breakthrough story on the blog today. https://t.co/timjB2YPys
BMJ Breakthrough infections from UK QResarch database: Among 6.95 million vaccinated, 74.1% recv two vaccine doses, there were 2031 covid-19 deaths & 1929 hosp admissions; ~4.0% deaths & admissions were ⋗14 days after 2nd dose Addendum: COVID deaths increased w/ age, deprivation, male, Indian & Pakistanis. Highest risk w/ Down’s syndr (HR 12.7), renal transplant (8.1), sickle cell (7.7), Nursing home (4.1), chemotherapy (4.3), HIV/AIDS (3.3), liver cirrhosis (3), CNS dz (2.6) Addendum: Other conditions w/ a 1.2-2 fold higher risk of COVID death (admission) were CKD, hematologic cancer, epilepsy, COPD, CVD, stroke, atrial fibrillation, CHF, thromboembolism, PVD, type 2 diabetes. https://t.co/bbDsb1zLhX
Claims case-controlled study shows statin use does not increase the risk of #RA - 32,726 RA and matched controls ; statin use (34 vs 32%) slightly increased RA risk (OR 1.12, 1.06–1.18), but signif lost after correcting for hyperlipidemia https://t.co/EcTlyE1MPx
High Comorbidity Rates with Inclusion Body Myositis Guselkumab Treats Axial Disease in Psoriatic Arthritis 11 Drugs That Cause Arthritis https://rheumnow.com/news/11-drugs-ca...
Viewer Question – A positive anti ds DNA in the absence of clinical evidence of lupus?
CONNECT WITH RheumNow
✩ Website - https://rheumnow.com/
✩ Subscribe @ RheumNow: https://rheumnow.com/user/register
✩ LinkedIn - https://www.linkedin.com/in/john-cush...
✩ RheumNow LinkedIn: https://www.linkedin.com/company/rheu...
✩ Twitter - https://twitter.com/RheumNow
Listen | PODCAST
Apple Podcasts: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/4Mjzj5j...
Stitcher: https://www.stitcher.com/show/the-rhe...
TuneIn: https://tunein.com/podcasts/Health--W...
Podbean: https://rheumnow.podbean.com/
Got a Rheumatology question or case for Dr. Jack Cush? Record it here and we'll feature it on an upcoming podcast. Tell us your name and where you practice rheumatology.
BackTalk:https://rheumnow.com/submit-podcast-question-or-comment
New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields.
In this episode, Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com
Metanalysis of JAK inhibition (tofacitinib & ruxolitinib) in alopecia areata - 12 studies, 346 Pts, Rx success (using SALT50 resp) was 66%, not influenced by age, sex, subtype. Alopecia recurrence seen w/in 3 mos of JAK D/C (in74%) https://t.co/CBSy4Kci80
Population study shows risk of H. Zoster in adults to be high among bDMARD and CTX, also increased w/ AZA and HCQ but not MTX SSZ or LEF users. Data from 254065, 1,826311 Pt-Yrs F/U, 6295 new DMARD users, 17024 incident HZ https://t.co/1TeOAWN9LB
MMWR reports that during the COVID Delta variant era, Vaccination against COVID-19: - Reduces risk of COVID-19 infection 5X - Reduces risk of COVID-19 Hospitalization ⋗10X - Reduces risk of COVID-19 DEATH 10X https://t.co/rMRY84xX5F
Study of 265 students w/ a positive COVID-19 test looked at 378 close contacts. Infx rates w both persons masked -7.7%, but when unmasked-32.4% (aORs = 4.9) https://t.co/fYdH33JbWR
Effect of Diet on COVID Outcomes Probenecid, an OAT3 inhibitor, has inhibitory effects on RNA viruses (influenza, RSV) & decreases ACE2 expression. May have utility in COVID-19 as it was shown to inhibit SARS-CoV-2 replication in animal modelshttps://t.co/MClSjpqpSa
Mease and colleagues have catalogued the current practices assessed in the CORRONA registry, noting that increased DMARD switching and decreased time on a given therapy by US physicians. https://t.co/cIWZw6KsuI
A retrospective study of systemic sclerosis patients shows that acute hospitalization and mortality were not uncommon and were often linked to SSc-related lung disease. #RheumNow https://t.co/s5wSlndTrt
Cases and Questions (AKA Back Talk) “What treatment do you use after 2 years of teraparitide in a woman with a hx of OP, spiral fracture while on a bisphosphonate”? Forteo PI. “Do you have any inside info on the vaccines for COVID-19 during pregnancy?” OCOG Statement “Status of the Tocilizumab Shortage”? Genentech Statement “How would you treat polyarthritis in a renal transplant patient?”
CONNECT WITH RheumNow
✩ Website - https://rheumnow.com/
✩ Subscribe @ RheumNow: https://rheumnow.com/user/register
✩ LinkedIn - https://www.linkedin.com/in/john-cush...
✩ RheumNow LinkedIn: https://www.linkedin.com/company/rheu...
✩ Twitter - https://twitter.com/RheumNow
Listen | PODCAST Apple Podcasts: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/4Mjzj5j...
Stitcher: https://www.stitcher.com/show/the-rhe...
TuneIn: https://tunein.com/podcasts/Health--W...
Podbean: https://rheumnow.podbean.com/
Got a Rheumatology question or case for Dr. Jack Cush? Record it here and we'll feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. BackTalk:
Dr. Jack Cush is joined by Drs. Kathryn Dao (Dallas), Rachel Tate (Palm Beach), William Shergy (Huntsville) and Jeffrey Sparks (Boston)
Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com
Dr. Jack Cush is joined by Drs. Roy Fleischmann (Dallas), Allan Gibofsky (NYC), and Artie Kavanaugh (San Diego)
Dr. Jack Cush reviews the news, journal articles and more from this past week on RheumNow.com
Dr Jack Cush reviews the news, journal reports and FDA approvals from the past week on RheumNow.com
Expert-Selected EULAR 2021 Abstracts Sponsored by Novartis Medical Affairs
Didn’t have time to join EULAR 2021? Listen to a panel of experts as they present their views on the key abstracts in SpA and Still’s disease.
Provide feedback on these videos by completing the survey: https://bit.ly/3xPW5dG
Expert-Selected EULAR 2021 Abstracts Sponsored by Novartis Medical Affairs
Didn’t have time to join EULAR 2021? Listen to a panel of experts as they present their views on the key abstracts in SpA and Still’s disease.
Provide feedback on these videos by completing the survey: https://bit.ly/3xPW5dG
Dr. Jack Cush talks on education, engagement and the challenge of speaking up, if not first!
Dr. Jack Cush reviews his highlight favorite abstracts and presentations from last weeks viirtual EULAR 2021 meeting
What does Scleroderma with ScL70 Look Like_ with Dr. Janet Pope, EULAR 2021 Abatacept in RA ILD_ Dr. Richard Conway Combined Analysis of Peripheral Blood + Synovial Tissue in Early RA_ Dr. Aurelie Najm Comparative Effectiveness_ Registries or Real Life_ Dr. Jonathan Kay Gender, Racial Disparities in PsA Patients_ Dr. Rachel Tate How to Watch EULAR 2021 with Dr. Jack Cush
Iberdomide_ A Novel Drug for Lupus_ Dr. Kathryn Dao IFN Scores Predict Resistance to Skin Disease During RTX Therapy in Lupus_ Drs. Yusof and Carter Impact of Pandemic on Rheumatology Training_ Drs. Dao and Young Impact of RA on Male Fertility_ New Data with Dr. Aurelie Najm, EULAR 2021 MUC5B and Lung Disease in RA_ Dr. Richard Conway New 2021 GRAPPA Treatment Guidelines for Adult PsO and PsA Patients with Dr. Rachel Tate, EULAR 2021 Predictors of PSA Development in Psoriasis Patients_ Drs. Studenic and Zabotti
Pregnancy and Disease Activity in RA with Dr. Richard Conway, EULAR 2021 Prevalence of Long Term HCQ in Retinal Toxicity_ Dr. Kathryn Dao Prospective Study of Complement Levels in Lupus Pregnancy_ Dr. Kathryn Dao Psoriatic Arthritis Highlights from EULAR21_ Dr. Jack Cush RA and Cardiovascular Risks_ Dr. Richard Conway RA_ Don't forget the Lungs_ Dr. Najm and Dr. Juge Rheumatoid Arthritis and Cancer_ Myth or Reality_ Dr. Jonathan Kay Rituximab + Belimumab for SLE_ Dr. Yuz Yusof
Serious Infection Risk from the Filgotinib Drug Development Program_ Dr. James Galloway Spacing Anti-TIF Inhibitors for Axial SpA_ Dr. Eric Dein The Future of Treatment of RA-ILD_ Dr. David Liew Three New Medications for Lupus_ Dr. Eric Dein Treatment Options for SpA Patients and Many Outcomes to be Considered in the Evaluation, EULAR 2021 What Does Limited Scleroderma with ScL70 Look Like_ Dr. Janet Pope A Woman with Lupus Contemplates Pregnancy_ Dr. Janet Pope
Fecal Transplantation as Potential PsA Treatment_ Dr. Eric Dein How to Measure Success in Lupus_ Dr. Kathryn Dao How to Treat SpA with Dr. Robert Chao, EULAR 2021 PROs in Spa and PSA_ Dr. Rachel Tate Sex Differences in Autoimmune Disease Susceptibility_ Drs. Yusof and Robinson SLE Molecular Phenotype for Personalized Medicine_ Drs. Yusof and Garantziotis
A Triple Header of RA Plenary Abstracts_ Dr. Jonathan Kay Are We Consistent in Making a SpA Diagnosis_ Dr. Eric Dein Blindness with Tocilizumab in GCA_ Is it a Worry_ Dr. David Liew Complex Immune Disturbances in ANA+ Individuals_ Drs. Yusof and Hassan Do Patients on Upadacitinib Need Labs_ with Dr. Janet Pope, EULAR 2021 Early Lupus Patients Die of Infection! with Dr. Janet Pope, EULAR 2021
Dr. Jack Cush Dr. Arthur Kavanaugh Dr. Michele Petri Dr. Maureen McMahon Dr. Clay Cockerell
Tuesday Night Rheumatology, Spondyloarthritis with Drs. Haroon, Kavanaugh and Wang by Dr. Cush
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com - a website for rheumatologists, by rheumatologists. We love Rheumatology!
Featuring: Dr. Eric Ruderman - Advancing Treatment in Psoriatic Arthritis Dr. Alexis Ogdie Beatty - Epidemiology of Psoriasis and PsA Melodie Young, MSN, ANP-c - Assessing Psoriasis
- Dr. Roy Fleischmann - Future Therapies in RA
- Dr. Maya Buch - Difficult RA
- Dr. Alan Matsumoto - EULAR 2019 and ACR 2020 Guidelines Drs. Jack Cush and Arthur Kavanaugh co-moderate host this week's episode of Tuesday Night Rheumatology with highlight sessions on RA from RheumNow Live 2021
"Listen to Ethan Craig, MD, MPH discuss 3 of his patient cases to identify and differentiate axial involvement within the spectrum of spondyloarthritis. Share feedback on this program by completing this survey: https://bit.ly/3wmluLI "
Dr Jack Cush reviews the news and Journal reports and takes "Back Talk" questions from viewers.
QD Clinic - Lessons from the clinic Why Pain Consults present Not Taking Pain Meds Features Dr. Jack Cush
Dr. Jack Cush reviews the news, FDA Denials and journal articles from the past week on RheumNow.com
Dr. Jack Cush rants on the journal reports, news and FDA actions featured this past week on RheumNow.com
QD147 - Combination Biologics https://youtu.be/6NUtX2Zjjfk QD146 - Anti-Intraarticular https://youtu.be/9vU43xoygTc QD145 - Notalgia? https://youtu.be/BWXbFegsKcM QD144 - Ms. RA https://youtu.be/sPpliG6VMIs QD143 - Blinded by Noncompliance https://youtu.be/82XHcpHV2pM-fly QD Clinic is sponsored by RheumNow.Live https://rheumnow.live/
Dr Jack Cush reviews the news, Journal reports, CDC guidelines and viewer questions from the last week on RheumNow.com
The Reflecting Rheum: Top Publications from 2020 Covering Still’s Disease Sponsored by Novartis Medical Affairs, The Reflecting Rheum: Top Publications from 2020 Covering Still’s Disease
The Reflecting Rheum: Top Publications from 2020 Covering SpA Disease Sponsored by Novartis Medical Affairs, The Reflecting Rheum: Top Publications from 2020 Covering SpA Disease
QD142 - RA and LFTs https://www.youtube.com/watch?v=mBCmIKajSe4 QD141 - Remission Time https://www.youtube.com/watch?v=yGaazTq9W5k QD140 - I'm Ready to Fly https://youtu.be/3L31sQTVxhE QD 139 - Don't Stop Believing https://youtu.be/Fg0Lu78JCmQ QD 138 - Self-Medicating Myself https://youtu.be/zWc3QdT-jCw QD Clinic is sponsored by RheumNow.Live
Dr. Jack Cush Reviews the news and journal reports from the past week on RheumNow.com This podcast is sponsored by RheumNow.live
QD137 - RA or Not https://youtu.be/WAoKvSybdhQ QD136 - Periorbital Mass https://youtu.be/eVfcgYS0PhY QD135 - Periorbital Edema https://youtu.be/7b9MTNRQ55I QD134 - PFAPA Syndrome https://youtu.be/4Sg7X_AwuKc WAoKvSybdhQ QD Clinic is sponsored by RheumNow.Live
QD128 - Sawtooth Steroid Taper https://youtu.be/wIzZEw2hWEg QD129 - Surgery Rules for DMARDs & Biologics https://youtu.be/V9zwoQhnbmk QD130 - RA & DVT https://youtu.be/b2FkusWZn88 QD131 - Traveling to Medical Meetings during COVID https://youtu.be/3rGwRFZIunI QD132 - Hemoptysis and SLE https://youtu.be/jpUsu1YtZuE QD133 - When to do Genetic Testing in Febrile Patients https://youtu.be/VDw_bpmxmHA QD Clinic is sponsored by RheumNow.Live
Dr Jack Cush reviews the news and journal reports from the past 2 weeks on RheumNow.com
QD127 - Chronic Monarthritis QD126 - Fever by the Numbers QD125 - "What Were You Thinking" QD124 - No Win Consults QD123 - When RA Meets UC QD Clinic is sponsored by RheumNow.Live
QD118 - Arthritis and Crohn's QD119 - Rhabdo or Not QD120 - Dadgummit, Where's Waldos COVID Vaccine? QD121 - "I Don't Know" QD122 - A Tale of Two Gouts QD Clinic is sponsored by RheumNow.Live
Dr Jack Cush reviews this past weeks journal articles and news features on RheumNow.com
QD115 - Myalgias & Arthralgias QD Clinic - Lessons from the clinic Differential Dx of Myalgias and Arthralgias Features Dr. Jack Cush QD116 - Smoking and RA QD Clinic - Lessons from the clinic The Dastardly, nastardly facts of smoking and RA Features Dr. Jack Cush QD117 - Oivay the Elevated ESR QD Clinic - Lessons from the clinic ESR 75, CRP 4 mg/dl - What to do? Features Dr. Jack Cush
QD110 - Clinic Emergencies QD111 - Stopping Meds QD112 - 3 Issues After COVID Vaccination QD113 - My New Clinic COVID Routine QD114 - Raynaud's or Not
Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more...
Dr Jack Cush reviews the news, journal articles and favorite blogs from this past week on RheumNow.com
ACR 2020 Fireside Chats - featuring Drs. Bella Mehta and Olga Petryna. Abstract discussions on Still's disease
ACR 2020 Fireside Chats - featuring Drs. Laura Coates and Alexis Ogdie. Abstract discussions on nr-axSpA, AS and axial PsA
Dr. Cush interviews Dr. Kevin Winthrop (OHSU) on the use and caveats to COVID-19 vaccination in patients with rheumatic disease and taking biologic and DMARD therapies
Dr. Jack Cush takes questions from RheumNow listeners PIANO Study - Safety of Biologics in Pregnancy https://rheumnow.com/news/piano-study-safety-biologics-pregnancy Premature osteoporosis and high tryptase Mega-methotrexate doses SLE criteria and SLEDAI substitutions
Dr. Jack Cush Reviews a few more ACR 2020 abstracts and presents a new plan to learn or take in ACR20 content
Drs. Artie Kavanaugh, Jack Cush, Eric Ruderman and Alexis Ogdie-Beatty discuss novel issues and new drug studies from ACR 2020.
Cardiovascular Safety for Feboxustat with Dr. Nicola Dalbeth Lifestyle and Risk of RA, Lupus: Dr. Janet Pope A Review of RA Studies at ACR: Dr. Janet Pope Exclusive interview with Dr. David Karp, 84th ACR president with Dr. Kathryn Dao
Dr. Tom Appleton and Dr. Peter Nash Highlight OA and PsA Studies Pregnancy Outcomes in Lupus and SpA: Dr. Kathryn Dao Adverse Events in Low-Dose Methotexate: Dr. Eric Dein The axSpa diagnosis, imaging and treatments: Dr. Lianne Gensler How FAST can you go? with Dr. Michael Pillinger Cardiovascular Risk on MTX in Rheumatoid Arthritis: Dr. Jonathan Kay COVID Concerns with Dr. Kevin Winthrop
Mid-Meeting Recap: Psoriatic Arthritis Mid-Meeting Recap: Gout Patient Outcomes on Low-Dose Steroids: Dr. Eric Dein Giant Cell Arteritis Panel Vaccination with Shingrix: Does it work for patients on JAKi? Is it safe?
Dr. Ken Saag -- RECIPE Study: MMF with Pegloticase Addressing Fatigue in Rheumatoid Arthritis: Dr Eric Dein Red Flags and Detours -- New RA Guidelines: Dr. Jack Cush FDA Updates Session: Dr. Kathryn Dao Mid Meeting Recap: Spondyloarthritis Mid-Meeting Recap: Rheumatoid Arthritis
Belimumab in Lupus Nephritis: Dr. Janet Pope Enthesitis in PsA: Dr. Robert Chao Equity and Inclusion in Rheumatology Education: Dr. Irene Blanco Osteoarthritis Studies: Dr. Janet Pope Outcomes of COVID in Rheumatic Disease Patients: Dr. Eric Dein Flu and Tofacitinib: Dr. Kathryn Dao
Pregnancy and ILD: Dr. David Liew Hepatitis B, RA and Drug Risk with Drs. Stanley Cohen and Jack Cush Antimalarials and Retinopathy: Dr. Janet Pope Febuxostat bad for the heart? Not so FAST: Dr. Jeffrey Curtis Pregnancy Outcomes in AxSpa: Dr. Robert Chao Who has more comorbidities? Dr. Janet Pope What's New in Calcium Pyrophosphate Disease? with Dr. Michael Pillinger
Missing the Mark: Axial Spondyloarthritis Treat to Target with Dr. Lianne Gensler Singin the Tight Control Tune: Same Song, Third Verse, Same as the First? TICOSPA. Dr. Jeff Curtis 081 Dr Bella Mehta Abstract 1633 Zoster Vaccine in Rheumatic Disease: Dr. David Liew Hesitancy around Steroids and Vaccines: Dr. Kevin Winthrop Roundtable on Gout: What's Hot at ACR 2020 with Gout Faculty
Dr Michelle Petri: Best Practices for APL Testing HOLD FOR MON AM Is COVID19 infection bad for rheumatic disease patients? Dr. Jeff Curtis 071 Dr Janet Pope Abstract 1462 Pregnancy in SpA Patients: Dr Rachel Tate Abstract 067 Dr Alexa S Meara Interview Dr Kaitlin Quinn Abstract 0428 0514 1922 A New Pathway (Deucravacitinib) in Psoriatic Arthritis with Dr. Eric Ruderman (MON)
Citrulline Reactive B Cells Present in Lungs of Risk, Early RA: Richard Conway IVIg in Dermatomyositis: Dr. Sheila Reyes 053 Dr Antoni Chan Abstract 369 and 886 050 David Liew Abstract 0429 COVID 19 and antiphospholipid Ab Measuring Disease Activity in Psoriatic Arthritis with Dr. Eric Ruderman (SUN) 075 Rachel Tate Dr Cassie Calabrese Mary Hinojos Mamut How Covid 19 has changed our work and workfl Pipeline Therapies: For Urate Lowering, Abstract 675 with Dr. Michael Pillinger Blood Brain Barrier Leakage in SLE: Dr. Janet Pope The Lungs: The Alpha and Omega of RA with Dr. Jonathan Kay
COVID 19 and Rheumatic Disease: Dr. Jeffrey Sparks Pregnancy in Spondyloarthritis: Dr Richard Conway interviews Dr. Sinead Maguire Check on Pneumococcal Vaccination: Dr. Janet Pope Outpatient Billing and Coding Pearls: Dr Rachel Tate Potpourri of Pathotypes of Predictors with Dr. Jonathan Kay and colleagues RA Risk Factors and Early RA: Dr. Jeffrey Sparks and Dr. Janet Pope
Can PT-CDAI in Telemedicine be Used for Care in RA? Dr. Eric Dein Long-Term Prognosis in Children with Kawasaki Disease: Dr. David Liew PROs in Psoriatic Arthritis: Dr. Antoni Chan Pegloticase in Severe Refractory Gout: Dr. Olga Petryna Risk of Skin Cancer with Methotrexate: Dr. Janet Pope Risk of HCQ Retinopathy: Dr. Kathryn Dao
Male Osteoporosis: Dr. Kathryn Dao Infection in rheumatic diseases: Dr. Mrinalini Dey interviews Dr. James Galloway Nomenclature, Uveitis and Other Spondyloarthritis Features with Dr. Lianne Gensler Improving Response to Pegloticase: Dr. Nicola Dalbeth SKIPPAIN Trial: Dr. Sheila Reyes Rheumatoid Arthritis and ILD: Dr. Janet Pope interviews Dr. Jeffrey Sparks
Staying on Therapy in RA: Dr. Janet Pope What is the SEAMless transition from combination Etanercept to Methotrexate? Dr. Jonathan Kay RWCS 2021, Maui. Mark Your Calendar! with Dr. Arthur Kavanaugh Treatment of Dermatomyositis Studies: Dr Robert Chao Combo Therapy v Monotherapy (SEAM-RA Trial): Dr. Richard Conway Treat to Target in Spondyloarthritis: Dr. Rachel Tate XRay Bone Erosions in CCP+ Patients: Dr Eric Dein Impact of Exercise on Sleep: Dr. Kathryn Dao Warfarin and End-Stage Osteoarthritis: Dr. David Liew
Increase Active Learning in Rheumatology Training: Dr. Robert Chao interviews Dr. Stefanie Wade Psoriatic Disease: Dr. Lianne Gensler What to do with Subclinical Synovitis? Dr. Jack Cush HCQ and QTc Prolongation: Dr David Liew PsA Studies: Entheses, Ultrasound, Swollen not Tender Joints: Dr. Antoni Chan SEAM-RA Trial: Dr. Jeff Curtis Improving Drug Adherence in RA: Dr Janet Pope Representation of Women Authors in Rheumatology: Dr Bella Mehta
Advanced Imaging for Crystal Arthritis: Which Test is Best? Dr. Nicola Dalbeth Dr. Janet Pope interviews A&R Editor Dr. Daniel Solomon Treat to Target for PsA Patients Abstracts: Dr. Rachel Tate Methotrexate Induced Liver Fibrosis: Dr. Sheila Reyes Dr. Mrinalini Dey Interviews Dr. Marwan Bukhari Healthcare Disparities: Dr. Eric Dein Outcomes for Rheumatic Disease Patients with COVID-19: Dr Kathryn Dao C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis: Dr. Arthur Kavanaugh Safety Data in JAKs: Dr. Kevin Winthrop
HCQ Not Associated with QTc Length in SLE and RA Patients: Dr. Janet Pope Reactive Arthritis - Chronic v. Acute: Dr. Janet Pope 023 Dr Mrinalini Dey Abstract 0006 Two Psoriatic Arthritis Studies: Dr Robert Chao Methotrexate and Nonalcoholic Fatty Liver Disease: Dr Eric Dein Racial Disparities - Stroke, Heart Attacks Risks Higher in SLE: Dr. Kathryn Dao Importance of Central Imaging Reads in SpA: Dr. Eric Ruderman Does Hydroxychloroquine Hurt the Heart? Dr. Jonathan Kay
Crystal Arthritis and Gout Highlights at ACR: Dr. Nicola Dalbeth Dr. Vibeke Strand previews ACR 2020 highlights, including The Great Debate Rheumatology Training and Education: Dr. Janet Pope Interviews Trainees Abatacept in RA and ILD Patients: Dr Richard Conway COVID, Artificial Intelligence and Metabolomics at ACR 2020: Dr. Arthur Kavanaugh Dr. Neal Birnbaum Previews ACR 2020 and Predicts the Future Spondyloarthritis at ACR 2020: Dr. Lianne Gensler
Non-radiographic axSpa ACR Abstracts: Dr. Rachel Tate Axial Involvement in Psoriatic Arthritis: Perspective by Dr. Eric Ruderman Pearls from the Virtual ACR20 Playbook: Dr. Meral El Ramahi Pearls for Navigating ACR 2020: Drs. Meral El Ramahi and Kevin Byram Pearls for Navigating ACR 2020 with Drs. Meral El Ramahi and David Leverenz Inadequate Response in Spondylitis: Dr. Olga Petryna RheumNow Preview by Dr. Jack Cush Antimalarials in Pre COVID-19 Era: Dr. Janet Pope The RECIPE Study -- MMF in Refractory Gout: Dr. Jack Cush
Differential Dx of Arthritis in HIV+ individuals Possibilities with hyperuricemia in Psoriatic Arthritis MDA5 myositis reviewed Difficult RA with Serious Infections and Limited options
QD101 - Episodic Arthritis QD102 - Undulating Fever QD103 Biologics and Pregnancy QD104 - You Are So Not Disabled QD105 - Dealing with Surgeons
Dr Jack Cush overviews the RheumNow committment, upcoming bonus coverage of ACR2020 and the good news and journal reports from the past week on RheumNow.com
RheumNow.com is a digital platform dedicated to rheumatology. Written by rheums for rheums we provide daily news, insights & perspectives on the field. If you scan our daily news (email), 15 seconds and you’ll know whats up in rheumatology. We only provide the stuff we deem to be important and encourage you to create and join the conversation by signing in and commenting, vote on our surveys, follow us on social media or enjoying our videos and podcasts. Please let me know when you have a suggestion, gripe, new idea or novel case – by using our “back talk” – find the tab on our email and website
QD Clinic - Lessons from the clinic Stopping DMARDs & Biologics for Surgery Features Dr. Jack Cush
QD Clinic - Lessons from the clinic Grappling with Disability Letter Requests Features Dr. Jack Cush
QD Clinic - Lessons from the clinic Pregnant? What to do about drugs and biologics! Features Dr. Jack Cush
QD Clinic - Lessons from the clinic Palindromic Rheumatism - Differential Dx and Rx Features Dr. Jack Cush
QD 98 Clinic - Lessons from the clinic Triage - what constitutes urgent, emergent and Patients you should see Features Dr. Jack Cush QD 99 Clinic - Lessons from the clinic An IgG4 Case and the Power of Discussion Features Dr. Jack Cush QD 100
Dr Jack Cush reviews the news, journal reports, survey results and "Back Talk" questions from Rheums
QD Clinic - Lessons from the clinic Triage - what constitutes urgent, emergent and Patients you should see Features Dr. Jack Cush
Dr Jack Cush sings the news and journal reports from the past week on RheumNow.com Discussions on H2H trial of UPA vs ABA in RA, DMARDs in localized scleroderma, VTE risk augmented by disease activity and more...
QD93 - Which IL-1 Inhibitor? QD94 - When it's Not RA QD95 - The Trigger Finger QD96 - Dx & Rx of Peripheral Spondyloarthritis QD97 - Gout Goes Chronic
QD Clinic - Lessons from the clinic How B/L Oligo synovitis can be SpA and how to treat it. Features Dr. Jack Cush
QD Clinic - Lessons from the clinic How I treat trigger finger with an ice cube Features Dr. Jack Cush
QD Clinic - Lessons from the clinic What to do when its no longer RA or is "burnt-out" RA Features Dr. Jack Cush
QD Clinic - Lessons from the clinic Considerations for which IL-1 inhibitor to use with RA, Stills or autoinflammatory disease Features Dr. Jack Cush
QD Clinic - Lessons from the clinic Delays in the diagnosis of Ankylosing spondylitis rest with wrong choices Features Dr. Jack Cush
Dr Jack Cush reviews the news and journal articles from the past week on RheumNow.com Regulatory approvals, update on global rheumatology alliance, smoking and psoriasis, gabapentin let down and defining difficult RA
Dr Jack Cush reviews the news and Journal articles from this past week on RheumNow.com Inf on PsA, CV Risk, Chemokines, relapsing polychondritis, Higher COVID rates in young adults, higher reimbursements for Rheumatologists
Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Good news on immunosuppressives, colchicine and baricitinib in COVID-19 patients. More on ILD with myositis, Lupus and Diet, Drug induced lupus and brand new biologics for SLE.
Dr Jack Cush reviews the 2020 ACR Reproductive Health Guidelines
This past week we presented an overview to the new 2020 ACR
ACR 2020 Reproductive Guidelines - Contraception & Counseling ACR 2020 Reproductive Guidelines - Medication Use with Pregnancy ACR 2020 Reproductive Guidelines - Lactation Guidance
Dr Jack Cush reviews the news, journal articles and takes a few Back Talk questions this week:
Dr. Jack Cush delivers a 30 min lecture on "Rheumatoid arthritis - Guidelines and Paradigms" Lecture to the Rheumatology Nurse Society Meeting on Aug 6, 2020 RNS2020
Dr Jack Cush reviews the news and journal reports from the past week on RheumNow. This week highlights filgotinib rejection, delays in Diagnosis, metformin benefits COVID, Abx and IBD, and UPA beats MTX.
Dr. Jack Cush highlights the latest numbers on COVID-19 and its impact on Rheumatic Patients. Also, Top 4 best sellers, new take on NR-Ax-SpA & enthesitis
Dr. Jack Cush reviews why we all love our rheumatology fellows and our best advice for them stemming from these articles"
Dr Jack Cush reviews the news, tweets and journal articles from the past week on RheumNow
Drs. Artie Kavanaugh and Jack Cush present highlights from the virtual EULAR2020 meeting June 3-6, 2020
Drs. Len Calabrese, David Liew, Sarah Mackie and Jack Cush discuss vasculitis highlights focused on GCA and PMR at EULAR2020 Virtual Conference
Drs. Kathryn Dao, Rachel Tate and Jack Cush discuss virtual meetings, EULAR2020, pluses, minuses and future proposals.
Dr. Olga Petryna from EULAR2020 Virtual Conference OP0079 - what MRI findings are mos OP0314 - Drug free remission in AxSpA
Dr. Olga Petryna from EULAR2020 Virtual Conference OP0149 Tocilizumab Treats Visual Loss in GCA OP0143 GCA in Israel and risk of Cancer
Dr. Rachel Tate from EULAR2020 Virtual Conference 0632 - ETN Biosimilar in Reactive Arthritis 0650 - Treasure Study in infliximab biosimilar in SpA
Dr. David Liew from EULAR2020 Virtual Conference RA beyond the joints - Tenosynovitis as a predictor, MRI and muscle changes in RA
Dr. David Liew from EULAR2020 Virtual Conference Early Patient Referrals Preclinical RA patients
Drs. Olga Petryna, Petros Efthimiou, Apostolos Kontzias and Jack Cush discuss autoinflammatory highlights from the Virtual EULAR 2020 meeting June 3-6
Dr. Kathryn Dao highlights SLE presentations from virtual EULAR 2020 meeting June 3-6, 2020 - HCQ levels predicts VTE - Can you withdraw MMF in stable SLE patients? -Updated EULAR Lupus Treatment guidelines
Dr. Olga Petryna reviews highlights from the virtual EULAR 2020 meeting June 3-6, 2020 OP0159
Tuesday Nite Rheumatology features Dr Jonathan Kay (U Mass) - he gives an update on Biosimilars and took questions the subject. The program was moderated by Dr. Jack Cush.
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
This is an updated virtual joint exam from Dr. Jack Cush at RheumNow.com Scripted elements - Inspection, ROM, contralateral comparison - Single Hand MCP frontal view, nail inspection - MCP squeeze, PIP/finger squeeze - Praying hands for prayer sign - Finger flextion - Fist bump to camera, Fist/wrist flexion - extend arms/elbows towards camera - Hands on ears, elbows out (abduction, ext rotation), Bring elbows together (adduction, Int rotation) - TMJ palpate and open mouth - Neck Flex, extend, Lateral bending R and L - Rise and walk away from Camera - Focus on patients primary problematic joint
Dr. Philip Robinson presents latest data on the Rheum-Covid.org Registry established by the Global Rheumatology Alliance. Dr. Peter Nash presents the impact of COVID in Australia and pragmatic COVID management.
Dr. Joan Merrill (OMRF) discusses lupus, thrombotic microangiopathy, complementopathies, catastrophic lupus syndrome and vascular pathology in COVID-19 infection
An Interview with Dr. Herb Baraf and Dr. Dan Ricciardi on the state of private practice rheumatology, technology, Telehealth, Return to normal, the future and more....
Dr Jack Cush reviews the news and journal articles from the past week. Many interesting early reports on the use of rheumatic drugs, including hydroxychlorquine, IL-6 inhibitors, canakinumab, baricitinib and colchicine. Below are some of the links or citations of interest.
Dr. Artie Kavnaugh from UCSD runs journal club and discusses Journal Article: Mathian A, et al. Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomized clinical trial. Annals of Rheumatic Disease 2020; Mar;79(3):339-34 https://bit.ly/2S3VOBc
Dr Jack Cush reviews the news, journal reports, twitter feed and COVID developments from the past week on RheumNow.com
Dr. Alvin Wells gives a primer on Telerheumatology and Telemedicine in the era of COVID-19. 30 minute lecture is followed by stimulating 30 minutes of QA
Dr Jack Cush reviews the news, journal articles and new ACR COVID-19 guidelines from the past week on RheumNow.com
Dr. Jack Cush reviews the appproach to evaluating fever in adults suspected of having a rheumatic disease, Stills disease or autoinflammatory conditions. Presentation, disease criteria and genetic testing are discussed. For more information on this subject go to StillsNow.com
Dr. Jack Cush reviews the appproach to evaluating fever in adults suspected of having a rheumatic disease, Stills disease or autoinflammatory conditions. Presentation, disease criteria and genetic testing are discussed. For more information on this subject go to StillsNow.com
Dr. Jack Cush reviews the safety of biologic agents and newer therapies for rheumatoid arthritis and inflammatory arthritis
Part III - Audience Questions 54:14 How comfortable are you with telephone or televideo visits with your patients? 57:24 A Covid (+) patient was treated at home, how long after the infection till you resume the biologic? 1:00:00 PsA Case, post TKR, off adalimumab, now flaring skin and joints and has low grade fever, cough and aches; is it safe to restart the TNF inhibitor in the COVID-19 era or what would you do? 1:03:58 Is hydroxychloroquine protective; Should we screen before IV infusions? 1:04:29 What dose of prednisone is immunosuppressive? 1:05:50 Is it Hydroxychloroquine may not be helpful in HIV and chikungunya? 1:07:03 What are your policies on seeing new patient consults in clinic? 1:09:10 What will happen to ongoing clinical trials in rheumatology? 1:11:41 Are you having a hard time getting HCQ for your patients? 1:12:04 Should we look at COVID-19 viral loads? 1:13:12 Who wears masks in your clinic – doctors; staff; patients? 1:16:22 During the PPE shortage, can masks be reused? 1:18:33 How good/valid are patient self-joint exams? 1:20:30 How are you handling patient requests for letters to be excused from work? 1:23:45 Adjorn; Look for Tuesday Night Rheumatology – Grand Rounds starting 4/7/20 8PM EST (5PM PST) John J. Cush, MD Executive Editor RheumNow.com Follow me on twitter @RheumNow
Part II – Audience Questions 33:32 What about the timing of hydroxychloroquine use and for how long? 34:50 Should patients on bDMARDs or tsDMARDs (because of presumed risk) not go to work and should we write letters for such people? 37:05 Bush Administration disaster preparedness guidelines and supporting patients 39:06 What infusions should we not do? Denosumab? Zolendronic acid? 41:09 What to do about tocilizumab infusions being COVID diverted? What are the alternatives? 44:09 Should you start your lupus or RA patient on hydroxychloroquine or a new biologic in this era? 46:58 A patient has a resolved COVID-19 infection, would you start a biologic if needed? 47:21 Is anyone worried about the cardiotoxicity of hydroxychloroquine or chloroquine? 48:42 Would you the doctor, self-medicate, or prophylax, with HCQ if you have new onset suspicious symptoms? 50:04 Should rheumatologists do inpatient consults during the COVID? 51:30 If tests were universally available, would you test all your rheumatology patients for COVID-19?
Part I Panel Questions 0:00 Introduction 1:22 How has the COVID-19 pandemic affected you? 4:09 What’s the most common question you’re getting and what is your response? 8:06 What adjustments have you made in your practice or how has your practice changed? 13:13 Things we are not doing anymore… 13:40 Questions amongst panelists 13:33 A Kavanaugh (to K Winthrop) What’s the evidence favoring the evidence hydroxychloroquine (French Study) 16:40 J Cush (to C Calabrese) Is azithromycin an effective COVID therapy? 17:45 C Calabrese (to K Winthrop) What about “Universal Masking”? 20:24 A Matsumoto (to ID docs CC, KW) When can patients (or healthcare workers) resume infliximab infusions after being symptomatic? 24:23 A Wells (to AK) what to do with trainees during this “shutdown”? 25:55 A Wells (to CC) What about the new 15 min test vs the ‘real time' (PCR) test? 26:22 J Cush on the Global Rheumatology Alliance - rheum-covid.org 27:25 Are Rheumatic patients “at-risk” for COVID-19 infection or worse outcomes?
Q&A with the Experts: Drs. Cassie Calabrese, Jack Cush, Artie Kavanaugh, Alan Matsumoto, Alvin Wells & Kevin Winthrop
Dr. Jack Cush reviews the news on COVID-19 and FDA actions this past week. Be sure to check out: - COVID-19 Town Hall for Rheumatologists - ID Specialist Dr. Jade Le answers questions about COVID issues https://t.co/o79FJ8QhDY - RheumNow interviews Dr @philipcrobinson about the COVID-Global Rheumatology Alliance Registry https://t.co/pOlm58QkZD
Dr. Jade Le is an infectious disease specialist in Dallas, TX She addresses PPE, masks, Package delivery, Managing suspicious Sxs, Testing and consulting ID
- Telemedicine
- Remote Care - Connecting and Coding
- Telemedicine in Academia and Private Practice - features Dr. Daniel Albert too!
Dr. Kevin Winthrop Answers COVID questions and advocates for "hit the pause button, lay low & Exercise". We discuss, baricitinib, losartan, COVID testing, Next Success and who to listen to.
Drs. Cush and Kavanaugh Discuss the downside of stopping Plaquenil, DMARDs and biologics in lupus, RA and pregnancy
Dr Jack Cush answers the following questions: Q: Do I stop my disease-modifying anti-rheumatic drugs? A: NO! This and my other tips for managing arthritis medicines: link Q: Do I stop my biologics? A: NO! See this and other tips I've put together for patients on managing arthritis medicines: link Q: What should I do about refills, and should I be worried about shortages? A: Watch the video to see what I'm telling my patients: link Q: Am I immunosuppressed?
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com YouTube Link: https://youtu.be/J-A3V1pILWA
QD Clinic - Lessons from the clinic The Rheumatologists Role in Comorbidity Management Features Dr. Jack Cush YouTUbe link: https://youtu.be/1R6J_-WM49Q
QD Clinic - Lessons from the clinic Tips on using Leflunomide Features Dr. Jack Cush YouTube link: https://youtu.be/XF2XKuWkg1Q
QD Clinic - Lessons from the clinic Tips on using Leflunomide Features Dr. Jack Cush YouTube Link: https://youtu.be/mLEFPYVl3vk
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com YouTube Link: https://youtu.be/Z95ZlSB-Dag
QD Clinic - Lessons from the clinic Review of the HOPE study - Prednisolone in Hand OA Features Dr. Jack Cush YouTube: https://youtu.be/rM3Ta3ARURY
QD Clinic - Lessons from the clinic What DMARD do you Choose when Many have Failed? Features Dr. Jack Cush YouTube link: https://youtu.be/nyPaPQXyjSM
QD Clinic - Lessons from the clinic Do you Comanage Psoriatic Disease with a Dermatologist? Features Dr. Jack Cush YouTube link: https://youtu.be/DRKQ-mJpnm0
QD Clinic - Lessons from the clinic What to do when blinded by noncomplianc! Features Dr. Jack Cush YouTUbe link: https://youtu.be/AJKaQKe1So8
QD 78- My Acute Gout https://youtu.be/3T3s-ohSK1I QD 80 - Latent TB https://youtu.be/Og5E8l8IYKw QD 79 - RheumNow Live 2020 Preview https://youtu.be/TxfH_3-zCY4
QD Clinic - Lessons from the clinic Dx and Treating LTBI with a TNFI inhibitor Features Dr. Jack Cush YouTube link: https://youtu.be/Og5E8l8IYKw
QD Clinic - Lessons from the clinic Managing Acute Gout - Without Colchicine! Features Dr. Jack Cush YouTube link: https://youtu.be/3T3s-ohSK1I
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com YouTube Link: https://youtu.be/9soH1KbtosM
QD Clinic - Lessons from the clinic "Let's Abolish Seronegative Spondyloarthritis" Features Dr. Jack Cush YouTube link: https://youtu.be/3CjXqgALq54
QD Clinic - Lessons from the clinic Weighing Decisions on Drug D/C, Weaning, Add-ons, etc Features Dr. Jack Cush YouTube link: https://youtu.be/aj3_t2yxbbU
QD Clinic - Lessons from the clinic The Seronegative Patient with CPPD
YouTube link: https://youtu.be/TojVJJiL_vo
QD 70 Clinic - Lessons from the clinic The Reluctant Rheumatologist and Pegloticase When do you consider using pegloticase? QD 71 Clinic - Lessons from the Clinic Musings on Seronegative RA QD 72 Clinic - Lessons from the clinic Same Day Hip Replacement, PT and Discharge Features Dr. Jack Cush
QD Clinic - Lessons from the clinic Same Day Hip Replacement, PT and Discharge Features Dr. Jack Cush
QD Clinic - Lessons from the clinic The Reluctant Rheumatologist and Pegloticase When do you consider using pegloticase?
QD Clinic - Lessons from the literature Part 5 2020 EULAR Recommendations for the Management of Rheumatoid Arthritis When to Withdraw
YouTube Link: https://youtu.be/BBBJMFVqgBs
QD Clinic - Lessons from the literature Part 4 2020 EULAR Recommendations for the Management of Rheumatoid Arthritis Adding Biologics or JAK inhibitors Features Dr Jack Cush
YouTube Link: https://youtu.be/5-1Ah8uyhf0
QD Clinic - Lessons from the literature Part 3 2020 EULAR Recommendations for the Management of Rheumatoid Arthritis MTX, GC & T2T Features Dr Jack Cush
https://youtu.be/TzZxMKw92Ds
QD Clinic - Lessons from the literature Part 2 review of the 2020 EULAR Recommendations for the Management of Rheumatoid Arthritis What to Start with Features Dr Jack Cush YouTube link: https://youtu.be/lB7Ir_xpk5E
QD Clinic - Lessons from the clinic and literature Part 1 of a review of the 2020 EULAR Recommendations for the Management of Rheumatoid Arthritis Features Dr Jack Cush
Featuring Dr. Jack Cush (RheumNow.com) QD 61 - When to Use Anakinra - https://www.youtube.com/watch?v=HXL2Pu1fKaY&t=6s QD 62 - The Problem with Pain - https://www.youtube.com/watch?v=yptkTq3YUe0&t=14s QD 63 - Inflammatory Hips - https://www.youtube.com/watch?v=Mks-rM7n1Gs&t=9s QD 64- Vasculitis Monitoring - https://www.youtube.com/watch?v=HXL2Pu1fKaY&t=6s
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
https://www.youtube.com/watch?v=LVuoixmLsLo
Featuring Dr. Jack Cush (RheumNow.com) QD 56 - Dealing with Nonaderence https://youtu.be/GyS6H4r0RjI QD 57 - "I Don't Know Why I'm Here" Consult https://youtu.be/Blmf-hKRSMw QD 58 - HBV & Biologics https://youtu.be/m3CsCgsZCbo QD 59 - Doc, When Can I Stop https://youtu.be/NHqM6Di-r-E QD 60 - Bugs vs Crystals https://youtu.be/Bol11nYdUcQ
QD51 - Medication Reminders, QD52 - Pushing to LDAS or Remission, QD53 - Smoking & RA, QD54 - Give them an inch, QD55 - Whos the Boss
QD41 - Biologic Class Switching, QD42 - Shingles Happens, QD43 - Secondary Loss of Efficacy, QD44 - RA and Gout, QD45 - Power of Patient Choice
Dysgeusia; A Torn Meniscus; Rheumatoid Cachexia; Less is Not Safer; and New Changes to Gout Guidelines
How to Optimize MTX, When to Stop Anakinra, The NP Says the Patient is Flaring Off Meds, Rules for Pregnancy, Change DMARD or Not
QD21 - Arthritis Drugs & Major Surgery, QD22 - Under Treated RA, QD23 - Zero to Sixty in PsA, QD24 - Aches and Pains, QD25 - Who Chooses_ Patient or MD_
QD16 - RA & Recurrent UTI, QD17 - The Tophi Guy, QD18 - EOA vs PsA, QD19 - How many daysof Fever_, QD20 - Normal ESR PMR
Bug-bite Arthralgias I wanna get pregnant The No Show Hemoptysis with Lupus A Different Kind of Visit
This podcast is a collection of the past weeks QD (daily) clinic/video lessons from the rheumatology clinic and Dr. Jack Cush Psoriatic arthritis and an elevated creatinine Enthesopathy-related arthritis Non-Traumatic Hemarthrosis The Nucleolar ANA
This podcast is a collection of the past weeks QD (daily) video lessons from the rheumatology clinic and Dr. Jack Cush Aches, Pains & Statins Seronegative inflammatory arthritis? HLA-B27 What? Evaluation of Takayasu Arteritis RA Plus 1 Joint RA and Thrombocytopenia
RheumNow Week In Review Father Knows Best %28Paternal Drugs OK%29 %288.31.18%29 by Dr. Cush
RhThe RheumNow Week In Review Fateful Outcomes In Rheumatology %287.13.18%29 by Dr. Cush
The RheumNow Week In Review Good News For GPA%2C CZP%2C Tofa But Not ERA %286.1.18%29 by Dr. Cush
The RheumNow Week In Review - Nonadherence And Astronomic Costs %285.11.18%29 by Dr. Cush
The RheumNow Week In Review Why Comorbidity Is A Lot Like The Weather %285.3.18%29 by Dr. Cush